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Pete is 56 years old and has human immunodeficiency virus (HIV) for about six years. He is on 
medication, which is effective. However, Pete often feels tired and sad. He has told some friends that 
he has HIV, but they did not always respond the way he expected. He has lost some friends because of 
these issues, and now he is thinking of not disclosing to others that he has HIV anymore. In addition, 
Pete lost his job a couple of weeks ago. He was a cook at an Italian restaurant, but he was replaced by 
a younger cook. He misses the work he loved to do and he feels like he has failed. Pete is bothered by 
negative thoughts a lot and sometimes he forgets to take his HIV medication. He does not know what 
to do with his feelings of sadness and is thinking of discussing it with his nursing consultant in the 
hospital. 
 
The case of Pete does not stand alone. Many people living with HIV (PLWH) suffer from sadness or 
depressive symptoms (1-3). Psychological interventions, such as cognitive behavioral therapy, were 
found to be effective in treating these depressive symptoms in PLWH (4-9). However, the traditional 
face-to-face interventions do not reach all PLWH with depressive symptoms, and experienced stigma 
is a barrier to seek treatment for some PLWH. Therefore, new interventions are needed that overcome 
these barriers, such as online interventions (eHealth). The aim of this dissertation is to evaluate the 
effectiveness of the eHealth intervention ‘Living positive with HIV’, for PLWH with depressive 
symptoms. 
 This general introduction begins with an explanation of HIV and AIDS and medical treatments 
for it. This is followed by a paragraph about the prevalence, risk factors, and consequences of 
depressive symptoms in PLWH. Thereafter, psychological interventions for depressive symptoms in 
PLWH are discussed. Furthermore, a description of self-help and eHealth interventions for PLWH with 
depressive symptoms follows. The introduction ends with the aims and outline of the dissertation. 
 
HIV and AIDS 
HIV is a virus that attacks the immune system of the human body (10). It reduces the number of cluster 
of differentiation 4 (CD4) cells, which keep the body protected against bacteria and viruses. As a result, 
the body becomes more vulnerable for infections. When the virus damages the immune system so 
much that the body cannot be adequately protected anymore, one may get opportunistic infections 
or cancers. This indicates that the person has progressed to the last stage of HIV infection: acquired 
immunodeficiency syndrome (AIDS) (10). If AIDS is not treated effectively, it is a fatal disease. 
 In the early acute phase of the HIV infection, flu-like symptoms may be experienced, such as 
fever, fatigue, and rash (11). However, some people do not experience symptoms at all. In the later 
chronic phase, many patients do not experience symptoms or only mild ones (10). Symptoms of AIDS 
include weight loss, fever with night sweats, prolonged diarrhea, shortness of breath, and fatigue. 
 
Many of these symptoms belong to opportunistic infections, such as candidiasis, herpes, pneumonia, 
and tuberculosis (12). HIV may be transmitted via sexual behaviors, sharing needles or syringes 
(common among injection drug users), and during pregnancy, birth, or breastfeeding (13). HIV is still 
very prevalent, 36.7 million people suffer from it worldwide, and in 2016 one million people died 
because of HIV/AIDS (14). It was estimated that there are 22900 PLWH living in the Netherlands at the 
end of 2016 (15). The majority of them are men who have sex with men (MSM) (16). 
More than 20 years ago, effective medication to treat HIV was developed: antiretroviral 
therapy (ART, also called HAART or cART). ART is a combination of at least two, but usually three, drug 
classes that reduce the amount of virus in the blood (17, 18). The goal of ART is to reach an 
undetectable viral load: such a low amount of HIV in the blood that it cannot be detected by standard 
tests. ART does not cure HIV, but improves the health of PLWH and slows/prevents the progression to 
AIDS. In addition, HIV transmission may be decreased when PLWH are on ART successfully (19, 20). For 
example, mother-to-child transmission decreases dramatically when ART is used (21). Because of ART, 
HIV has become a chronic disease instead of a disease that is related to sickness and death. However, 
PLWH may still suffer from physical and psychological symptoms. The symptoms that were most often 
reported among PLWH are pain, lack of energy, sleep difficulties, worrying, and feeling sad (22, 23). 
In the Netherlands, most PLWH are on ART (15), but in other countries ART is not accessible 
for everyone (24). In 2014, UNAIDS set the ambitious 90-90-90 goals: 90% of PLWH are diagnosed with 
HIV, of which 90% are on ART, of which 90% are virally suppressed (virus level in the blood is very low 
or undetectable) (25). The aim is to reach the goals globally in 2020. It was found that in 2016 only 
Denmark and Sweden reached all goals, so there is much work to be done (26). Many PLWH do not 
sufficiently adhere to ART, it has been found that only 62% took their prescribed doses more than 90% 
of the time (27). Non-adherence may have negative consequences, such as more viral replication, HIV-
related morbidity, and drug resistance (28). When many PLWH do not optimally adhere to ART, it will 
be difficult to reach the 90-90-90 goals (24). So, optimizing adherence should be a major focus of HIV 
care. During the last years, pre-exposure prophylaxis (PrEP) was developed and investigated. PrEP is 
antiretroviral medication that people without HIV but in a risk group (e.g. MSM) can take to prevent 
infection (29). PrEP was found to be effective to prevent HIV in recent studies (29-31), although 
adherence is also important here, and the efficacy among women cannot be confirmed yet (29). 
 
Depressive symptoms in people with HIV 
Depressive symptoms are quite common among PLWH, approximately one third of them suffers from 
mood disorders or clinically significant depressive symptoms (1-3). Why are depressive symptoms so 
prevalent among PLWH? This may be related to psychosocial factors, such as the stigma that is 
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adherence is also important here, and the efficacy among women cannot be confirmed yet (29). 
 
Depressive symptoms in people with HIV 
Depressive symptoms are quite common among PLWH, approximately one third of them suffers from 
mood disorders or clinically significant depressive symptoms (1-3). Why are depressive symptoms so 
prevalent among PLWH? This may be related to psychosocial factors, such as the stigma that is 
associated with having HIV (32), taking ART each day for the rest of one’s life (33), difficulties with 
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coping with HIV (34), and concerns about disclosing the illness to others (35). In addition, 
neurobiological changes caused by the presence of HIV in the central nervous system may play a role 
in developing depressive symptoms (36, 37). Furthermore, depressive symptoms may already be 
present before HIV infection. Certain risk groups for HIV infection, such as homosexual men (38) and 
intravenous drug users (38, 39), have higher rates of depressive symptoms than people that do not 
belong to these risk groups. This may be another explanation for the high prevalence of depressive 
symptoms among PLWH. 
Signs and symptoms of depression are the same in PLWH as in people without HIV. However, 
the following symptoms were found to be most common in PLWH: anhedonia, insomnia, loss of 
appetite, and difficulties in memory and concentration (33). Diagnosing depression in PLWH may be 
difficult, because some symptoms of depression overlap with symptoms of HIV or side effects of ART 
(33). For instance, fatigue, insomnia, and anorexia are symptoms that can be present in both HIV and 
depression (40, 41). Therefore, depressive symptoms may not always be recognized by physicians.  
The consequences of depressive symptoms in PLWH may have a large impact as well. More 
specifically, depressive symptoms were found to be associated with non-adherence to ART (42). 
Furthermore, depressive symptoms in PLWH have an influence on quality of life. Next to an effect on 
mental health related quality of life of PLWH, depressive symptoms also have an effect on quality of 
life related to physical health, role functioning, and social functioning (43, 44). Additionally, the 
economic burden of PLWH with depressive symptoms is high. Costs for general medical services (e.g. 
inpatient and emergency services) were found to be higher for PLWH with depression than for PLWH 
without depression (45). Healthcare costs such as medication, inpatient and outpatient care, for PLWH 
with depression (or other psychiatric disease) were approximately $17,911 to $33,037 per person per 
year in the USA between 1995 and 2010 (45-47). Furthermore, the indirect costs due to being less 
productive at work because of HIV and depression are also substantial. As far as we know, there are 
no previous studies that investigated these indirect costs in PLWH with depression. Though, they were 
found to range from €1,353 per person in 2010 in Italy (48), to €19,786 per person in 2002 in 
Switzerland (49) for PLWH without depressive symptoms (48), and €1,782 on average per person for 
people with depression irrespective of HIV in Europe in 2010 (50). 
 
Psychological interventions for people with HIV and depressive symptoms 
The burden of depressive symptoms in PLWH is high on an individual and societal level. Therefore, it 
is important to treat depressive symptoms adequately. Many psychological interventions have been 
developed to reduce depressive symptoms in PLWH, such as cognitive behavioral therapy (CBT), 
interpersonal psychotherapy, and mindfulness. Of all interventions that were developed to treat 
depressive symptoms in PLWH, CBT is used most often. In CBT, unhelpful thoughts and behaviors are 
 
adapted in order to feel better (51). Exercises are used to change dysfunctional beliefs about self or 
the world into more realistic, functional beliefs. Traditionally, CBT is provided face-to-face to 
individuals, groups, couples, or families. 
Many studies have been conducted into the effectiveness of CBT. It has been found that CBT 
is effective in reducing depressive symptoms in PLWH (4-9). In addition, CBT may also improve quality 
of life (7) and ART adherence (52). Other psychological interventions, such as interpersonal 
psychotherapy (53, 54), peer support (8), or mindfulness (55) may also be effective in decreasing 
depressive symptoms in PLWH. Though, the face-to-face format of interventions has some 
disadvantages, such as the time it takes for patients and therapists, the stigma that may be perceived 
by patients, and the high costs. 
 
Self-help and eHealth for people with depressive symptoms 
As face-to-face interventions have some limitations, in the past years other treatment formats have 
been developed and investigated. Initially, self-help interventions for depressive symptoms have been 
developed. Self-help refers to a psychological intervention that a patient can work through 
independently from any place of preference (56). The intervention can be provided in booklet format 
or via other media such as audio or video. Self-help interventions can be guided (e.g. by a professional 
or peer) or unguided. Guidance often involves supporting the patient to work with the intervention 
and providing information (56). Guidance can be provided via various channels, such as telephone, e-
mail, and chat. Self-help interventions, mostly CBT, were found to be effective in reducing depressive 
symptoms (56, 57), also in people with a physical illness (58, 59). Moreover, it has been found that 
guided self-help CBT was equally effective as face-to-face CBT for depressive symptoms (60). However, 
guidance seems important in self-help; guided self-help interventions for depression were found to be 
more effective than unguided interventions (57).  
 In the past years, more and more computerized self-help interventions for depressive 
symptoms have been developed: eHealth interventions. eHealth has been defined as the use of 
emerging information and communications technology, especially the Internet, to improve or enable 
health and healthcare (61). Typically, eHealth interventions consist of multiple modules with text to 
read and assignments to complete (62). This may be accompanied by special elements, such as videos 
or audio files. Guidance may also be offered next to eHealth interventions. eHealth interventions have 
certain benefits compared to face-to-face interventions, such as a larger reach, reduced stigma due to 
following the intervention anonymously, the possibility to work on the intervention in a place and time 
of choice, and lower costs. It has been found that eHealth interventions (especially CBT) are effective 
in people with depressive symptoms (62-67) and in people with a chronic somatic disease with 
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comorbid depressive symptoms (68). Again, guidance was found to be important; previous meta-
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analyses have found larger effects (63, 66, 67) and less attrition (57, 66) in guided eHealth interventions 
compared to unguided interventions. 
 
eHealth for people with HIV and depressive symptoms 
A lot of eHealth interventions were developed and investigated for people with depressive symptoms, 
but only four eHealth interventions were developed for PLWH with depressive symptoms (69-72). One 
of these interventions was an online support group (71), which was found to be effective. However, 
this study did not include a control condition. The other interventions were based on metacognitive 
therapy and positive psychology (69), CBT to manage adherence, stress, and mood (70), and stress 
management (72). No effects of these interventions on mood were found. An explanation for not 
findings any effects may be that the interventions did not met the needs of PLWH with depressive 
symptoms (70, 72). For example, one of the interventions focused more on improving medication 
adherence than on improving depressive symptoms (70). Since eHealth interventions have certain 
advantages compared to face-to-face interventions, and were found to be effective for people with 
depressive symptoms in previous meta-analyses, more research should be conducted into eHealth 
interventions for PLWH to reduce depressive symptoms. 
Therefore, we have developed a new eHealth intervention for PLWH with depressive 
symptoms: Living positive with HIV. It is based on a self-help intervention in booklet format that was 
developed by the same research group (73). The self-help booklet was developed after studies that 
investigated correlates of well-being and depressive symptoms in PLWH, and a needs assessment (34, 
74, 75). The self-help booklet contains CBT and includes psychoeducation and exercises. It consists of 
eight lessons which can be completed in about eight weeks, in one to two hours a week. In a 
randomized controlled trial (RCT), it has been found that the self-help intervention was effective in 
decreasing depressive symptoms, compared to a waiting list control condition (76). 
After the RCT, the booklet was converted into an eHealth intervention. The intervention was 
expanded in three ways: 1) an activation component was included in the first lesson, to stimulate 
participants to perform small positive activities to improve mood; 2) minimal telephone coaching with 
motivational interviewing was added to reduce attrition and improve motivation; and 3) the 
intervention was available in Dutch and English to reach more PLWH. When the eHealth intervention 
was finalized, a focus group of four volunteers from the Dutch HIV association was invited to evaluate 
the intervention. Thereafter, the intervention was adapted and a pilot study was conducted. Twenty 
PLWH recruited via the Dutch HIV association worked through the whole intervention, received 
coaching, and provided feedback. Depressive symptoms decreased significantly after following the 
intervention and participants evaluated the intervention positively. Now the time has come to 
investigate the effectiveness of the eHealth intervention in a large scale RCT. In addition, it is important 
 
to investigate for whom the intervention is most effective and what are mediators of intervention 
effect? Lastly, the balance between costs and benefits is crucial, so the cost-utility of the intervention 
compared to attention only (control group) is investigated. 
 
Conclusions 
Depressive symptoms in PLWH are common and have a large impact on the individual and societal 
level. Psychological interventions, especially CBT, for PLWH with depressive symptoms were found to 
be effective. However, there is a need for interventions that overcome the barrier of stigma, are more 
flexible in terms of time and place to follow the intervention, reach more people, and are less 
expensive. eHealth interventions may address these needs and were found to be effective in people 
with depressive symptoms. Though, not much eHealth research is conducted in PLWH with depressive 
symptoms, while this is a group that may benefit a lot from eHealth interventions. In addition, studies 
into moderators and mediators of intervention effect in eHealth interventions are scarce, as are 
economic evaluations of eHealth interventions. 
 
Aims and outline of this dissertation 
The first aim of this dissertation is to study and provide an overview of the effectiveness of various 
psychosocial interventions for PLWH to improve mental health and ART adherence. The second aim is 
to evaluate the effectiveness of the eHealth intervention ‘Living positive with HIV’ for PLWH with 
depressive symptoms. Additionally, secondary questions regarding moderators and mediators of 
intervention effect and the cost-utility of the intervention compared to attention only, are investigated. 
The content of the chapters of the dissertation is explained below. 
 
Chapter 2 contains a systematic review and meta-analysis on the effectiveness of psychosocial 
interventions for PLWH to improve mental health. The aim is to investigate the effectiveness of various 
psychosocial interventions, such as CBT, mindfulness, and peer support. Depression, anxiety, quality 
of life, and psychological well-being are the treatment outcome measures in this study. We also assess 
characteristics that may influence the effectiveness of an intervention (e.g. treatment provider). 
 
Chapter 3 includes a systematic review and meta-analysis which aims to study the effectiveness of 
psychosocial interventions to enhance ART adherence. The effects of study characteristics and 
treatment characteristics on the effectiveness of interventions is also investigated. 
 
Chapter 4 describes the study protocol for the RCT about the effectiveness of the guided online self-




analyses have found larger effects (63, 66, 67) and less attrition (57, 66) in guided eHealth interventions 
compared to unguided interventions. 
 
eHealth for people with HIV and depressive symptoms 
A lot of eHealth interventions were developed and investigated for people with depressive symptoms, 
but only four eHealth interventions were developed for PLWH with depressive symptoms (69-72). One 
of these interventions was an online support group (71), which was found to be effective. However, 
this study did not include a control condition. The other interventions were based on metacognitive 
therapy and positive psychology (69), CBT to manage adherence, stress, and mood (70), and stress 
management (72). No effects of these interventions on mood were found. An explanation for not 
findings any effects may be that the interventions did not met the needs of PLWH with depressive 
symptoms (70, 72). For example, one of the interventions focused more on improving medication 
adherence than on improving depressive symptoms (70). Since eHealth interventions have certain 
advantages compared to face-to-face interventions, and were found to be effective for people with 
depressive symptoms in previous meta-analyses, more research should be conducted into eHealth 
interventions for PLWH to reduce depressive symptoms. 
Therefore, we have developed a new eHealth intervention for PLWH with depressive 
symptoms: Living positive with HIV. It is based on a self-help intervention in booklet format that was 
developed by the same research group (73). The self-help booklet was developed after studies that 
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intervention was available in Dutch and English to reach more PLWH. When the eHealth intervention 
was finalized, a focus group of four volunteers from the Dutch HIV association was invited to evaluate 
the intervention. Thereafter, the intervention was adapted and a pilot study was conducted. Twenty 
PLWH recruited via the Dutch HIV association worked through the whole intervention, received 
coaching, and provided feedback. Depressive symptoms decreased significantly after following the 
intervention and participants evaluated the intervention positively. Now the time has come to 
investigate the effectiveness of the eHealth intervention in a large scale RCT. In addition, it is important 
 
to investigate for whom the intervention is most effective and what are mediators of intervention 
effect? Lastly, the balance between costs and benefits is crucial, so the cost-utility of the intervention 
compared to attention only (control group) is investigated. 
 
Conclusions 
Depressive symptoms in PLWH are common and have a large impact on the individual and societal 
level. Psychological interventions, especially CBT, for PLWH with depressive symptoms were found to 
be effective. However, there is a need for interventions that overcome the barrier of stigma, are more 
flexible in terms of time and place to follow the intervention, reach more people, and are less 
expensive. eHealth interventions may address these needs and were found to be effective in people 
with depressive symptoms. Though, not much eHealth research is conducted in PLWH with depressive 
symptoms, while this is a group that may benefit a lot from eHealth interventions. In addition, studies 
into moderators and mediators of intervention effect in eHealth interventions are scarce, as are 
economic evaluations of eHealth interventions. 
 
Aims and outline of this dissertation 
The first aim of this dissertation is to study and provide an overview of the effectiveness of various 
psychosocial interventions for PLWH to improve mental health and ART adherence. The second aim is 
to evaluate the effectiveness of the eHealth intervention ‘Living positive with HIV’ for PLWH with 
depressive symptoms. Additionally, secondary questions regarding moderators and mediators of 
intervention effect and the cost-utility of the intervention compared to attention only, are investigated. 
The content of the chapters of the dissertation is explained below. 
 
Chapter 2 contains a systematic review and meta-analysis on the effectiveness of psychosocial 
interventions for PLWH to improve mental health. The aim is to investigate the effectiveness of various 
psychosocial interventions, such as CBT, mindfulness, and peer support. Depression, anxiety, quality 
of life, and psychological well-being are the treatment outcome measures in this study. We also assess 
characteristics that may influence the effectiveness of an intervention (e.g. treatment provider). 
 
Chapter 3 includes a systematic review and meta-analysis which aims to study the effectiveness of 
psychosocial interventions to enhance ART adherence. The effects of study characteristics and 
treatment characteristics on the effectiveness of interventions is also investigated. 
 
Chapter 4 describes the study protocol for the RCT about the effectiveness of the guided online self-
help intervention for PLWH with depressive symptoms. The protocol explains the research questions 
Chapter 1
14 
of the study and the methods (e.g. content of the intervention and measurements). Chapters 5 to 8 
include the results of the different research questions of the RCT. 
 
Chapter 5 reports on the results of the RCT regarding the effectiveness of the guided Internet-based 
self-help intervention for PLWH with depressive symptoms, compared to a control condition that 
receives minimal attention only. The effects of the intervention are assessed on the short term and on 
the long term. Furthermore, the effect on anxiety symptoms is investigated and the user satisfaction 
of participants with the intervention is examined. 
 
In Chapter 6 possible moderators of change of the online self-help intervention ‘Living positive with 
HIV’ are studied. For whom does guided online self-help work best? Many potential moderators are 
investigated, e.g. demographic characteristics, HIV characteristics, and psychological characteristics. 
 
In Chapter 7 possible mediators of intervention effect of the guided online self-help intervention are 
examined. These mediators may help to identify mechanisms of change of the intervention. Possible 
mediators that are investigated are related to components of the intervention, for example behavioral 
activation and relaxation. 
 
Chapter 8 describes the cost-utility of the guided online self-help intervention, compared to attention 
only. The differences between the intervention condition and the control condition regarding quality 
of life and healthcare and non-healthcare costs are outlined. An economic evaluation is conducted 
alongside the RCT and the results are reported. 
 
Chapter 9 summarizes the results of the dissertation and discusses the findings with regard to previous 
research. Strengths and limitations of the studies are discussed, just as recommendations for future 
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In this systematic review and meta-analysis we investigated the effectiveness of different psychosocial 
treatments for people living with HIV (PLWH) and mental health problems. Additionally, characteristics 
that may influence the effectiveness of a treatment (e.g., treatment duration) were studied. PubMed, 
PsycINFO and Embase were searched for randomized controlled trials on psychosocial interventions 
for PLWH. Depression, anxiety, quality of life, and psychological well-being were investigated as 
treatment outcome measures. Sixty-two studies were included in the meta-analysis. It was found that 
psychosocial interventions for PLWH had a small positive effect on mental health (ĝ = 0.19, 95% CI 
[0.13, 0.25]). Furthermore, there was evidence for publication bias. Six characteristics influenced the 
effectiveness of a treatment for depression. For example, larger effects were found for studies with 
psychologists as treatment providers. To conclude, this systematic review and meta-analysis suggests 
that psychosocial interventions have a beneficial effect for PLWH with mental health problems.  
 




En esta revisión sistemática y meta-análisis se ha investigado la efectividad de los diferentes 
tratamientos psicosociales para las personas viviendo con VIH (PVVIH) y con problemas de salud 
mental. Adicionalmente, hemos estudiado las características que pueden influir en la efectividad de 
un tratamiento (por ejemplo, duración del tratamiento). Como medidas de tratamiento, pruebas 
controladas aleatorizadas de las intevenciones psicosociales para depresión, ansiedad, calidad de vida 
y bienestar psicológico fueron buscadas en PubMed, PsycINFO y Embase. Sesenta y dos estudios se 
han incluido en el metanálisis. Hemos encontrado que intervenciones psicosociales para las PVVIH 
tuvieron un menor efecto positivo en la salud mental (ĝ = 0.19, IC del 95% [0.13, 0.25]). Además,  hubo 
evidencia de sesgo en la publicación. Seis características influyeron la efectividad del tratamiento para 
la depresión. Por ejemplo, hemos encontrado efectos mayores en estudios con psicólogos como 
proveedores del tratamiento. Concluyendo, esta revisión sistemática y meta-análisis indica que las 
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In recent decades, due to the use of antiretroviral medication, HIV has become a chronic illness instead 
of a disease that rapidly leads to severe sickness and death. However, people living with HIV (PLWH) 
may still suffer from physical symptoms, such as pain and lack of energy (1). In addition, mental health 
problems such as depression and anxiety are common among PLWH (2-4). In PLWH, the prevalence 
rate of mood disorders or clinically significant depressive symptoms is approximately 33% (5), and the 
prevalence rate of anxiety disorders about 20% (6). Several psychosocial factors – such as isolation, 
stigma, discrimination, lack of support, and drug abuse – can contribute to feelings of depression and 
anxiety (4, 7). In turn, mental health problems may have various negative consequences for PLWH. For 
example, it has been shown that PLWH with depressive symptoms have a higher risk of poor adherence 
to antiretroviral therapy (ART); they are also more at risk for HIV-related morbidity and mortality (8). 
More specifically, in PLWH psychological factors (such as depressive symptoms and stress) have been 
shown to be related to immune measures, such as decreased cluster of differentiation 4 (CD4) cell 
count and increased viral load (9, 10). In view of the above research, it seems apparent that depression 
and anxiety in PLWH may decrease well-being and quality of life (11). 
Given the impact that psychological symptoms have on the health and well-being of PLWH, it 
is very important to treat these symptoms. Several psychosocial interventions, such as cognitive 
behavioral therapy (CBT), supportive interventions, meditation, and stress management interventions, 
have been developed for PLWH with mental disorders. Various reviews and meta-analyses have found 
that these interventions are effective in reducing symptoms of depression, anxiety, and distress in 
PLWH (12-18). The format of these interventions may differ from a group-based or individualized 
format to interventions where the PLWH’s partner or other family members are also involved. In 
addition to assessing the overall effectiveness of various psychosocial interventions, it is also important 
to compare interventions with each other and determine whether specific interventions stand out as 
the most effective to improve mental health in PLWH. With this information, more targeted treatment 
may be provided in the future. The interventions that seem to be the most effective could be offered 
first, which might improve the psychological care of PLWH. However, previous meta-analyses and 
reviews (12, 13, 15-18) have not compared interventions with each other to discover which specific 
psychosocial interventions are the most effective for PLWH with mental health problems. 
Additionally, it is also meaningful to investigate whether certain characteristics may influence 
the effectiveness of the treatment. We can distinguish two types of characteristics that may act as 
moderators. The first type are characteristics of the intervention, such as treatment duration, 
intervention techniques, or the provider of the therapy. If we have more knowledge about the effect 
of treatment characteristics on the effectiveness of an intervention, this can be used to improve 
 
existing interventions by including the most beneficial aspects when designing new interventions for 
PLWH with mental health problems. If we find, for example, that interventions provided online or by 
a psychologist are more effective than interventions provided by others (e.g., peers), it may be useful 
to design new interventions that are provided online or by psychologists. The second type of possible 
moderators are characteristics of the study, such as the sample that was used or the type of control 
group. These characteristics may partly explain why some studies find larger effects than others. For 
instance, it may be that studies with many female participants show larger effects than studies with 
many males. If this is the case, it may be useful to consider this aspect in future studies. As yet, not 
much research is available about moderators of treatment effect in PLWH. However, moderating 
factors were taken into account in one meta-analysis, which found that stress-management 
interventions for PLWH reduced anxiety symptoms. In this research, the effect of the intervention was 
found to be larger when they included more women, more participants with anxiety symptoms at 
baseline, younger participants, and made less use of medication adherence information and/or 
planning in an intervention (16).  
Most previous meta-analyses have focused on particular psychological interventions (e.g., CBT 
or meditation) and mostly also on a particular outcome (such as alleviation of depression or anxiety) 
(12-18). However, no meta-analysis has yet investigated which psychosocial interventions are the most 
effective on psychological outcomes. The first aim of the present systematic review and meta-analysis 
was to investigate this. This meta-analysis included various psychosocial interventions for PLWH, 
including CBT, support interventions (e.g., peer support), interpersonal psychotherapy, stress 
management, mindfulness, coping improvement interventions, and family interventions. In addition, 
multiple outcomes were studied: depression, anxiety, quality of life, and psychological well-being. Only 
randomized controlled trials (RCTs) were included in the meta-analysis. As it is important to investigate 
moderators of intervention effect, and this was not examined in detail in previous meta-analyses, the 
second aim of the current meta-analysis was to carry out a moderator analysis. Since we included a lot 
of different intervention types and outcomes, we expected that there would be large differences 
between study effect sizes. A moderator analysis could give more information about which 
characteristics might explain these differences in results. Various possible moderators were included: 
intervention characteristics such as intervention duration, therapy provider, and intervention 
techniques (e.g., stress-management); and study characteristics such as attrition, study quality, and 
sample characteristics. To conclude: we investigated and provide an overview of the effectiveness for 
PLWH of psychosocial interventions in decreasing depression and anxiety and improving quality of life 
and psychological well-being. In addition, we investigated whether specific interventions stood out as 
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Search strategy and study selection 
Several strategies were used to search for relevant RCTs. First, we searched in the electronic databases 
PubMed, PsycINFO, and Embase on September 29, 2014. Search words included terms related to 
HIV/AIDS, various types of psychosocial interventions (e.g., CBT, psychotherapy), and outcomes (e.g., 
depression, quality of life). The search strategy with keywords can be found in Appendix A. Second, we 
also searched for papers in the references of available meta-analyses and reviews about the subject. 
Studies were included when they met all of the following criteria: 1) RCT; 2) evaluation of a 
psychosocial intervention (see definition below); 3) participants in the study are HIV positive and are 
18 years or older; 4) year of data collection is later than 1995 (see explanation below); 5) the outcome 
variables that were studied belong to one or more of the following categories: depression, anxiety, 
psychological well-being, or quality of life; 6) studies were written in the English language; and 7) data 
to calculate effect sizes was present in the paper or retrieved from the authors. Regarding the second 
inclusion criterion, a psychosocial intervention was operationalized as an intervention that aimed to 
change thoughts, emotions and/or behavior of PLWH and had a psychosocial component. Therefore, 
physical interventions (such as exercise), were not included in the meta-analysis. Regarding the fourth 
inclusion criterion, we decided to include studies that collected data later than 1995, since 
antiretroviral medication was developed in 1996 and consequently the future prospects of PLWH 
changed a lot after that period. Furthermore, the outcome domains depression, anxiety and quality of 
life were specified a priori. Only the outcome psychological well-being was first intended for stress-
related outcomes, but this was a rather small category, so we decided to enlarge it. Positive and 
negative affect, psychological functioning and general mental health were examples of concepts that 
were included in the outcome psychological well-being. Studies that had posttraumatic stress disorder 
(PTSD) as an outcome were not included in the meta-analysis. Regarding the seventh criterion, authors 
of the included papers were contacted to retrieve data that was not available in the paper. When the 
authors did not respond to the requests (even after reminder e-mails) and the data to calculate effect 
sizes was not available, the study was not included in the meta-analysis. 
The first step was the selection of studies on title and abstract, and was performed by two 
persons (first and fourth author). The first 100 studies were selected by both authors independently, 
to determine the agreement among selectors, which was substantial (19), Cohen’s kappa = 0.80. 
Thereafter, both selected half of the remaining studies. For the second step of selecting studies, based 
on full text, the studies were divided among three persons (first and fourth author and a Master 
student in clinical psychology). The inclusion criteria, as described above, were used in the following 
 
order to ensure a fast and equal decision: 6, 3, 1, 4, 2, 5, 7. When there was doubt about including a 
study, the paper was discussed with one or more of the other authors to make a decision. 
 
Problems of multiplicity 
Some decisions had to be made when multiple papers were published about the same data or when 
multiple measuring instruments, time points or interventions were used in one study. When there 
were multiple papers about the same data, the paper with the most relevant outcome data was used 
as the main paper. Other papers were used to add information that was not present in the main paper. 
In addition, when there were multiple measuring instruments for one outcome, two instruments were 
included in the analysis and their data was averaged. The instruments that were most validated and 
comparable to other studies were chosen. When there were assessments at more than one time point 
after the termination of the intervention, the first time point (first post-test) was included in the main 
analysis. Moreover, we did investigate overall differences between time points post intervention. For 
this analysis, time points were classified into these categories: 0-3 months post intervention, more 
than 3-6 months post intervention, more than 6-9 months post intervention, and more than 9 months 
post intervention. When two assessments occurred in one time period, both were included in the 
analysis and the data was averaged. At last, when there were multiple intervention and/or control 
conditions in a study, they were all included in the analysis and coded as intervention or control 
conditions. In the analysis concerning the overall effectiveness of psychosocial interventions on mental 
health, the data of multiple intervention conditions was averaged. To investigate which interventions 
and techniques were most effective in the moderator analysis, all interventions were investigated 
separately. Therefore, some studies were represented multiple times in this analysis. To be included 
as an intervention condition, the intervention should have a psychosocial component. In the control 
condition, people were put on a waiting list, received standard care or were in an active control 
condition. This last category included for example (psycho)education, support and telephone check-
ups. 
 
Data extraction and coding 
We developed a protocol to extract the data from the articles. The following information was extracted 
from the papers: year of publication, baseline scores on outcome variables, post-treatment results, 
follow-up results, country of data collection, years of recruitment, study setting (inpatient; outpatient; 
combination), number of participants in each group, percentage attrition, percentage females, mean 
age, percentage MSM, percentage participants with AIDS, mean number of years with HIV, percentage 
participants that use ART, screening on depression (yes; no), intervention type (symptom-oriented 
intervention; supportive intervention; meditation intervention), intervention techniques (relaxation; 
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Methods 
Search strategy and study selection 
Several strategies were used to search for relevant RCTs. First, we searched in the electronic databases 
PubMed, PsycINFO, and Embase on September 29, 2014. Search words included terms related to 
HIV/AIDS, various types of psychosocial interventions (e.g., CBT, psychotherapy), and outcomes (e.g., 
depression, quality of life). The search strategy with keywords can be found in Appendix A. Second, we 
also searched for papers in the references of available meta-analyses and reviews about the subject. 
Studies were included when they met all of the following criteria: 1) RCT; 2) evaluation of a 
psychosocial intervention (see definition below); 3) participants in the study are HIV positive and are 
18 years or older; 4) year of data collection is later than 1995 (see explanation below); 5) the outcome 
variables that were studied belong to one or more of the following categories: depression, anxiety, 
psychological well-being, or quality of life; 6) studies were written in the English language; and 7) data 
to calculate effect sizes was present in the paper or retrieved from the authors. Regarding the second 
inclusion criterion, a psychosocial intervention was operationalized as an intervention that aimed to 
change thoughts, emotions and/or behavior of PLWH and had a psychosocial component. Therefore, 
physical interventions (such as exercise), were not included in the meta-analysis. Regarding the fourth 
inclusion criterion, we decided to include studies that collected data later than 1995, since 
antiretroviral medication was developed in 1996 and consequently the future prospects of PLWH 
changed a lot after that period. Furthermore, the outcome domains depression, anxiety and quality of 
life were specified a priori. Only the outcome psychological well-being was first intended for stress-
related outcomes, but this was a rather small category, so we decided to enlarge it. Positive and 
negative affect, psychological functioning and general mental health were examples of concepts that 
were included in the outcome psychological well-being. Studies that had posttraumatic stress disorder 
(PTSD) as an outcome were not included in the meta-analysis. Regarding the seventh criterion, authors 
of the included papers were contacted to retrieve data that was not available in the paper. When the 
authors did not respond to the requests (even after reminder e-mails) and the data to calculate effect 
sizes was not available, the study was not included in the meta-analysis. 
The first step was the selection of studies on title and abstract, and was performed by two 
persons (first and fourth author). The first 100 studies were selected by both authors independently, 
to determine the agreement among selectors, which was substantial (19), Cohen’s kappa = 0.80. 
Thereafter, both selected half of the remaining studies. For the second step of selecting studies, based 
on full text, the studies were divided among three persons (first and fourth author and a Master 
student in clinical psychology). The inclusion criteria, as described above, were used in the following 
 
order to ensure a fast and equal decision: 6, 3, 1, 4, 2, 5, 7. When there was doubt about including a 
study, the paper was discussed with one or more of the other authors to make a decision. 
 
Problems of multiplicity 
Some decisions had to be made when multiple papers were published about the same data or when 
multiple measuring instruments, time points or interventions were used in one study. When there 
were multiple papers about the same data, the paper with the most relevant outcome data was used 
as the main paper. Other papers were used to add information that was not present in the main paper. 
In addition, when there were multiple measuring instruments for one outcome, two instruments were 
included in the analysis and their data was averaged. The instruments that were most validated and 
comparable to other studies were chosen. When there were assessments at more than one time point 
after the termination of the intervention, the first time point (first post-test) was included in the main 
analysis. Moreover, we did investigate overall differences between time points post intervention. For 
this analysis, time points were classified into these categories: 0-3 months post intervention, more 
than 3-6 months post intervention, more than 6-9 months post intervention, and more than 9 months 
post intervention. When two assessments occurred in one time period, both were included in the 
analysis and the data was averaged. At last, when there were multiple intervention and/or control 
conditions in a study, they were all included in the analysis and coded as intervention or control 
conditions. In the analysis concerning the overall effectiveness of psychosocial interventions on mental 
health, the data of multiple intervention conditions was averaged. To investigate which interventions 
and techniques were most effective in the moderator analysis, all interventions were investigated 
separately. Therefore, some studies were represented multiple times in this analysis. To be included 
as an intervention condition, the intervention should have a psychosocial component. In the control 
condition, people were put on a waiting list, received standard care or were in an active control 
condition. This last category included for example (psycho)education, support and telephone check-
ups. 
 
Data extraction and coding 
We developed a protocol to extract the data from the articles. The following information was extracted 
from the papers: year of publication, baseline scores on outcome variables, post-treatment results, 
follow-up results, country of data collection, years of recruitment, study setting (inpatient; outpatient; 
combination), number of participants in each group, percentage attrition, percentage females, mean 
age, percentage MSM, percentage participants with AIDS, mean number of years with HIV, percentage 
participants that use ART, screening on depression (yes; no), intervention type (symptom-oriented 




CBT; motivational interviewing; stress-management), intervention duration (total duration in hours; 
duration in weeks; number of sessions; duration of one session), therapy provider 
[psychologist/psychotherapist; counsellor (e.g., nurse, HIV specialist, social worker, trained facilitator]; 
peer; none (e.g., computer); other), intervention format [group; individual; combination; other (e.g., 
family interventions)], primary focus of intervention (mental health; no mental health), primary 
outcome (mental health; no mental health), theory content of intervention (theory-driven; not theory-
driven), type of control group (waiting list; standard care; active control group), length of follow-up, 
type of analysis [intent-to-treat (ITT); no ITT], and study quality (see next paragraph). 
The intervention type variable included three categories: symptom-oriented interventions, 
supportive interventions and meditation interventions. These categories were created post-hoc, after 
examining the content of the included interventions. The category symptom-oriented interventions 
included mostly cognitive and/or behavioral therapy, stress-management, and interpersonal therapy. 
Furthermore, the category supportive interventions consisted of (peer) support and psycho-education, 
and the category meditation interventions included interventions that incorporated mindfulness, 
meditation, or relaxation. Since the symptom-oriented interventions used various psychological 
techniques, it was further investigated whether symptom-oriented interventions that used a specific 
technique would have larger effects than symptom-oriented interventions that did not use this specific 
technique. This was investigated in the symptom-oriented interventions only, because the supportive 
and meditation interventions mostly did not make use of additional psychological techniques. The 
assessed intervention techniques were relaxation, CBT (defined as containing cognitive and/or 
behavioral techniques), motivational interviewing and stress-management. One symptom-oriented 
intervention may use multiple psychological techniques. For example, a symptom-oriented 
intervention may include CBT techniques and relaxation techniques. The explanation of intervention 
types and intervention techniques is depicted in Table 1. The variable theory content of intervention 
contains two categories: 1) it was described that the intervention was based on theory or a theoretical 
model (e.g., social cognitive theory or the health belief model) or 2) it was not described that the 
intervention was based on theory or a theoretical model. The type of control group was categorized 
as waiting list, standard care or an active control condition. Standard care included for example 
standard medical care and referral to mental health services when needed. The last category included 
for instance (psycho)education, support and telephone check-ups.  
The following information was asked from the authors, when it was not available in the paper: 
baseline, post-treatment and follow-up data, years of recruitment, number of participants in each 
group, percentage attrition, percentage females, mean age, intervention duration, therapy provider, 
intervention format, type of control group, length of follow-up and type of analysis. The data was 
extracted by two persons (first author and a psychologist). Both coded a portion of the studies and 17 
 
of the studies (27%) were coded by both authors. The intraclass correlation coefficient was calculated 
for the agreement on continuous variables, which was 0.99. For the categorical variables a Cohen’s 
kappa was calculated, this was 0.72, which is substantial.  
 
Study quality 
Study quality was assessed by using two methods: the Cochrane Collaboration’s tool for assessing risk 
of bias (20) and three criteria from a review about defining empirically supported psychological 
treatments (21). The Cochrane Collaboration’s tool for assessing risk of bias consists of six domains. 
Four domains were used in this study: (1) sequence generation for allocation to conditions; (2) 
concealment of allocation to conditions; (3) addressing incomplete outcome data; and (4) selective 
outcome reporting. The domain blinding of participants and researchers was not used, because in 
almost all studies participants and researchers could not be blinded to the allocation to conditions. 
Furthermore, the domain other sources of bias was not used, because in most studies there were no 
other sources of bias. On each domain, a study received the judgement low risk of bias (+), high risk of 
bias (-) or unclear risk of bias (?) using the criteria from the tool.  
Furthermore, we used three criteria from a review about defining empirically supported 
psychological treatments, to assess the quality of administering the intervention: (1) the availability of 
a treatment manual that was followed (published or designed for the study); (2) the use of a training 
for the therapy providers (for the study or general training); and (3) treatment integrity was checked 
during the study (e.g., supervision of therapy providers, recording of sessions, checking of protocol 
adherence). For each criterion a study received a judgement of yes (+, low risk of bias), no (-, high risk 
of bias), unclear (?) or not applicable (NA; e.g., when the intervention is a self-help program). Two 
persons (first author and a psychologist) rated the quality of the studies. Both rated a portion of the 
studies and 17 studies were rated by both authors to calculate their agreement. Cohen’s kappa was 
0.67, which is substantial. 
 
Table 1. Intervention types and intervention techniques 
Intervention types Intervention techniques (in symptom-
oriented interventions only) 
Symptom-oriented intervention (e.g. cognitive and/or behavioral 
therapy, stress-management, interpersonal therapy) 
Relaxation 
 
Supportive intervention (e.g., support, psycho-education) CBT 
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CBT; motivational interviewing; stress-management), intervention duration (total duration in hours; 
duration in weeks; number of sessions; duration of one session), therapy provider 
[psychologist/psychotherapist; counsellor (e.g., nurse, HIV specialist, social worker, trained facilitator]; 
peer; none (e.g., computer); other), intervention format [group; individual; combination; other (e.g., 
family interventions)], primary focus of intervention (mental health; no mental health), primary 
outcome (mental health; no mental health), theory content of intervention (theory-driven; not theory-
driven), type of control group (waiting list; standard care; active control group), length of follow-up, 
type of analysis [intent-to-treat (ITT); no ITT], and study quality (see next paragraph). 
The intervention type variable included three categories: symptom-oriented interventions, 
supportive interventions and meditation interventions. These categories were created post-hoc, after 
examining the content of the included interventions. The category symptom-oriented interventions 
included mostly cognitive and/or behavioral therapy, stress-management, and interpersonal therapy. 
Furthermore, the category supportive interventions consisted of (peer) support and psycho-education, 
and the category meditation interventions included interventions that incorporated mindfulness, 
meditation, or relaxation. Since the symptom-oriented interventions used various psychological 
techniques, it was further investigated whether symptom-oriented interventions that used a specific 
technique would have larger effects than symptom-oriented interventions that did not use this specific 
technique. This was investigated in the symptom-oriented interventions only, because the supportive 
and meditation interventions mostly did not make use of additional psychological techniques. The 
assessed intervention techniques were relaxation, CBT (defined as containing cognitive and/or 
behavioral techniques), motivational interviewing and stress-management. One symptom-oriented 
intervention may use multiple psychological techniques. For example, a symptom-oriented 
intervention may include CBT techniques and relaxation techniques. The explanation of intervention 
types and intervention techniques is depicted in Table 1. The variable theory content of intervention 
contains two categories: 1) it was described that the intervention was based on theory or a theoretical 
model (e.g., social cognitive theory or the health belief model) or 2) it was not described that the 
intervention was based on theory or a theoretical model. The type of control group was categorized 
as waiting list, standard care or an active control condition. Standard care included for example 
standard medical care and referral to mental health services when needed. The last category included 
for instance (psycho)education, support and telephone check-ups.  
The following information was asked from the authors, when it was not available in the paper: 
baseline, post-treatment and follow-up data, years of recruitment, number of participants in each 
group, percentage attrition, percentage females, mean age, intervention duration, therapy provider, 
intervention format, type of control group, length of follow-up and type of analysis. The data was 
extracted by two persons (first author and a psychologist). Both coded a portion of the studies and 17 
 
of the studies (27%) were coded by both authors. The intraclass correlation coefficient was calculated 
for the agreement on continuous variables, which was 0.99. For the categorical variables a Cohen’s 
kappa was calculated, this was 0.72, which is substantial.  
 
Study quality 
Study quality was assessed by using two methods: the Cochrane Collaboration’s tool for assessing risk 
of bias (20) and three criteria from a review about defining empirically supported psychological 
treatments (21). The Cochrane Collaboration’s tool for assessing risk of bias consists of six domains. 
Four domains were used in this study: (1) sequence generation for allocation to conditions; (2) 
concealment of allocation to conditions; (3) addressing incomplete outcome data; and (4) selective 
outcome reporting. The domain blinding of participants and researchers was not used, because in 
almost all studies participants and researchers could not be blinded to the allocation to conditions. 
Furthermore, the domain other sources of bias was not used, because in most studies there were no 
other sources of bias. On each domain, a study received the judgement low risk of bias (+), high risk of 
bias (-) or unclear risk of bias (?) using the criteria from the tool.  
Furthermore, we used three criteria from a review about defining empirically supported 
psychological treatments, to assess the quality of administering the intervention: (1) the availability of 
a treatment manual that was followed (published or designed for the study); (2) the use of a training 
for the therapy providers (for the study or general training); and (3) treatment integrity was checked 
during the study (e.g., supervision of therapy providers, recording of sessions, checking of protocol 
adherence). For each criterion a study received a judgement of yes (+, low risk of bias), no (-, high risk 
of bias), unclear (?) or not applicable (NA; e.g., when the intervention is a self-help program). Two 
persons (first author and a psychologist) rated the quality of the studies. Both rated a portion of the 
studies and 17 studies were rated by both authors to calculate their agreement. Cohen’s kappa was 
0.67, which is substantial. 
 
Table 1. Intervention types and intervention techniques 
Intervention types Intervention techniques (in symptom-
oriented interventions only) 
Symptom-oriented intervention (e.g. cognitive and/or behavioral 
therapy, stress-management, interpersonal therapy) 
Relaxation 
 
Supportive intervention (e.g., support, psycho-education) CBT 







The following moderators were investigated: country of data collection, first year of participant 
recruitment, percentage attrition, percentage females, mean age, percentage MSM, percentage 
participants with AIDS, mean number of years with HIV, percentage participants that use ART, 
screening on depression, intervention techniques, intervention duration, therapy provider, 
intervention format, primary focus intervention, primary outcome mental health, theory content of 
intervention, type of control group, type of analysis and study quality. 
 For the moderator analyses with continuous variables, the assumptions for meta-regression 
were checked (normality and linearity). None of the variables met both assumptions. Therefore, the 
continuous variables were transformed into categorical variables. The categorization was based on 
statistical and content related reasons. The variable first year of recruitment was categorized into three 
periods: 1996-2001, 2002-2006 and 2007-2012. The variable percentage of drop-out was separated 
into three categories: 0-10, 10-20 and > 20%, as was the variable percentage of females: 0-20%, 20-80 
and 80-100%. The variable mean age was divided based on a median split: < 42.40 years and ≥ 42.40 
years. The variable percentage MSM was divided into two categories: 0 and > 0% (because most studies 
had no MSM, so the median was 0%). The variable percentage of people with AIDS was separated into 
two categories based on a median split: < 40 and ≥ 40%, as was the variable number of years with HIV: 
< 10.02 years and ≥ 10.02 years and the variable percentage of people on ART: < 87 and ≥ 87%. Finally, 
the variable total intervention duration was divided into four categories: 1-5, 5-12, 12-18 and 18-30 
hours. 
Study quality was included as a moderator in the analysis. When a study met 0-2 out of seven 
quality criteria (0-2 times a +), the study was classified as a study with low quality. When a study met 
3-4 quality criteria, the study was classified as a study with medium quality and when 5-7 criteria were 
met, the study was classified as a study with high quality. A rating of unclear risk of bias was scored as 
a high risk of bias (–) in this classification. For studies with a judgement of NA on the three criteria 
regarding the quality of administering the intervention, a low quality rating was given to studies which 
had a low risk of bias rating on 0-1 on the four other quality criteria, a medium quality rating was given 
to studies which had a low risk of bias on two of the other quality criteria and a high quality rating was 
for the studies which had a low risk of bias on 3-4 of the other quality criteria. 
 
Data analysis 
The program comprehensive meta-analysis (CMA; version 3) was used for the analysis. Hedges’ g was 
calculated as a measure of effect size. Baseline, post intervention and follow-up means, standard 
deviations, sample sizes and/or other available data were used to calculate effect sizes (e.g., F, t or p 
values). One study (22) reported median decreases in depression scores, instead of mean decreases. 
 
These medians were entered into CMA, because the means could not be retrieved. Also, five studies 
(23-27) found no differences between intervention and control conditions on one or more outcome 
measures, but no data was available. The effect sizes of these outcome measures of the studies were 
set at zero. Cohen’s guidelines were applied to interpret effect sizes: 0.2 may indicate a small effect 
size, 0.5 may indicate a medium effect size and 0.8 may indicate a large effect size (28). Two-tailed p-
values were used in all analyses. In CMA, a correlation between pre- and posttest should be indicated 
for each study. Since this correlation was rarely reported in study papers, this was set at 0.5 (as 
suggested by (29)). Standardized residuals were inspected to find outliers, defined as studies with 
standardized residuals larger than |3| (30). 
A random effects model was used for the main analysis to estimate the pooled effect size of 
psychosocial interventions on mental health (expressed as Hedges’ ĝ). Separate analyses were 
conducted for each outcome (depression, anxiety, quality of life, and psychological well-being), 
intervention type (symptom-oriented intervention, supportive intervention, and meditation 
intervention) and time point (0-3 months post intervention, 3-6 months post intervention, 6-9 months 
post intervention, and > 9 months post intervention). The random effects model was used because we 
assumed heterogeneity across studies. To investigate the presence and amount of heterogeneity, Q 
and I² were calculated. When Q is significant, this means that the results of the studies are probably 
not consistent. The amount of heterogeneity can be identified with I². Values of 25% indicate low 
heterogeneity, 50% indicates moderate heterogeneity and 75% indicates high heterogeneity (31). 
For the moderator analysis, a mixed effects model was used, in which the random effects 
model was used to combine studies in one subgroup and a fixed effects model was used to compare 
across subgroups (32). In CMA, the mixed and random effects option was set to: do not assume a 
common among-study variance component across subgroups (do not pool within-group estimates of 
tau-squared). 
To examine the presence of publication bias different methods were used. First, a funnel plot 
was created, where the standard error is plotted as a function of effect size. Studies with small 
standard errors (large studies in general) are displayed at the top of the plot and studies with large 
standard errors (small studies in general) are displayed at the bottom of the plot. When the studies 
are symmetrically distributed around the pooled effect size estimate, there is no indication of 
publication bias. When it seems that studies are missing on the lower left side, this may be an 
indication of publication bias (small studies with results lower than the pooled estimate are missing). 
Second, Egger’s test of the intercept (33) was used to statistically test for publication bias. There is an 
indication of publication bias when the test is significant. Last, Duval and Tweedie’s trim and fill analysis 
(34) was used to investigate whether it was necessary to impute studies in the funnel plot due to 
publication bias. After the imputation of missing studies, an adjusted effect size was calculated. 
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Moderators 
The following moderators were investigated: country of data collection, first year of participant 
recruitment, percentage attrition, percentage females, mean age, percentage MSM, percentage 
participants with AIDS, mean number of years with HIV, percentage participants that use ART, 
screening on depression, intervention techniques, intervention duration, therapy provider, 
intervention format, primary focus intervention, primary outcome mental health, theory content of 
intervention, type of control group, type of analysis and study quality. 
 For the moderator analyses with continuous variables, the assumptions for meta-regression 
were checked (normality and linearity). None of the variables met both assumptions. Therefore, the 
continuous variables were transformed into categorical variables. The categorization was based on 
statistical and content related reasons. The variable first year of recruitment was categorized into three 
periods: 1996-2001, 2002-2006 and 2007-2012. The variable percentage of drop-out was separated 
into three categories: 0-10, 10-20 and > 20%, as was the variable percentage of females: 0-20%, 20-80 
and 80-100%. The variable mean age was divided based on a median split: < 42.40 years and ≥ 42.40 
years. The variable percentage MSM was divided into two categories: 0 and > 0% (because most studies 
had no MSM, so the median was 0%). The variable percentage of people with AIDS was separated into 
two categories based on a median split: < 40 and ≥ 40%, as was the variable number of years with HIV: 
< 10.02 years and ≥ 10.02 years and the variable percentage of people on ART: < 87 and ≥ 87%. Finally, 
the variable total intervention duration was divided into four categories: 1-5, 5-12, 12-18 and 18-30 
hours. 
Study quality was included as a moderator in the analysis. When a study met 0-2 out of seven 
quality criteria (0-2 times a +), the study was classified as a study with low quality. When a study met 
3-4 quality criteria, the study was classified as a study with medium quality and when 5-7 criteria were 
met, the study was classified as a study with high quality. A rating of unclear risk of bias was scored as 
a high risk of bias (–) in this classification. For studies with a judgement of NA on the three criteria 
regarding the quality of administering the intervention, a low quality rating was given to studies which 
had a low risk of bias rating on 0-1 on the four other quality criteria, a medium quality rating was given 
to studies which had a low risk of bias on two of the other quality criteria and a high quality rating was 
for the studies which had a low risk of bias on 3-4 of the other quality criteria. 
 
Data analysis 
The program comprehensive meta-analysis (CMA; version 3) was used for the analysis. Hedges’ g was 
calculated as a measure of effect size. Baseline, post intervention and follow-up means, standard 
deviations, sample sizes and/or other available data were used to calculate effect sizes (e.g., F, t or p 
values). One study (22) reported median decreases in depression scores, instead of mean decreases. 
 
These medians were entered into CMA, because the means could not be retrieved. Also, five studies 
(23-27) found no differences between intervention and control conditions on one or more outcome 
measures, but no data was available. The effect sizes of these outcome measures of the studies were 
set at zero. Cohen’s guidelines were applied to interpret effect sizes: 0.2 may indicate a small effect 
size, 0.5 may indicate a medium effect size and 0.8 may indicate a large effect size (28). Two-tailed p-
values were used in all analyses. In CMA, a correlation between pre- and posttest should be indicated 
for each study. Since this correlation was rarely reported in study papers, this was set at 0.5 (as 
suggested by (29)). Standardized residuals were inspected to find outliers, defined as studies with 
standardized residuals larger than |3| (30). 
A random effects model was used for the main analysis to estimate the pooled effect size of 
psychosocial interventions on mental health (expressed as Hedges’ ĝ). Separate analyses were 
conducted for each outcome (depression, anxiety, quality of life, and psychological well-being), 
intervention type (symptom-oriented intervention, supportive intervention, and meditation 
intervention) and time point (0-3 months post intervention, 3-6 months post intervention, 6-9 months 
post intervention, and > 9 months post intervention). The random effects model was used because we 
assumed heterogeneity across studies. To investigate the presence and amount of heterogeneity, Q 
and I² were calculated. When Q is significant, this means that the results of the studies are probably 
not consistent. The amount of heterogeneity can be identified with I². Values of 25% indicate low 
heterogeneity, 50% indicates moderate heterogeneity and 75% indicates high heterogeneity (31). 
For the moderator analysis, a mixed effects model was used, in which the random effects 
model was used to combine studies in one subgroup and a fixed effects model was used to compare 
across subgroups (32). In CMA, the mixed and random effects option was set to: do not assume a 
common among-study variance component across subgroups (do not pool within-group estimates of 
tau-squared). 
To examine the presence of publication bias different methods were used. First, a funnel plot 
was created, where the standard error is plotted as a function of effect size. Studies with small 
standard errors (large studies in general) are displayed at the top of the plot and studies with large 
standard errors (small studies in general) are displayed at the bottom of the plot. When the studies 
are symmetrically distributed around the pooled effect size estimate, there is no indication of 
publication bias. When it seems that studies are missing on the lower left side, this may be an 
indication of publication bias (small studies with results lower than the pooled estimate are missing). 
Second, Egger’s test of the intercept (33) was used to statistically test for publication bias. There is an 
indication of publication bias when the test is significant. Last, Duval and Tweedie’s trim and fill analysis 
(34) was used to investigate whether it was necessary to impute studies in the funnel plot due to 





Through electronic databases, 905 articles were identified (see flow-chart of study inclusion and 
exclusion in Figure 1). After removal of duplicates (228), 677 articles were screened on title and 
abstract. Thereafter, 197 articles were screened on full text. After this screening, 64 studies met the 
inclusion criteria. In addition, three studies were found in previous meta-analyses and systematic 
reviews. From 20 of the 67 studies, data to calculate effect sizes was not present in the paper. 
Therefore, the authors were contacted to obtain these data. Of 15 studies, the authors were able to 
provide the data, one author could not provide the data, the authors of one study did not want to be 
included in the meta-analysis (because study aim did not fit with the aim of the meta-analysis), and 
three authors did not respond. In total, 62 studies were included in the meta-analysis.  
 
Study characteristics 
The characteristics of all included studies are presented in Table 2. In total, 10,307 participants were 
randomized to intervention and control conditions (range 12-936; k = 62). Drop-out (the percentage 
of participants that did not complete the first posttest) ranged from 0 to 55%, with a mean of 18% (SD 
= 11.93; k = 58). Seven studies (7/60) included only males and 13 included only females, the percentage 
of females in the included studies was 44% on average (SD = 34.54). The mean of the mean age of 
participants across studies was 42.01 years (SD = 5.98, range of the mean: 26.00-59.00 years, k = 54). 
The mean percentage of MSM in the studies that reported on it was 31% (SD = 38.27; k = 22). Across 
the studies that documented it, the mean percentage of people with AIDS was 45% (SD = 28.59; k = 15) 
and the mean duration of HIV was 9.81 years (SD = 3.59, range of the mean: 0-18 years; k = 28). Most 
participants in the studies that reported on it used ART, the mean percentage of people that used it is 
76% (SD = 34.28; k = 28). For some characteristics, the number of studies that reported on it was very 
low. Therefore, these results should be interpreted with caution. 
The majority of studies was conducted in the USA and Canada (k = 46). Other countries of data 
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Netherlands, Uganda, and Vietnam. One study recruited participants in the USA and Mexico and one 
study in South Africa, Puerto Rico, and the USA. The years of participant recruitment ranged from 1996 
to 2013 (k = 57). The majority of studies was conducted in an outpatient setting (58/62), only two 
studies were conducted in an inpatient setting and two studies combined inpatients and outpatients. 
Ten studies (10/62) incorporated the presence of depressive symptoms as an inclusion criterion. In the 
majority of studies (54/62), mental health (i.e., depression, anxiety, quality of life, or psychological 
well-being) was a primary outcome measure. Depression was measured in 47 studies, anxiety in 22, 
quality of life in 19, and psychological well-being in 25 studies. Some studies (31/62) used an active 
 
control condition, 9 studies used a waiting list condition, and 22 studies had a standard care control 
condition. Furthermore, more than half of the studies (32/51) used an ITT analysis, and included one 
or more follow-up assessments (40/62); 22 studies had one follow-up, 16 studies had two follow-ups, 
one study had three follow-ups, and one study had four follow-ups. The timing of follow-ups ranged 
from 1 to 17 months after treatment completion. 
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The description of intervention characteristics was based on all interventions, so eight studies (46, 52-
54, 61, 64, 87, 91) were represented twice in this analysis and one study (65) was represented three 
times, because multiple interventions were investigated in these studies. The letter m will be used to 
indicate the number of interventions. Regarding intervention types (see Table 1), a majority of the 
interventions were symptom-oriented (41/72), the rest were supportive (20/72), or meditation 
interventions (11/72). Regarding techniques used in symptom-oriented interventions (m = 41), CBT 
techniques were used in 29 interventions, relaxation techniques in 14, stress-management techniques 
in 16, and finally motivational interviewing techniques in 6 interventions. Almost two-thirds of the 
interventions (47/72) were focused on one of our outcome measures (depression, anxiety, quality of 
life, or psychological well-being). Studies that investigated interventions that were not focused on one 
of our outcome measures, were often aimed at medication adherence or sexual risk behavior, and 
sometimes at coping, disclosure, general health, family functioning, posttraumatic stress disorder 
symptoms, or smoking. A majority (44/72) of the interventions were theory-driven and 28 
interventions were not theory-driven. Concerning the duration of the interventions, the total length 
ranged from 1 to 30 hours (m = 62), with a mean of 12.63 (SD = 8.46). The duration of the intervention 
in weeks ranged from 1 to 54 (M = 12.20, SD = 13.27, m = 66) and the number of sessions ranged from 
1 to 48 (M = 9.92, SD = 8.62, m = 67). The average length of one session was 1.37 hour (SD = 0.66, range 
15 minutes to 3 hours, m = 63). Providers of the interventions were psychologists/psychotherapists 
(18/65), counsellors (e.g., nurses, 29/65), peers (4/65), none (e.g., computer interventions, 9/65), and 
other (e.g., investigators, 5/65). The format of the intervention was either individual (31/72), group 
(30/72), a combination of individual and group (6/72), or other (e.g., family interventions, 5/72). 
 
Quality of the included studies 
The quality ratings of the studies are presented in Table 3. The first quality criterion, regarding the 
sequence generation for allocation to conditions, was reported in more than half of the studies (32/62), 
in the other studies it was unclear. The criterion about the concealment of allocation to conditions was 
often not reported, only 13 studies mentioned it, in the other studies it was unclear. Incomplete 
outcome data (the third criterion) was adequately addressed in half of the studies (31/62, e.g., with an 
ITT analysis), in 20 studies it was not adequately addressed and in 11 studies this was not clear. For 
most studies (58/62) there was no study protocol available, so the criterion of selective outcome 
reporting was unclear, only four studies had a rating of low risk of bias on this criterion. 
 Eight studies investigated an intervention without a provider (e.g., computer or self-help 
interventions). These studies were not coded on the quality of the administered intervention. In 36 of 
the 54 studies a treatment manual was available and followed and in 18 studies this was not described. 
47
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(18/65), counsellors (e.g., nurses, 29/65), peers (4/65), none (e.g., computer interventions, 9/65), and 
other (e.g., investigators, 5/65). The format of the intervention was either individual (31/72), group 
(30/72), a combination of individual and group (6/72), or other (e.g., family interventions, 5/72). 
 
Quality of the included studies 
The quality ratings of the studies are presented in Table 3. The first quality criterion, regarding the 
sequence generation for allocation to conditions, was reported in more than half of the studies (32/62), 
in the other studies it was unclear. The criterion about the concealment of allocation to conditions was 
often not reported, only 13 studies mentioned it, in the other studies it was unclear. Incomplete 
outcome data (the third criterion) was adequately addressed in half of the studies (31/62, e.g., with an 
ITT analysis), in 20 studies it was not adequately addressed and in 11 studies this was not clear. For 
most studies (58/62) there was no study protocol available, so the criterion of selective outcome 
reporting was unclear, only four studies had a rating of low risk of bias on this criterion. 
 Eight studies investigated an intervention without a provider (e.g., computer or self-help 
interventions). These studies were not coded on the quality of the administered intervention. In 36 of 




Trained providers were used in 36 of the 54 studies, in 17 studies this was unclear and one study 
explained that they did not make use of trained providers. Finally, in 31 of the 54 studies treatment 
integrity was checked and in 23 studies this was not described. A summary of the ratings on all quality 
criteria is presented in Figure 2. Regarding the overall quality classification, most studies were classified 
as low (24/62) or medium (28/62) quality. Only 10 studies were classified as high quality. None of the 
studies met all quality criteria, but five studies met all except one criterion. 
 
Intervention effectiveness 
The overall effect of psychosocial interventions on mental health outcomes was Hedges’ ĝ = 0.19, 95% 
CI [0.13, 0.25], p < 0.001 (see Figure 3). Thus, psychosocial interventions may have a positive effect on 
mental health, compared to a control condition. However, the effect size was small. Standardized 
residuals were inspected to identify outliers (studies with standardized residuals |3|), but none were 
found. 
Table 4 shows the overall effect of psychosocial interventions on mental health and the effect 
sizes for each outcome, intervention type and time point separately. It shows that the pooled effect 
sizes for depression and psychological well-being were larger (ĝ = 0.21 and ĝ = 0.20) than those for 
anxiety and quality of life (ĝ = 0.09 and ĝ = 0.13). Furthermore, heterogeneity was moderate and 
significant for the outcomes depression and psychological well-being and smaller and not significant 
for anxiety and quality of life. Therefore, we decided to conduct the moderator analysis only on the 
outcomes depression and psychological well-being. Results are presented for the moderator analyses 
on depression and differences with the moderator analyses of psychological well-being will be 
discussed. 
The results regarding intervention type (categories: symptom-oriented intervention, 
supportive intervention, and meditation intervention; Table 4) show that each intervention type had 
a pooled effect size of approximately ĝ = 0.20. The analysis on time points shows that the first and 
third time point had pooled effect sizes of ĝ = 0.18, while the second (ĝ = 0.13) and last (ĝ = 0.08) time 
point had smaller pooled effect sizes. The pooled effect size of the last time point was not significant 
and it should be noted that it was based on only nine studies. In sum, the overall effect of psychosocial 
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residuals were inspected to identify outliers (studies with standardized residuals |3|), but none were 
found. 
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sizes for each outcome, intervention type and time point separately. It shows that the pooled effect 
sizes for depression and psychological well-being were larger (ĝ = 0.21 and ĝ = 0.20) than those for 
anxiety and quality of life (ĝ = 0.09 and ĝ = 0.13). Furthermore, heterogeneity was moderate and 
significant for the outcomes depression and psychological well-being and smaller and not significant 
for anxiety and quality of life. Therefore, we decided to conduct the moderator analysis only on the 
outcomes depression and psychological well-being. Results are presented for the moderator analyses 
on depression and differences with the moderator analyses of psychological well-being will be 
discussed. 
The results regarding intervention type (categories: symptom-oriented intervention, 
supportive intervention, and meditation intervention; Table 4) show that each intervention type had 
a pooled effect size of approximately ĝ = 0.20. The analysis on time points shows that the first and 
third time point had pooled effect sizes of ĝ = 0.18, while the second (ĝ = 0.13) and last (ĝ = 0.08) time 
point had smaller pooled effect sizes. The pooled effect size of the last time point was not significant 
and it should be noted that it was based on only nine studies. In sum, the overall effect of psychosocial 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
 
 
Figure 2. Risk of bias graph 
 
Intervention effectiveness: analysis on last time point 
The analysis on outcome type and intervention type described above was also conducted with the last 
available time point for each study, instead of the first time point. The analysis on the last time point 
was conducted, as we were also interested in the results on the long term, next to the results on the 
short term. Differences between those analyses were examined and will be depicted here. The overall 
effect of psychosocial interventions on mental health was comparable, ĝ = 0.18, 95% CI [0.12, 0.25], p 
< 0.001; Q = 110.25, p < 0.001, I² = 45%. The pooled effect size on the outcome of anxiety was 
somewhat larger in this analysis, ĝ = 0.14, 95% CI [0.02, 0.25], p < 0.05 and heterogeneity was 
significant, Q = 39.44, p < 0.01, I² = 47%. The pooled effect size on the outcome psychological well-
being was comparable, but heterogeneity was smaller and not significant in this analysis, Q = 34.06, p 
= 0.08, I² = 30%. Furthermore, the effects of supportive interventions (ĝ = 0.18, 95% CI [0.04, 0.33], p 
< 0.05) and meditation (ĝ = 0.16, 95% CI [0.02, 0.31], p < 0.05) were somewhat smaller in this analysis 
and the effect of symptom-oriented interventions was larger (ĝ = 0.21, 95% CI [0.14, 0.28], p < 0.001). 
Summarizing, the analysis on the first time point and the analysis on the last time point were 
comparable and only small differences were found. 
  




















































































































































































































































































































































































































































































   
 
 
Figure 2. Risk of bias graph 
 
Intervention effectiveness: analysis on last time point 
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Figure 3. Forest plot showing the effect of psychosocial interventions on mental health outcomes 
 
 
Table 4. Overall analysis and analysis separately for each outcome, intervention type and time point 
Analysis Subgroup ka Hedges’ ĝ 95% CI Qb I² (%)c 
Overall effect  62 0.19d 0.13, 0.25 99.35d 39 
Outcome Depression 47 0.21d 0.13, 0.29 87.32d 47 
 Anxiety 22 0.09 -0.01, 0.19 31.29 33 
 Quality of life 19 0.13d 0.04, 0.21 21.07 15 
 Psychological well-being 25 0.20d 0.09, 0.31 44.63d 46 
Intervention type Symptom-oriented intervention 39 0.19d 0.11, 0.28 69.71d 46 
 Supportive intervention 20 0.21d 0.09, 0.33 43.58d 56 
 Meditation intervention 9 0.20d 0.06, 0.35 2.00 0 
Time point Posttest 0-3 months 59 0.18d 0.12, 0.25 85.79e 32 
 Posttest 3-6 months 19 0.13d 0.05, 0.22 28.31 36 
 Posttest 6-9 months 12 0.18d 0.05, 0.31 22.97e 52 
 Posttest > 9 months 9 0.08 -0.05, 0.21 13.79 42 
a k = number of studies, b Q = heterogeneity test, c I² = % of heterogeneity, d p < 0.01, e p < 0.05. 
 
Publication bias 
When the funnel plot was inspected (see Figure 4), it was clear that studies were missing on the left 
side of the plot. This may be an indication of publication bias. Egger’s test of the intercept was 
significant, intercept 0.82, 95% CI [0.09, 1.54], t(60) = 2.24, p < 0.05. This also indicates that there may 
be publication bias. Lastly, Duval and Tweedie’s trim and fill analysis demonstrated that 14 studies 
were missing on the left side of the plot (see black dots in Figure 4). After imputation of these 14 
studies, the adjusted effect size was ĝ = 0.11, 95% CI [0.04, 0.17]. This effect size is substantially smaller 
than the unadjusted effect size of ĝ = 0.19. In sum, there seems to be evidence for publication bias in 
this meta-analysis, as studies with smaller effect sizes are missing. 
 
Moderator analysis on the outcome depression 
Table 5 shows the effects of the subgroup analysis on the outcome depression. It shows that the type 
of control group was a significant moderator. Contrary to expectations, studies that used a waiting list 
control group had smaller effect sizes in general, than studies that used an active or standard care 
control condition. However, there were only five studies in this analysis that used a waiting list control 
group. Also, the percentage of people with AIDS in a study was a significant moderator, i.e., when less 
than 40% of the participants in the studies had AIDS the effect sizes were on average larger than when 
40% or more of the participants in the studies had AIDS. Furthermore, the moderator a priori screening 
on depression was significant, which means that studies that only included participants with 
depressive symptoms had larger effect sizes in general (ĝ = 0.46, 95% CI [0.25, 0.68]), than studies that 
did not had the presence of depressive symptoms as an inclusion criterion (ĝ = 0.12, 95% CI [0.05, 
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0.18]). Last, the moderator provider of the intervention was significant. Studies that had a psychologist 
or a psychotherapist as a provider of the intervention had the largest pooled effect sizes. Studies that 
used other providers (e.g., a counsellor or peer or a computer) had smaller pooled effect sizes. 
Concluding, the moderators that were found to be significant were: type of control group, percentage 
of people with AIDS, a priori screening on depression, and provider of the intervention. 
 
Figure 4. Funnel plot of standard error by Hedges’ g with imputed studies from Duval and Tweedie’s 
trim and fill analysis 
 
 
Table 5. Moderators of intervention effect on depression (k = 47) 
Moderator Subgroup ka Hedges’ ĝ 95% CI Q for 
differenceb 
Control group Active control group 24 0.22c 0.11, 0.33 6.74d 
 Standard care 18 0.25c 0.14, 0.36  
 Waiting list 5 -0.04  -0.24, 0.16  
Location Africa/Asia 8 0.19c 0.05, 0.33 0.01 
 North America/Europe 38 0.19c 0.10, 0.27  
 Othere 1    
First year recruitment 1996-2001 16 0.13d 0.02, 0.24 4.37 
 2002-2006 15 0.32c 0.16, 0.47  
 2007-2012 13 0.13 -0.01, 0.28  
 Missing 3    
% Attrition 0-10% 14 0.18d 0.01, 0.36 1.14 
 10-20% 17 0.20c 0.08, 0.32  
 
Moderator Subgroup ka Hedges’ ĝ 95% CI Q for 
differenceb 
 > 20% 14 0.28c 0.15, 0.41  
 Missing 2 0.03   
% Females 0-20% 14 0.27c 0.15, 0.40 4.54 
 20-80% 22 0.21c 0.09, 0.33  
 80-100% 10 0.08 -0.06, 0.21  
 Missing 1    
Mean age < 42.40 years 19 0.14c 0.04, 0.24 0.74 
 ≥ 42.40 years 22 0.21c 0.09, 0.32  
 Missing 6    
% MSMf 0% 10 0.10 -0.05, 0.24 0.50 
 > 0% 10 0.17d 0.02, 0.31  
 Missing 27    
% Participants with AIDS < 40% 5 0.54c 0.38, 0.71 7.24c 
 ≥ 40% 5 0.19 -0.01, 0.38  
 Missing 37    
Mean duration HIV < 10.02 years 10 0.16 -0.05, 0.38 0.21 
 ≥ 10.02 years 13 0.22c 0.07, 0.38  
 Missing 24    
% on ARTg < 87% 10 0.34c 0.15, 0.52 0.00 
 ≥ 87% 12 0.34c 0.18, 0.49  
 Missing 25    
Screening on depression No 37 0.12c 0.05, 0.18 9.13c 
 Yes 10 0.46c 0.25, 0.68  
Mental health primary 
outcome 
No 6 0.17 -0.02, 0.36 0.19 
 Yes 41 0.22c 0.13, 0.30  
Provider intervention Psychologist 13 0.42c 0.28, 0.56 12.92d 
 Counsellor 21 0.15c 0.05, 0.25  
 Peer 2 0.10 -0.04, 0.25  
 None 5 0.18 -0.19, 0.54  
 Other (practitioner) 1 0.06 -0.22, 0.33  
 Missing 5    
Format intervention Group 19 0.23c 0.14, 0.33  4.58 
 Individual 20 0.25c 0.10, 0.40  
 Combination 4 0.09 -0.16, 0.33  
 Other 4 -0.01 -0.26, 0.23  
Analysis ITTh 24 0.22c 0.11, 0.34 1.32 
 No ITTh 15 0.13d 0.02, 0.24  
 Missing 8    
Study quality Low 17 0.23c 0.08, 0.38 0.53 
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Moderator Subgroup ka Hedges’ ĝ 95% CI Q for 
differenceb 
 Medium 24 0.19c 0.09, 0.29  
 High 6 0.28d 0.001, 0.57  
a k = number of studies, b Q = Q for difference between subgroups, c p < 0.01, d p < 0.05, e One study recruited participants in 
South Africa, Puerto Rico and the USA. This study could not be classified into one of the categories, so it was removed from 
the moderator analysis on location, f MSM = men that have sex with men, g ART = antiretroviral therapy, h ITT = intent to treat 
analysis. 
 
Moderator analysis: effect of intervention characteristics on the outcome depression 
Table 6 shows the effects of intervention characteristics on the outcome of depression. In this analysis, 
all interventions were investigated separately, so some studies are represented twice. When mental 
health (i.e., depression, anxiety, quality of life, or psychological well-being) was a primary focus of the 
intervention in a study, the effect sizes were in general larger than when mental health was not a 
primary focus of an intervention. Furthermore, treatment duration was a significant moderator. 
Studies with treatment durations of 12 to 18 hours had the largest effect sizes. Studies with shorter or 
longer treatment durations had smaller effect sizes in general. In sum, the following moderators were 
significant in this analysis: mental health primary focus of the intervention and treatment duration. 
 
Moderator analysis on the outcome psychological well-being 
The moderator analysis was also conducted on the outcome psychological well-being, next to the 
moderator analysis on the outcome depression. It was decided to do the moderator analysis on these 
two outcomes, because the largest pooled effect sizes were found for depression and psychological 
well-being and heterogeneity was highest and significant for these outcomes (see Table 4). Differences 
between the moderator analysis on the outcome depression and psychological well-being will be 
discussed here. The moderators percentage of people with AIDS, provider of the intervention, whether 
mental health was a primary focus of the intervention and treatment duration were not significant in 
the analysis on well-being, all p’s > 0.06. The type of control group remained a significant moderator. 
The moderator screening on the presence of depressive symptoms was not included in this analysis, 
since the outcome was psychological well-being and therefore most studies did not screen on 
depressive symptoms in these studies. Furthermore, the percentage of people on ART (Q = 4.10, p < 
0.05) and study quality (Q = 8.71, p < 0.05) were significant moderators in this analysis. Regarding the 
percentage of people on ART, the largest effect sizes were in general for studies with 87% or more of 
the participants on ART (ĝ = 0.39, 95% CI [0.14, 0.64], p < 0.01, k = 8), and studies with less than 87% 
of participants on ART had smaller effect sizes (ĝ = 0.07, 95% CI [-0.11, 0.25], p = 0.45, k = 3). Though, 
the last category contained only three studies. Regarding study quality, studies with a medium quality 
 
had larger effect sizes on average (ĝ = 0.30, 95% CI [0.14, 0.46], p < 0.001, k = 14), than studies with a 
low (ĝ = 0.15, 95% CI [-0.05, 0.35], p = 0.15, k = 7) or high quality (ĝ = -0.04, 95% CI [-0.21, 0.12], p = 
0.61, k = 4). However, there were only four studies in the category high quality in this analysis. 
Summarizing, in the moderator analysis on the outcome psychological well-being the significant 
moderators were: type of control group, percentage of people on ART, and study quality. 
 
Table 6. Effect of intervention characteristics on depression 
Moderator Subgroup ma Hedges’ ĝ 95% CI Q for 
differenceb 
Relaxation techniquec No 22 0.18d 0.06, 0.29 2.75 
 Yes 9 0.38d 0.17, 0.59  
Cognitive behavioral techniquec No 9 0.15 -0.07, 0.38 0.53 
 Yes 22 0.25d 0.13, 0.37  
Motivational interviewing techniquec No 25 0.23d 0.12, 0.34 0.07 
 Yes 6 0.18 -0.16, 0.52  
Stress-management techniquec No 20 0.19d 0.06, 0.31 1.04 
 Yes 11 0.29d 0.13, 0.45  
Mental health primary focus intervention No 22 0.14d 0.06, 0.22 4.02e 
 Yes 31 0.29d 0.02, 0.41  
Theory-driven intervention No 19 0.22 d 0.09, 0.36 0.01 
 Yes 34 0.21 d 0.12, 0.31  
Treatment duration 1-5 h 13 0.06 -0.09, 0.20 10.76e 
 5-12 h 14 0.12 -0.01, 0.25  
 12-18 h 11 0.38d 0.23, 0.53  
 18-30 h 9 0.17 -0.003, 0.33  
 Missing 6    
a m = number of interventions, b Q = Q for difference between subgroups, c the effect of the use of specific intervention 
techniques was investigated in symptom-oriented interventions only (m = 31), d p < 0.01, e p < 0.05. 
 
Discussion 
The first aim of this systematic review and meta-analysis was to investigate the effectiveness for PLWH 
of various psychosocial interventions aimed at decreasing depression and anxiety, and improving 
quality of life and psychological well-being, and to investigate which interventions were the most 
effective on these outcomes. Sixty-two studies were included in the analysis, and it was found that 
psychosocial interventions had a positive effect on the mental health outcomes described, although 
the effect size was small. In addition, there was evidence of publication bias, so the corrected effect 
size was smaller. Most studies in the meta-analysis were categorized as low or medium quality studies, 
there was a lack of high quality studies. Furthermore, a range of psychosocial intervention types can 
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low (ĝ = 0.15, 95% CI [-0.05, 0.35], p = 0.15, k = 7) or high quality (ĝ = -0.04, 95% CI [-0.21, 0.12], p = 
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size was smaller. Most studies in the meta-analysis were categorized as low or medium quality studies, 




be effective for PLWH, from symptom-oriented interventions such as CBT, to supportive interventions 
and meditation. There were no differences in effectiveness between these different intervention types, 
so they all seem to be helpful in improving the mental health of PLWH.  
The second aim of the current meta-analysis was to study moderators of intervention effect, 
to determine whether important characteristics of a study or a therapy may influence the effectiveness 
of the treatments in question. We found that six factors may influence the effectiveness of a treatment 
for depression. Of these six factors, three could be classified as intervention characteristics: who 
provided the intervention, whether mental health was a primary focus of the intervention, and what 
the duration of treatment was. The other three were study characteristics: whether there was a priori 
screening for depression, what percentage of the participants in a study had AIDS, and what type of 
control group was included. Other factors, such as intervention techniques, were shown not to 
moderate intervention effect. 
We found that, overall, psychosocial interventions had a positive effect on depression, anxiety, 
quality of life, and psychological well-being of PLWH. However, the pooled effect size was small, ĝ = 
0.19. When the pooled effect sizes of the separate outcomes were examined, it was found that the 
pooled effect sizes on depression and psychological well-being were the largest; smaller pooled effect 
sizes were found on anxiety and quality of life. Previous meta-analyses (14-16) found mostly small to 
moderate effect sizes of psychosocial interventions for PLWH for the outcomes depression and anxiety. 
The effect size on the outcome quality of life was comparable with a previous meta-analysis, which 
also found a small effect (16). Furthermore, two previous meta-analyses investigated the effects of 
CBT and stress-management on stress (stress was included in the outcome psychological well-being in 
the present meta-analysis), and one of these found a moderate (14) and the other a small pooled effect 
size (16). These differences in effect sizes between the current study and previous ones may be 
explained by a difference in the focus of the interventions included. When the moderator analysis was 
conducted, it was found that when mental health was the primary focus of an intervention, the effects 
were larger than when this was not the primary focus of an intervention. Previous meta-analyses 
mainly included interventions whose primary aim was to improve mental health. This important 
difference between the current meta-analysis and previous meta-analyses may explain the smaller 
effects in this study. In addition, the current meta-analysis included 62 studies, while most previous 
meta-analyses included less than half this number of studies. The inclusion criteria of this meta-analysis 
were also broader: various psychosocial interventions and outcomes were included. For these reasons, 
this meta-analysis may have more power to detect a true effect.  
Furthermore, the analysis was conducted at several time points, to study the effect of 
interventions in both the short and the long term. It was found that the effect size was much smaller 
at the last time point (nine months or more after the intervention had ended), than at the earlier time 
 
points. Two previous meta-analyses (14, 18) about the effectiveness of CBT for PLWH with mental 
health problems also found that the effects were smaller on later follow-up assessments. This may 
indicate that the positive effects of interventions on the mental health of PLWH may wear off after a 
while. Booster sessions, follow-up sessions after termination of the therapy to prevent relapse, could 
be helpful to retain the effects. A similar finding emerged in a meta-analysis about the long-term 
effects of psychotherapy for depression (94). However, only nine studies in our meta-analysis had data 
available on the last time point, so the results should be interpreted with caution. For future studies 
into psychosocial interventions for PLWH with mental health problems, we advise including a longer 
follow-up period to further investigate the long-term effects. In addition, future research could study 
the effect of booster sessions. 
In the analysis on intervention types, no differences were found between the various 
intervention types. This is in line with previous meta-analyses about psychological therapies for 
depression in the general population or in people with medical disorders, which also found no 
differences in effectiveness between interventions such as CBT, interpersonal therapy, supportive 
therapy, and problem-solving therapy (94-98). It seems that several types of interventions may be 
useful to improve the mental health of PLWH. It has previously been argued more generally that 
various forms of psychotherapy may have the same effect, because they share common factors, such 
as the relationship with the therapist (99, 100). The specific type of therapy does not seem to be that 
important. This corresponds with our findings. For a more thorough investigation of the differences in 
effect between psychosocial interventions for PLWH, it is important to design studies that compare 
different types of interventions. Furthermore, it would also be interesting to know more about how 
treatments work (mediating factors), and to compare this between different treatments. Future 
studies should focus on these topics.  
In addition to the analysis on intervention types, we also investigated differences in effect 
between intervention techniques in the symptom-oriented interventions. No differences in effect 
were found between symptom-oriented interventions that included techniques of relaxation, CBT, 
stress-management, or motivational interviewing, on the one hand, and symptom-oriented 
interventions that did not include these techniques, on the other. This is related to the findings about 
intervention types and a previous meta-analysis that also did not find any differences between 
interventions that included or did not include stress management skills training (14). 
The subgroup analyses indicated that there were several moderators that influenced the 
effects of interventions on depression. An important moderator was a priori screening for depressive 
symptoms: when studies included only participants with depressive symptoms the effect sizes were 
larger than when the presence of depressive symptoms did not serve as an inclusion criterion. This 
result seems evident: there is more to gain for PLWH with depressive symptoms than for PLWH without 
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be effective for PLWH, from symptom-oriented interventions such as CBT, to supportive interventions 
and meditation. There were no differences in effectiveness between these different intervention types, 
so they all seem to be helpful in improving the mental health of PLWH.  
The second aim of the current meta-analysis was to study moderators of intervention effect, 
to determine whether important characteristics of a study or a therapy may influence the effectiveness 
of the treatments in question. We found that six factors may influence the effectiveness of a treatment 
for depression. Of these six factors, three could be classified as intervention characteristics: who 
provided the intervention, whether mental health was a primary focus of the intervention, and what 
the duration of treatment was. The other three were study characteristics: whether there was a priori 
screening for depression, what percentage of the participants in a study had AIDS, and what type of 
control group was included. Other factors, such as intervention techniques, were shown not to 
moderate intervention effect. 
We found that, overall, psychosocial interventions had a positive effect on depression, anxiety, 
quality of life, and psychological well-being of PLWH. However, the pooled effect size was small, ĝ = 
0.19. When the pooled effect sizes of the separate outcomes were examined, it was found that the 
pooled effect sizes on depression and psychological well-being were the largest; smaller pooled effect 
sizes were found on anxiety and quality of life. Previous meta-analyses (14-16) found mostly small to 
moderate effect sizes of psychosocial interventions for PLWH for the outcomes depression and anxiety. 
The effect size on the outcome quality of life was comparable with a previous meta-analysis, which 
also found a small effect (16). Furthermore, two previous meta-analyses investigated the effects of 
CBT and stress-management on stress (stress was included in the outcome psychological well-being in 
the present meta-analysis), and one of these found a moderate (14) and the other a small pooled effect 
size (16). These differences in effect sizes between the current study and previous ones may be 
explained by a difference in the focus of the interventions included. When the moderator analysis was 
conducted, it was found that when mental health was the primary focus of an intervention, the effects 
were larger than when this was not the primary focus of an intervention. Previous meta-analyses 
mainly included interventions whose primary aim was to improve mental health. This important 
difference between the current meta-analysis and previous meta-analyses may explain the smaller 
effects in this study. In addition, the current meta-analysis included 62 studies, while most previous 
meta-analyses included less than half this number of studies. The inclusion criteria of this meta-analysis 
were also broader: various psychosocial interventions and outcomes were included. For these reasons, 
this meta-analysis may have more power to detect a true effect.  
Furthermore, the analysis was conducted at several time points, to study the effect of 
interventions in both the short and the long term. It was found that the effect size was much smaller 
at the last time point (nine months or more after the intervention had ended), than at the earlier time 
 
points. Two previous meta-analyses (14, 18) about the effectiveness of CBT for PLWH with mental 
health problems also found that the effects were smaller on later follow-up assessments. This may 
indicate that the positive effects of interventions on the mental health of PLWH may wear off after a 
while. Booster sessions, follow-up sessions after termination of the therapy to prevent relapse, could 
be helpful to retain the effects. A similar finding emerged in a meta-analysis about the long-term 
effects of psychotherapy for depression (94). However, only nine studies in our meta-analysis had data 
available on the last time point, so the results should be interpreted with caution. For future studies 
into psychosocial interventions for PLWH with mental health problems, we advise including a longer 
follow-up period to further investigate the long-term effects. In addition, future research could study 
the effect of booster sessions. 
In the analysis on intervention types, no differences were found between the various 
intervention types. This is in line with previous meta-analyses about psychological therapies for 
depression in the general population or in people with medical disorders, which also found no 
differences in effectiveness between interventions such as CBT, interpersonal therapy, supportive 
therapy, and problem-solving therapy (94-98). It seems that several types of interventions may be 
useful to improve the mental health of PLWH. It has previously been argued more generally that 
various forms of psychotherapy may have the same effect, because they share common factors, such 
as the relationship with the therapist (99, 100). The specific type of therapy does not seem to be that 
important. This corresponds with our findings. For a more thorough investigation of the differences in 
effect between psychosocial interventions for PLWH, it is important to design studies that compare 
different types of interventions. Furthermore, it would also be interesting to know more about how 
treatments work (mediating factors), and to compare this between different treatments. Future 
studies should focus on these topics.  
In addition to the analysis on intervention types, we also investigated differences in effect 
between intervention techniques in the symptom-oriented interventions. No differences in effect 
were found between symptom-oriented interventions that included techniques of relaxation, CBT, 
stress-management, or motivational interviewing, on the one hand, and symptom-oriented 
interventions that did not include these techniques, on the other. This is related to the findings about 
intervention types and a previous meta-analysis that also did not find any differences between 
interventions that included or did not include stress management skills training (14). 
The subgroup analyses indicated that there were several moderators that influenced the 
effects of interventions on depression. An important moderator was a priori screening for depressive 
symptoms: when studies included only participants with depressive symptoms the effect sizes were 
larger than when the presence of depressive symptoms did not serve as an inclusion criterion. This 




depressive symptoms. A previous meta-analysis also found that in studies that included PLWH with 
more anxiety symptoms at baseline, the participants benefited more from stress-management 
interventions (16). On the other hand, another meta-analysis into the effectiveness of CBT for PLWH 
with depression and anxiety found no inclusion- related differences between studies: there was no 
difference between studies that restricted participation to those with depressive symptoms and 
studies that did not have the presence of depressive symptoms as an inclusion criterion (14). However, 
in this meta-analysis the number of studies in each category was low. All in all, when an intervention 
is aimed at reducing depression, it seems favorable to screen PLWH a priori and only offer them the 
treatment if they actually suffer from depressive symptoms.  
Another significant moderator was whether mental health was the primary focus of an 
intervention. In studies where mental health was the primary focus of the intervention, the effects 
were larger than in studies where mental health was not the primary focus. Again, this result seems 
logical: if the aim of an intervention is to reduce depression, participants will work on reducing 
symptoms during treatment, and it is expected that this will be effective. If the aim of an intervention 
is to quit smoking, for example, this will be the focus of the therapy and it is not so likely that 
participants’ psychological symptoms will also improve. 
We found that studies that had a psychologist or psychotherapist as a provider of the 
intervention had the largest pooled effect sizes. Studies that had other providers, e.g., 
counsellors, peers, or computers, all had smaller effect sizes in general. This shows that it may 
not be so important which specific therapy or technique is used to treat mental health problems 
in PLWH; the key element may be the provider of the intervention. Psychologists have a broad 
training in treating mental health problems, so they may be more experienced and more 
competent to help PLWH in need. This is in contrast with most other providers; they may be 
trained to provide the intervention, but this may not be comparable to psychologists’ education 
and experience in mental health care. However, a previous meta-analysis about CBT for 
depression and anxiety in PLWH found no differences in effects between studies in which 
interventions were provided by a psychologist or psychiatrist and studies in which interventions 
were delivered by trained research staff (e.g., graduate- and doctoral-level students) (14). 
Further, two meta-analyses on guided self-help (101) or guided computerized interventions (102) 
for depression or anxiety also did not find differences in effects between studies involving 
experienced providers (e.g., psychologists) and those involving less experienced providers (e.g., 
students). However, the moderator analysis in this meta-analysis comprised many more studies 
than those in the previous meta-analyses, so it has more power to detect differences. To 
conclude, psychologists and psychotherapists may be the most qualified providers of 
 
psychosocial treatments for PLWH with mental health problems. More research is needed to 
confirm this. 
The duration of treatment was another important moderator in this meta-analysis. We found 
that studies with a treatment duration of 12-18 hours had the largest effect sizes, compared to 
treatments of shorter or longer duration. So, it seems that therapies of average duration may be more 
effective than treatments of short or long duration. However, there is a trend toward designing concise 
treatments for mental health problems, which can be provided via the Internet and are thought to be 
more cost-effective. An RCT that compared the effectiveness of concise CBT with standard CBT for 
depression and anxiety found that they were equivalent (103). Most previous meta-analyses that have 
investigated the effectiveness of psychological interventions for depression or anxiety have also found 
no differences between treatments with a short or long duration (14, 95, 97, 101, 102). One meta-
analysis about online CBT for patients with chronic somatic conditions and depression did find an effect 
of treatment duration, with a larger effect size for treatments with a longer duration (104). Some of 
the previous meta-analyses (14, 101, 102, 104) included a small number of studies in the moderator 
analysis, but other meta-analyses (95, 97) included more than 100 studies. Hence, it is not yet clear 
whether the effectiveness of a treatment is related to its duration. When comparing short and long 
treatments for mental health problems, it may be useful to take the severity of the symptoms into 
account. People with more severe symptoms may need more sessions than people with a mild or 
moderate symptom severity (105). Future studies may focus on this topic. 
Contrary to expectations, the type of control group was a significant moderator in this meta-
analysis. Studies that had a waiting list control group had smaller effect sizes than studies with a 
standard care or active control group. This is counterintuitive, since participants on a waiting list do 
not receive any treatment, which would lead us to expect large differences between the intervention 
and the control condition (106). However, there were only five studies in the moderator analysis that 
used a waiting list control condition, so firm conclusions cannot be drawn. Previous meta-analyses on 
the effectiveness of interventions for depression and anxiety found no differences between control 
group types (14, 94, 102), or found that the studies that used a waiting list control condition had larger 
effect sizes than other control group types (95, 101, 102).  
The last significant moderator was the percentage of participants in the study who had AIDS. 
When fewer than 40% of the participants in a study had received a diagnosis of AIDS, the effect sizes 
were larger than when more than 40% of the participants had AIDS. People with AIDS are generally 
more physically ill – they suffer from more pain and lack of energy – than people without AIDS. This 
physical discomfort may have a great influence on their mental well-being: i.e., they may feel more 
sad, worry more, or have difficulties sleeping (1). Therefore, it may be more difficult to treat these 
psychological symptoms in people with AIDS. That is, the physical symptoms remain, and their 
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depressive symptoms. A previous meta-analysis also found that in studies that included PLWH with 
more anxiety symptoms at baseline, the participants benefited more from stress-management 
interventions (16). On the other hand, another meta-analysis into the effectiveness of CBT for PLWH 
with depression and anxiety found no inclusion- related differences between studies: there was no 
difference between studies that restricted participation to those with depressive symptoms and 
studies that did not have the presence of depressive symptoms as an inclusion criterion (14). However, 
in this meta-analysis the number of studies in each category was low. All in all, when an intervention 
is aimed at reducing depression, it seems favorable to screen PLWH a priori and only offer them the 
treatment if they actually suffer from depressive symptoms.  
Another significant moderator was whether mental health was the primary focus of an 
intervention. In studies where mental health was the primary focus of the intervention, the effects 
were larger than in studies where mental health was not the primary focus. Again, this result seems 
logical: if the aim of an intervention is to reduce depression, participants will work on reducing 
symptoms during treatment, and it is expected that this will be effective. If the aim of an intervention 
is to quit smoking, for example, this will be the focus of the therapy and it is not so likely that 
participants’ psychological symptoms will also improve. 
We found that studies that had a psychologist or psychotherapist as a provider of the 
intervention had the largest pooled effect sizes. Studies that had other providers, e.g., 
counsellors, peers, or computers, all had smaller effect sizes in general. This shows that it may 
not be so important which specific therapy or technique is used to treat mental health problems 
in PLWH; the key element may be the provider of the intervention. Psychologists have a broad 
training in treating mental health problems, so they may be more experienced and more 
competent to help PLWH in need. This is in contrast with most other providers; they may be 
trained to provide the intervention, but this may not be comparable to psychologists’ education 
and experience in mental health care. However, a previous meta-analysis about CBT for 
depression and anxiety in PLWH found no differences in effects between studies in which 
interventions were provided by a psychologist or psychiatrist and studies in which interventions 
were delivered by trained research staff (e.g., graduate- and doctoral-level students) (14). 
Further, two meta-analyses on guided self-help (101) or guided computerized interventions (102) 
for depression or anxiety also did not find differences in effects between studies involving 
experienced providers (e.g., psychologists) and those involving less experienced providers (e.g., 
students). However, the moderator analysis in this meta-analysis comprised many more studies 
than those in the previous meta-analyses, so it has more power to detect differences. To 
conclude, psychologists and psychotherapists may be the most qualified providers of 
 
psychosocial treatments for PLWH with mental health problems. More research is needed to 
confirm this. 
The duration of treatment was another important moderator in this meta-analysis. We found 
that studies with a treatment duration of 12-18 hours had the largest effect sizes, compared to 
treatments of shorter or longer duration. So, it seems that therapies of average duration may be more 
effective than treatments of short or long duration. However, there is a trend toward designing concise 
treatments for mental health problems, which can be provided via the Internet and are thought to be 
more cost-effective. An RCT that compared the effectiveness of concise CBT with standard CBT for 
depression and anxiety found that they were equivalent (103). Most previous meta-analyses that have 
investigated the effectiveness of psychological interventions for depression or anxiety have also found 
no differences between treatments with a short or long duration (14, 95, 97, 101, 102). One meta-
analysis about online CBT for patients with chronic somatic conditions and depression did find an effect 
of treatment duration, with a larger effect size for treatments with a longer duration (104). Some of 
the previous meta-analyses (14, 101, 102, 104) included a small number of studies in the moderator 
analysis, but other meta-analyses (95, 97) included more than 100 studies. Hence, it is not yet clear 
whether the effectiveness of a treatment is related to its duration. When comparing short and long 
treatments for mental health problems, it may be useful to take the severity of the symptoms into 
account. People with more severe symptoms may need more sessions than people with a mild or 
moderate symptom severity (105). Future studies may focus on this topic. 
Contrary to expectations, the type of control group was a significant moderator in this meta-
analysis. Studies that had a waiting list control group had smaller effect sizes than studies with a 
standard care or active control group. This is counterintuitive, since participants on a waiting list do 
not receive any treatment, which would lead us to expect large differences between the intervention 
and the control condition (106). However, there were only five studies in the moderator analysis that 
used a waiting list control condition, so firm conclusions cannot be drawn. Previous meta-analyses on 
the effectiveness of interventions for depression and anxiety found no differences between control 
group types (14, 94, 102), or found that the studies that used a waiting list control condition had larger 
effect sizes than other control group types (95, 101, 102).  
The last significant moderator was the percentage of participants in the study who had AIDS. 
When fewer than 40% of the participants in a study had received a diagnosis of AIDS, the effect sizes 
were larger than when more than 40% of the participants had AIDS. People with AIDS are generally 
more physically ill – they suffer from more pain and lack of energy – than people without AIDS. This 
physical discomfort may have a great influence on their mental well-being: i.e., they may feel more 
sad, worry more, or have difficulties sleeping (1). Therefore, it may be more difficult to treat these 




influence on the mental state may hamper a successful response to treatment. Therefore, it may be 
important to combine medical and psychosocial treatments in people with AIDS, to try to improve or 
stabilize both the physical and psychological symptoms. In this situation, effective collaboration 
between treatment providers is crucial. It should be noted that this moderator analysis was based on 
only ten studies, so the results should be interpreted cautiously and may not be generalizable to other 
study samples. 
This meta-analysis had some limitations, which will be discussed here. First, there was 
evidence of publication bias. This may indicate that studies with negative effect sizes were missing in 
the analysis. When these possible missing studies were imputed and a corrected effect size was 
calculated, it was smaller than the uncorrected effect size. So, it has to be concluded that the overall 
effect of psychosocial interventions on the mental health of PLWH is small. Second, the quality of the 
studies included was mostly low or medium; only 16% of the studies included was of high quality. The 
quality criteria regarding the concealment of allocation to conditions and the availability of a published 
study protocol, especially, were often not clearly reported in the studies included. Therefore, it is 
possible that some studies were classified as low or medium quality studies now, while they may have 
been classified as high quality studies when there would be more information in the paper concerning 
these criteria. Besides this, it is evident that low quality studies often did not do an intent-to-treat 
analysis. It would be advisable for future studies to state whether they have complied with the criteria, 
and that incomplete outcome data will be adequately addressed. A limitation of the instruments used 
to assess study quality is that when many criteria are not clearly described in a paper, a study was 
classified as a low quality study. However, study quality was not a significant moderator in the analysis 
on depression, so studies of high quality did not have larger effect sizes than studies of lower quality. 
Third, in some of the moderator analyses, only a few studies could be included. This is related to the 
fact that some studies did not report on all moderator variables. Consequently, the results of the 
moderator analyses with few studies may not be representative for all of the studies included, and the 
power is lower in these analyses. Fourth, many moderator analyses were performed in this study, and 
no correction for multiple testing was applied. This increases the risk of finding spurious moderator 
effects. Fifth, the outcomes in this meta-analysis were restricted, so the effect of psychosocial 
interventions on other relevant outcomes (e.g., PTSD) was not investigated. Though, a recent review 
(107) found two CBT-based interventions that were effective in decreasing PTSD symptoms in PLWH. 
Therefore, it is possible that the findings of the current meta-analysis also apply to PTSD. However, 
only two studies were found in the review, so more research into interventions for PTSD in PLWH is 
necessary. Sixth, although we searched in three databases and in the references of previous meta-
analyses and reviews, it is still possible that some relevant articles were not found with this search 
strategy. Seventh, the moderator concerning the theory content of the intervention had two 
 
categories: theory driven or not theory-driven. For each study, it was determined to which of the 
categories it belonged by reading the paper. It could be argued that this is not a completely thorough 
approach, because an intervention may still be based on theory, despite the fact that it is not stated in 
the paper. Furthermore, interventions may be evidence-based, but not based on a specific theory. Or 
the other way around: it may be based on a theory, but it is not evidence-based. So, it is recommended 
for future studies to mention in the paper whether the investigated intervention was theory-driven 
and/or evidence-based. Last, in the moderator analysis on the effect of intervention characteristics, all 
interventions were investigated separately. This approach was chosen because in some studies two 
interventions were investigated, and the interventions did not always belong to the same category of 
a moderator (e.g., one intervention in a given study may have a treatment duration of four hours and 
another a treatment duration of eight hours). Therefore, six studies were represented twice in these 
analyses. It would be preferable to use each study just once in the analysis, but this was not possible 
here. 
Some recommendations for future research may be derived from the results of this meta-
analysis. First, future studies should focus on investigating differences between various interventions: 
how they work and for whom they work. Second, the long-term effects of psychosocial interventions 
and the effect of booster sessions should be investigated more thoroughly in the future. Third, most 
studies in the current meta-analysis were conducted in the USA and in Europe. Since the prevalence 
of HIV is high in low and middle income countries and mental health problems are common in this 
population, interventions to treat these problems are needed (108). However, there are significant 
barriers to providing mental health services in these countries, e.g., there is a lack of trained mental 
health workers (109). Therefore, it is important that these interventions are adapted to the local 
culture, are brief, can be provided by non-specialists, and are tailored for PLWH. It was found that 
interventions for PLWH in low and middle income countries were effective when they were focused 
on the family and integrated into community based health care (110). More research is recommended 
on mental health interventions for PLWH in low and middle income countries. Fourth, there were a lot 
of changes in the past twenty years in the mental health care for PLWH and in study methodologies. 
We investigated the effects of many moderators, but there will be issues that were not addressed. For 
future studies, it is important to be aware of the changes in mental health care and study design. Fifth, 
it is likely that moderator effects were relsated, e.g., when there was a screening for depression in a 
study, this may be related to the fact that the primary focus of the intervention in the study was on 
mental health. These relations between moderators were not examined in the current meta-analysis, 
but are interesting to investigate in future meta-analyses. The most optimal result of an intervention 
may be obtained when the most effective characteristics will be combined in an intervention. Sixth, 
the moderation analysis indicated that the effect sizes were larger for studies that solely included 
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influence on the mental state may hamper a successful response to treatment. Therefore, it may be 
important to combine medical and psychosocial treatments in people with AIDS, to try to improve or 
stabilize both the physical and psychological symptoms. In this situation, effective collaboration 
between treatment providers is crucial. It should be noted that this moderator analysis was based on 
only ten studies, so the results should be interpreted cautiously and may not be generalizable to other 
study samples. 
This meta-analysis had some limitations, which will be discussed here. First, there was 
evidence of publication bias. This may indicate that studies with negative effect sizes were missing in 
the analysis. When these possible missing studies were imputed and a corrected effect size was 
calculated, it was smaller than the uncorrected effect size. So, it has to be concluded that the overall 
effect of psychosocial interventions on the mental health of PLWH is small. Second, the quality of the 
studies included was mostly low or medium; only 16% of the studies included was of high quality. The 
quality criteria regarding the concealment of allocation to conditions and the availability of a published 
study protocol, especially, were often not clearly reported in the studies included. Therefore, it is 
possible that some studies were classified as low or medium quality studies now, while they may have 
been classified as high quality studies when there would be more information in the paper concerning 
these criteria. Besides this, it is evident that low quality studies often did not do an intent-to-treat 
analysis. It would be advisable for future studies to state whether they have complied with the criteria, 
and that incomplete outcome data will be adequately addressed. A limitation of the instruments used 
to assess study quality is that when many criteria are not clearly described in a paper, a study was 
classified as a low quality study. However, study quality was not a significant moderator in the analysis 
on depression, so studies of high quality did not have larger effect sizes than studies of lower quality. 
Third, in some of the moderator analyses, only a few studies could be included. This is related to the 
fact that some studies did not report on all moderator variables. Consequently, the results of the 
moderator analyses with few studies may not be representative for all of the studies included, and the 
power is lower in these analyses. Fourth, many moderator analyses were performed in this study, and 
no correction for multiple testing was applied. This increases the risk of finding spurious moderator 
effects. Fifth, the outcomes in this meta-analysis were restricted, so the effect of psychosocial 
interventions on other relevant outcomes (e.g., PTSD) was not investigated. Though, a recent review 
(107) found two CBT-based interventions that were effective in decreasing PTSD symptoms in PLWH. 
Therefore, it is possible that the findings of the current meta-analysis also apply to PTSD. However, 
only two studies were found in the review, so more research into interventions for PTSD in PLWH is 
necessary. Sixth, although we searched in three databases and in the references of previous meta-
analyses and reviews, it is still possible that some relevant articles were not found with this search 
strategy. Seventh, the moderator concerning the theory content of the intervention had two 
 
categories: theory driven or not theory-driven. For each study, it was determined to which of the 
categories it belonged by reading the paper. It could be argued that this is not a completely thorough 
approach, because an intervention may still be based on theory, despite the fact that it is not stated in 
the paper. Furthermore, interventions may be evidence-based, but not based on a specific theory. Or 
the other way around: it may be based on a theory, but it is not evidence-based. So, it is recommended 
for future studies to mention in the paper whether the investigated intervention was theory-driven 
and/or evidence-based. Last, in the moderator analysis on the effect of intervention characteristics, all 
interventions were investigated separately. This approach was chosen because in some studies two 
interventions were investigated, and the interventions did not always belong to the same category of 
a moderator (e.g., one intervention in a given study may have a treatment duration of four hours and 
another a treatment duration of eight hours). Therefore, six studies were represented twice in these 
analyses. It would be preferable to use each study just once in the analysis, but this was not possible 
here. 
Some recommendations for future research may be derived from the results of this meta-
analysis. First, future studies should focus on investigating differences between various interventions: 
how they work and for whom they work. Second, the long-term effects of psychosocial interventions 
and the effect of booster sessions should be investigated more thoroughly in the future. Third, most 
studies in the current meta-analysis were conducted in the USA and in Europe. Since the prevalence 
of HIV is high in low and middle income countries and mental health problems are common in this 
population, interventions to treat these problems are needed (108). However, there are significant 
barriers to providing mental health services in these countries, e.g., there is a lack of trained mental 
health workers (109). Therefore, it is important that these interventions are adapted to the local 
culture, are brief, can be provided by non-specialists, and are tailored for PLWH. It was found that 
interventions for PLWH in low and middle income countries were effective when they were focused 
on the family and integrated into community based health care (110). More research is recommended 
on mental health interventions for PLWH in low and middle income countries. Fourth, there were a lot 
of changes in the past twenty years in the mental health care for PLWH and in study methodologies. 
We investigated the effects of many moderators, but there will be issues that were not addressed. For 
future studies, it is important to be aware of the changes in mental health care and study design. Fifth, 
it is likely that moderator effects were relsated, e.g., when there was a screening for depression in a 
study, this may be related to the fact that the primary focus of the intervention in the study was on 
mental health. These relations between moderators were not examined in the current meta-analysis, 
but are interesting to investigate in future meta-analyses. The most optimal result of an intervention 
may be obtained when the most effective characteristics will be combined in an intervention. Sixth, 




PLWH with mental health problems and for interventions that were focused on mental health. 
Therefore, it is recommended in future intervention studies to restrict the inclusion to participants 
with mental health problems and to design interventions that are focused on improving mental health. 
Last, for new studies, it is important to measure and report on study and treatment characteristics, so 
that studies and interventions can be compared in meta-analyses. 
To conclude, this systematic review and meta-analysis included 62 RCTs and therefore has high 
power. In addition, the effects of multiple intervention and study characteristics on treatment 
outcome were investigated. The meta-analysis found that, overall, psychosocial interventions may 
have a small positive effect on the mental health of PLWH. No differences in effect were found 
between the three intervention types, which means that symptom-oriented interventions, supportive 
interventions, and meditation may all be effective. A larger improvement in depression may be 
obtained when only participants with depressive symptoms are included in the study; when 
interventions are provided by psychologists; when treatment duration is 12-18 hours; and when the 
intervention is focused on improving mental health. Based on the results of this meta-analysis, it is 
important to incorporate psychosocial therapies into the care of PLWH with mental health problems. 
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(exp "Human immunodeficiency virus"/ OR exp "Human immunodeficiency virus infection"/ OR exp 
"Acquired immune deficiency syndrome"/ OR hiv.tw. OR aids.tw. ) AND (exp psychotherapy/ or exp 
"mental health services"/ or exp "self care"/ OR exp "self help"/ OR exp teletherapy/ OR exp "computer 
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About 40% of people living with HIV do not sufficiently adhere to their medication regimen, which 
adversely affects their health. The current meta-analysis investigated the effect of psychosocial 
interventions on medication adherence in people living with HIV. Databases were systematically 
searched, resulting in 43 included randomized controlled trials. Study and intervention characteristics 
were investigated as moderators. The overall effect size indicates a small to moderate positive effect 
(Hedges’ g = 0.37) of psychosocial interventions on medication adherence in people living with HIV. No 
evidence for publication bias was found. This meta-analysis study concludes that various psychosocial 
interventions can improve medication adherence and thereby the health of people living with HIV.  
 




The WHO (2016) estimated that by the end of 2014, 37 million people worldwide were living with HIV, 
and two million became infected that year. If the virus is not treated with medication, it attacks the 
immune system, which may result in various health problems, AIDS, and eventually death (1). 
Medication adherence is important in tackling this pandemic and promoting health in people living 
with HIV (PLWH). Effective drug treatment has made HIV a chronic rather than a lethal condition. 
However, it also introduced new challenges. HIV drug treatment involves taking pills daily and adhering 
to treatment is difficult for many PLWH. 
Antiretroviral therapy (ART) is a combination of at least two, but usually three, antiretroviral 
drug classes that suppresses viral replication (2). In addition, ART lowers the chances of transmission 
through sexual risk behaviour (3), birth and breastfeeding (4), and prevents spreading of the HIV 
pandemic. Its introduction in 1996 provided PLWH with the chance to stop disease progression and 
lethality (5). Initially, treatment involved taking several pills daily and had many adverse effects. 
Nowadays, ART has less side effects and simpler pill regimens. These developments have increased 
treatment adherence (6). Major remaining challenges are the daily dosing, lifelong treatment, and side 
effects. A meta-analysis that included 84 studies conducted worldwide from 1999 to 2009 found that 
only 62% of people on ART took their prescribed doses > 90% of the time (7). Increasing medication 
adherence should be a focus in the HIV care. 
Non-adherence to ART is associated with mental health problems and psychological stressors 
such as depression (8), life events (9), substance abuse (10), and anxiety (11). A meta-analysis found 
that psychological factors are among the strongest correlates of non-adherence, stronger than other 
factors, for example, pill burden (12). Furthermore, mental health problems are highly prevalent in 
PLWH; the prevalence of depression is about 34%, and of anxiety 28% (13). The way in which mental 
health problems and non-adherence are related is complex. Some antiretroviral drugs can have side 
effects such as mood changes, depression, and anxiety. In turn, PLWH with mental health problems 
may have more difficulty adhering, because of cognitive or behavioural problems, for example, fatigue, 
hopelessness, lowered motivation and concentration (14).  
Like physical and mental health, sexual health is related to ART. ART non-adherence has been 
linked to more sexual risk taking, for example, having unprotected sex, and greater risk of transmission. 
Depression, sexual risk behaviour, and adherence may be related: it was found that depression leads 
to less ART adherence and condom use (15). Non-adherence may also be related to lower 
socioeconomic status, such as lower income and education, and more unemployment. However, not 
all studies support this relationship (16). Psychosocial interventions may influence vulnerabilities in 
socioeconomic status physical, mental and sexual health.  
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It is important to treat medication non-adherence in PLWH, because optimal adherence should 
improve PLWH’s health and well-being, and lower transmission risks. Treatments that do not address 
mental health problems as possible causes of non-adherence may be less effective than those that do. 
For instance, medication reminder devices focus on forgetfulness rather than mental health and have 
shown inconsistent effectiveness (17). In contrast, antidepressant treatments for PLWH consistently 
increase ART adherence (18). However, psychopharmacological treatment may cause side effects (e.g. 
reduced libido and inorgasmia), drug interaction, and increased pill burden, which predict lower 
adherence and worse virologic suppression (6). Therefore, psychosocial treatments may be preferred 
to treat non-adherence in PLWH. 
Psychosocial interventions are primarily focussed on psychological or social factors, instead of 
purely focussing on medical factors such as pharmacological treatment or exercise (19). Systematic 
reviews and meta-analyses that investigated the effectiveness of psychosocial interventions on ART 
adherence, such as motivational interviewing, cognitive behavioural therapy (CBT), peer support, or 
counselling, have found promising but inconsistent results. Most reviews (20) and meta-analyses  (21-
23) found that psychosocial interventions may increase ART adherence. However, some reviews 
showed negative or mixed results (24-26). A limitation of these findings is that they are partly based 
on low quality studies. Furthermore, some results come from systematic reviews that do not 
recombine the raw data.  
In addition to investigating the effectiveness of psychosocial interventions, it is important to 
examine factors (moderators) that may influence it. First, treatment characteristics are factors of the 
therapy, such as duration. Knowledge about which treatment characteristics influence effectiveness 
positively may be used when designing interventions. Furthermore, study characteristics, such as the 
geographical and temporal context of data collection, may partially explain differences between 
studies. Previous reviews and meta-analyses found larger effects on ART adherence when 
interventions involved CBT components (24), more therapist training (20), targeted adherence risk or 
difficulty groups (21) or people with more severe depression (23), longer duration (23, 26), individual 
setting (26), and adherence measures with recall periods > 7 days (22).  
The current meta-analysis investigated the effectiveness of various types of psychosocial 
interventions on medication adherence in PLWH. To promote the methodological quality of the meta-
analysis and strength of the conclusions, only randomized controlled trials (RCTs) were included. 






Literature search and study selection 
Published literature was searched on November 5, 2014 through the databases PsycInfo (EBSCOhost), 
Embase (Ovid), and Medline (PubMed). Search words were related to three categories; that is, words 
related to HIV, psychosocial interventions, and ART adherence. An overview of the used search terms 
is provided in Supplement A. Trials were also identified in published review articles and meta-analyses. 
Unpublished studies were not included.   
Database searches yielded 687 unique articles; Figure 1 shows the search and selection process. 
Titles and abstracts were reviewed, and if the article appeared to meet inclusion criteria (described 
below), its full text was retrieved. Then, a final selection was made based on their accordance with the 
inclusion criteria. This process resulted in 51 unique articles. Consulting previous review articles and 
meta-analyses resulted in another three articles. Data from 19 articles were not sufficient to calculate 
an effect size. The study authors were requested by e-mail to provide such data; eight authors provided 
the data (42%), nine replied but could not provide data (47%), and two could not be reached (11%). 
The final analysis included 43 studies.  
The selection of the first 50 titles and abstracts was executed independently by two 
researchers (first and second authors). The interrater reliability for this selection indicated substantial 
agreement (27), κ = 0.63, p < 0.001. The rest of the studies were selected by the first author. In cases 




Studies were included in the meta-analysis if they (a) used a randomized controlled design, (b) 
provided a psychosocial intervention, (c) provided the intervention post 1996, after development of 
ART, (d) included PLWH age ≥ 18 years, (e) reported ART adherence as outcome, and (f) were published 
in English. For criterion (b), psychosocial interventions are defined as interventions primarily focussed 
on psychological or social factors, in contrast to treatments that focus purely on medical factors such 
as pharmacological treatment or exercise (19). Full-text articles’ eligibility was inspected in the order: 
(f), (d), (a), (c), (b), and (e).   
Using these criteria, selected studies could overlap in terms of sample or data. Rules for 
addressing multiplicity were set a priori. First, if multiple articles reported on the same trial, the article 
with the most relevant outcome data (e.g. on the complete sample) was used to determine the effect 
size. Second, if a study researched multiple interventions and a control group, the most intensive 
intervention was used in the analysis. Third, when studies had multiple control groups, the control 
group most similar to standard care was used in the analysis. Studies including only active interventions, 
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but no control group, were not included. If multiple outcome measures were used, the most precise 




Figure 1. Flowchart illustrating study identification, inclusion and exclusion. 
 
Data coding 
Data coding was conducted with an a priori developed protocol. Coding included effect size data and 
sample, study and intervention characteristics data. Ten studies were coded by two independent 
researchers (first and second authors). The percentage of agreement over 37 variables was 86%, 
indicating acceptable agreement in most situations (28). In case of disagreement the article was 
consulted again. The first author coded the remaining studies.  
Medication adherence was coded for the treatment and control group based on the average 
percentage of post-treatment ART adherence. When articles did not provide the statistics necessary 
to calculate the effect size (sample size, mean and standard deviation (SD) or mean difference, t-value 
or p-value), the authors were contacted by e-mail. When the data could be not obtained, studies were 
excluded.  
Coding of study characteristics included study aim (increasing adherence or improving overall 
mental or physical health), location, type of control group (waiting list, standard care or active control 
group), measurement type (self-report, monitoring device or pill count), recall period of the measure 
 
(≤ 14 days, > 14 days or no recall: monitoring devices or pill count), percentage retention (participants 
that were available at the post-treatment assessment), mean age of the sample, percentage of females, 
sexual orientation or identity (homosexual/gay, heterosexual/straight or bisexual), ethnicity (African 
American or Black, Caucasian or White and Hispanic or Latino), percentage of participants with AIDS, 
years since HIV diagnosis and type of risk group (general, risk group or difficulty group). The sample 
was considered an a priori risk group if known risk factors, for example, experiencing distress from side 
effects, were an inclusion criterion. The sample was considered an a priori difficulty group if 
problematic adherence was an inclusion criterion. Other samples were considered general PLWH 
groups. Standard care control groups usually consisted of consultations with a physician or nurse and 
short education on medication use and adherence (e.g. (29)). An active control group was an intensive 
control condition, for example, of similar duration (time-matched) or intensity (dose-matched) as the 
intervention.  
The intervention characteristics included treatment type (CBT, peer/social support or 
counselling), provider (psychologist/psychiatrist, counsellor, nurse, peer, healthcare professional or 
other), setting (individual, group or both), treatment duration (1-5, 5-12, 12-30 hours), and use of 
cognitive and/or behavioural techniques, motivational interviewing and relaxation. An intervention 
was categorised as CBT if it involved treatment techniques aimed at behavioural and cognitive change. 
Peer or social support interventions included support through peers or others. Counselling 
interventions were non-directive or aimed at problem-solving or changing adherence motivation or 
behaviour. Treatment duration would originally be used in meta-regression to test a dose-response 
effect. However, meta-regression assumptions (normality and linearity) were not met. Therefore, it 
was transformed to a categorical variable. 
 
Statistical analysis 
The meta-analysis was conducted using Comprehensive Meta-Analysis Version 2 (CMA; (30)). Effect 
sizes were expressed as Hedges’ g, computed with the standardized mean difference between the 
intervention and control group in average percentage of post-treatment medication adherence. Effect 
sizes of 0.2 were considered small, 0.5 medium and 0.8 large (31). Reported p-values are two-tailed. 
The effect sizes were checked for outliers with standardized residuals > 3. Outliers were transformed 
toward the mean (winsorized), so that they had a less disproportionate effect on the analyses. The 
effect sizes were winsorized to 3 SDs from the mean in the original direction (32). Two positive outliers 
were found and transformed (33, 34). 
Effect sizes were analysed using the random effects model. This model assumes heterogeneity 
across studies (32). For moderator analyses, a mixed model was used. The random effects model 
combined the studies per subgroup. Because subgroups were assumed to be exhaustive, a fixed effects 
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model combined the subgroup effects. Between-study variance was assumed to be similar across 
subgroups and was pooled. To examine heterogeneity between studies, the Q and I² statistics were 
used. When Q is significant, this indicates important outcome differences across studies. I² represents 
the amount of heterogeneity, where values of 25%, 50% and 75% indicate low, moderate and high 
heterogeneity respectively (35). Unfortunately, CMA version 2 does not allow post hoc multiple 
comparisons. If a significant moderator analysis compares more than two subgroups, it is unclear 
which subgroups differ from each other. In these cases, confidence intervals (CIs) were inspected to 
interpret differences.  
Trim-and-fill analysis and Egger’s regression were conducted to test for publication bias. Duval 
and Tweedie’s trim-and-fill analysis (36) estimates the amount of missing studies due to publication 
bias and the effect size when correcting for it. Egger’s regression tests whether the intercept 




The 43 studies included 5095 participants recruited from 1997 to 2013. Key characteristics per study 
are presented in Supplement B. Almost two-thirds of the participants were male (65%). Study samples 
ranged from 33 to 249 participants. Most studies were conducted in the United States (35/43) and the 
rest in Brazil, China, India, Kenya, the Netherlands, Nigeria, Spain and Switzerland. Participant’s 
average age was 42 years (k = 42, pooled SD = 8.9, k = 37; the discrepancy in the amount of studies is 
due to reporting differences). In studies that reported on the sexual orientation or identity of their 
sample, most participants described themselves as heterosexual or straight (38%, k = 17), homosexual 
or gay (35%, k = 13) and some as bisexual (8%, k = 13). Regarding ethnicity, the authors reported that 
45% of participants self-identified as Black or African American (k = 35), 35% as White or Caucasian (k 
= 34) and 21% as Latino or Hispanic (k = 25). The average time of HIV infection at baseline was 10 years 
in the 18 studies that reported on it (pooled SD = 6.8, k =14) and 41% of participants had AIDS (k = 11). 
Forty percent of studies focussed on at-risk populations (17/43), 42% on adherence difficulties’ 
populations (18/43) and 19% screened neither on risk factors nor difficulties (8/43). 
Study aim was mostly increasing adherence (28/43) and sometimes improving (mental) health 
(15/43). Adherence was mostly measured with self-report (21/43) or a monitoring device (19/43), and 
rarely by pill count (3/43). Eleven self-report studies had recall periods ≤ 2 weeks; 10 had longer periods. 
Control groups frequently received standard care (28/43) and sometimes more active interventions 
(9/43). Alternatively, participants were put on a waiting list (6/43). The average percentage of 
retention was 83% in treatment groups and 84% in control groups (k = 41). 
 
Intervention characteristics 
In all, 22 studies investigated the effectiveness of counselling, 15 investigated CBT and 6 peer support. 
Cognitive and/or behavioural techniques were used in 58% of interventions (25/43), motivational 
interviewing in 40% (17/43) and relaxation in 19% (8/43). Most interventions were provided 
individually (32/43), some in group format (7/43) or a combination (4/43). All interventions except one 
were provided in an outpatient setting. Interventions were provided by psychiatrists or psychologists 
(10/43), counsellors (4/43), nurses (8/43), peers (7/43), healthcare professionals (case or social 
workers, 9/43) or other (including online interventions; 5/43).  
 Treatment duration could be estimated for 33 studies (77%). An outlier was removed from this 
analysis because the study was unique in terms of setting and an extreme, influential outlier (38). Its 
treatment duration was 104 hours and it was the only study with an inpatient setting. The average 
treatment duration in the rest of the studies was 8.15 hours (SD = 8.08, range: 1–30). 
 
Main analysis 
The random effects model meta-analysis of the overall sample (k = 43) resulted in a Hedges’ g effect 
size of 0.37 (95% CI [0.23, 0.52], p < 0.001). This indicates that average post-treatment medication 
adherence was higher in treatment than control groups, and the overall effect size was statistically 
different from zero. It shows a small to moderate positive effect of psychosocial interventions on 
medication adherence in PLWH. Figure 2 shows the effect size and 95% CI per study in a forest plot. 
The test of heterogeneity indicated significant between-study variance, Q(42) = 240.05, p < 
0.001. The variance caused by effect differences between studies, rather than chance (I2 = 83%), was 
considerable (35). This result supports the a priori choice of the random effects model and allows 
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Figure 2. Forest plot showing the effect of psychosocial interventions on medication adherence. 
 
Moderator analyses 
Study characteristics explain some heterogeneity between studies, specifically the measurement type 
and recall period; see Table 1. Effect sizes were largest for studies measuring adherence by pill count; 
next were studies that used a monitoring device and the smallest effects were found for studies that 
used self-report measures. Unfortunately, the measurement type moderator analysis was unfit for 
further inferential interpretation; it included a subgroup based on three samples (pill count) and had 
incomparable CIs. Because the pill-count group was small, the results were influenced largely by a 
winsorized outlier, regardless of its transformation toward the mean (34). Therefore, the results in 
Table 2 regarding measure type should be interpreted with caution. The moderator analysis with recall 
 
periods showed that studies with recall periods ≤ 14 days had smaller effect sizes than studies with no 
recall period. The studies with a recall period > 14 days did not differ significantly from those with 
shorter or no recall periods. Study aim, population, type of control group, and location did not 
moderate effect size, nor did intervention characteristics; see Table 2. 
 
Table 1. Overview of subgroup effect sizes and heterogeneity for study characteristics. 
Moderator Subgroup ka Hedges’ g 95% CIb Qc P 
Study aim Increasing 
adherence 
28 0.44 0.25, 0.62 1.34 0.25 
 Improving 
health 
15 0.25 −0.001, 0.51   
Sample General 8 0.43 0.08, 0.78 0.17 0.92 
 Risk group 17 0.38 0.14, 0.63   
 Difficulties’ 
group 
18 0.34 0.11, 0.58   
Control group Waiting list 6 0.13 −0.25, 0.52 5.52 0.06 
 Standard care 28 0.33 0.14, 0.51   
 Active control 
group 
9 0.71 0.37, 1.04   
Measure type Self-report 21 0.19 −0.02, 0.39 8.65 0.01d 
 Monitoring 
device 
19 0.49 0.28, 0.71   
 Pill count 3 0.97 0.41, 1.53   
Recall period <14 days 11 0.13 −0.16, 0.42 6.52 0.04d 
 >14 days 10 0.25 −0.05, 0.54   
 No recall 22 0.55 0.35, 0.75   
Location United States 35 0.32 0.16, 0.49 2.09 0.15 
 Other 8 0.61 0.26, 0.95   
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Table 2. Overview of subgroup effect sizes and heterogeneity for intervention characteristics. 
Moderator Subgroup ka Hedges’ g 95% CIb Qc p 
Intervention CBTd 15 0.29 0.03, 0.55 0.67 0.72 
type Peer or social support 6 0.45 0.05, 0.85   
 Counselling 22 0.41 0.20, 0.62   
CBe No 18 0.49 0.27, 0.72 1.83 0.18 
 Yes 25 0.29 0.09, 0.48   
MIf No 26 0.31 0.12, 0.50 1.19 0.28 
 Yes 17 0.48 0.24, 0.71   
Relaxation No 35 0.42 0.26, 0.58 1.69 0.19 
 Yes 8 0.16 −0.18, 0.51   
Setting Group 7 0.11 −0.26, 0.48 2.47 0.29 
 Individual 32 0.41 0.24, 0.59   
 Combination 4 0.52 0.02, 1.03   
Therapy Psychologist/psychiatrist 10 0.39 0.07, 0.71 3.37 0.64 
provider Counsellor 4 0.35 −0.15, 0.84   
 Nurse 8 0.62 0.29, 0.95   
 Peer 7 0.37 0.00, 0.73   
 Healthcare professional 9 0.24 −0.08, 0.56   
 Other 5 0.21 −0.22, 0.63   
Treatment Short 16 0.40 0.15, 0.64 1.13 0.57 
duration Medium 8 0.29 −0.06, 0.65   
 Long 8 0.17 −0.19, 0.52   
 Missing 10     
a k = number of studies, b CI = confidence interval, c Q = between-group Q, d CBT = cognitive behavioural therapy, e CB = cognitive 
and/or behavioural techniques, f MI = motivational interviewing. 
 
Publication bias 
Duval and Tweedie’s trim-and-fill funnel plot showed that the studies in this meta-analysis are 
distributed symmetrically around the mean effect size. No studies were trimmed or filled, indicating 
no evidence of publication bias. Egger’s test of the intercept was not significant, intercept 1.02, (95% 
CI [-1.74, 3.78], t(41) = 0.75, p = 0.46. This also indicates that there is no publication bias. 
 
Discussion 
The results of the current meta-analysis show that psychosocial interventions have a small to moderate 
positive effect on medication adherence in PLWH. This finding has important implications because 
better ART adherence is related to disease suppression and lowers transmission risk. This effect is likely 
due to psychosocial interventions treating important causes of ART non-adherence. Those may include 
the psychological correlates found in an earlier meta-analysis, such as depressive symptoms, stigma 
 
and lack of social support. In addition to mental health, non-adherence is related to many factors 
including pill burden, side effects, physical health, sexual health and socioeconomic status. 
Psychosocial interventions may influence how PLWH cope with challenges in these fields. The findings 
of this study are in line with previous meta-analyses and reviews that have shown promising results 
for treatments involving behavioural components (22), counselling (21), motivational interviewing (20) 
and treatments aimed at depression (23). Contrastingly, some reviews found negative or mixed results 
of psychosocial interventions aimed at improving adherence (24-26). This may be explained by the 
method; this study uses meta-analysis on 43 studies, while previous reviews did not combine the 
individual study data to determine an overall effect. In addition, two reviews had fewer studies than 
the current meta-analysis (24, 26). In terms of geographical and temporal context, previous reviews 
and meta-analyses were similar to the current meta-analysis and featured studies conducted post 1996 
and mainly in the United States. In short, the results of this meta-analysis are in line with a number of 
previous studies and indicate that offering psychosocial interventions to PLWH may improve 
medication adherence. 
Intervention characteristics did not explain differences in treatment effectiveness in this study. 
Therefore, findings that interventions were more effective when they included at-risk or adherence 
difficulty groups (21), involved CBT components (24), had longer treatment duration (23, 26) or 
provided individual therapy (26) were not replicated. The current meta-analysis results indicate that 
many different forms of psychosocial treatment in many different settings may be effective. The results 
are in accordance with the dodo bird verdict and common factors theory. These claim that various 
psychosocial interventions lead to similar outcomes, due to common effective factors such as 
therapeutic alliance (39).  
Differences in methodology and included studies may explain differences in results regarding 
the moderating effect of intervention characteristics between this study and previous studies. It may 
be that moderating factors that seem effective in a systematic review, based on the number of studies 
with positive findings, were not found to be effective in this meta-analysis, based on pooled and 
weighted results. It could also be that such findings were not present in this sample because it is based 
on RCTs only, or because the sample consists of a various psychosocial interventions rather than, for 
instance, motivational interviewing alone. Another explanation might be that moderating effects of 
these characteristics are small and more studies are necessary to find subgroup differences.  
Two study characteristics showed a relationship with treatment effectiveness: the type of 
adherence measure and its recall period. However, the measure type analysis included a subgroup of 
three studies, including one influential outlier, hence findings should be interpreted with caution. With 
this in mind, the results indicate that studies that used pill-count measures may have larger effect sizes 
than studies that used self-report measures. This suggests that pill-count measures are more sensitive 
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to detect differences than self-report measures, which agrees with earlier findings (40). In addition, 
pill count and monitoring devices are more objective than self-report measures; they do not rely on 
the participant’s memory. Second, studies that used measures without recall period had larger effect 
sizes than those with recall. This may be associated with the previous result that pill-count measures, 
which have no recall period, have larger effect sizes than self-report measures, which have a recall 
period. Combining previous and current study findings, it seems that objective measures that do not 
rely on recall may be more sensitive to changes in adherence than subjective measures that rely on 
self-report. For future studies, researchers should keep in mind these possible sensitivity differences 
when deciding on a measurement method. 
 
Strengths and limitations 
This study combined and analysed the data of 43 studies meta-analytically, which resulted in high 
statistical power. In addition, a wide range of psychosocial interventions were included in this meta-
analysis. This study adds to previous research by analysing results from RCTs only, which are 
considered high-quality studies in experimental psychology. Another strength is that results indicated 
no influence of publication bias. However, some studies that were identified during the systematic 
search were excluded due to missing data. 
The study also had limitations. First, the study investigated only short-term post-treatment 
effects. Therefore, the long-term effectiveness of psychosocial interventions remains unclear. Second, 
some moderators had categories with few studies, making it hard to generalize their results. Third, the 
mechanisms of change remain unclear, as psychosocial interventions may influence factors related to 
adherence, such as physical, mental and sexual health, and socioeconomic status.  
The current meta-analysis was influenced by limitations of the included studies and identified 
some gaps in the literature. First, most studies were conducted in the United States, leaving other 
locations greatly influenced by HIV, such as Sub-Saharan Africa and Asia, underrepresented. The 
minority of women in the meta-analysis (35%) correspond with the ratio of women with HIV in the 
United States, (41) but not Sub-Saharan Africa (42), where HIV disproportionally impacts women. 
Furthermore, outcomes, study and sample characteristics, such as mean age and ethnicity, were not 
always reported, which hindered coding. ART pill burden and side effects were often not reported, and 
thus not analysed. Standardized reporting could be improved by following CONSORT guidelines (43).  
 
Future research 
It would be interesting to study common factors in psychosocial treatments, such as therapeutic 
alliance and empathy. Second, it would be interesting to investigate long-term effects of psychosocial 
treatments, to assess whether positive results can be retained. Since the intervention provider was not 
 
a significant moderator, future research could study the effectiveness of online interventions, which 
may be more accessible and cost-effective. Fourth, future research might focus on investigating the 
effectiveness of psychosocial interventions in non-USA samples. Furthermore, studying factors that 
are related to high or consistent adherence, rather than non-adherence, might provide new insights 
for psychosocial interventions. Finally, since the effect size was small to moderate, research on 
supplemental strategies to increase adherence is recommended. The best result may be obtained by 
fine-tuning and combining medical and psychosocial treatments for PLWH.  
 
Conclusion 
This study adds to HIV care literature by establishing the positive effect of a wide range of psychosocial 
interventions on medication adherence in PLWH in the form of a meta-analysis of RCTs. Better 
medication adherence promotes the health of PLWH and impacts public health by lowering 
transmission risk. This study finds that various types of psychosocial interventions can be effective for 
various PLWH groups. It is important that healthcare professionals are made aware of this, so they can 
refer PLWH with adherence challenges. Increasing medication adherence in PLWH remains an 
important public health goal and can potentially help millions of people to suppress the virus and 
increase their well-being.  
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Appendix 1. Search Strategy 
 
Embase Search Term 
(exp "Human immunodeficiency virus"/ OR exp "Human immunodeficiency virus infection"/ OR exp 
"Acquired immune deficiency syndrome"/ OR hiv.tw. OR aids.tw. ) AND (exp psychotherapy/ or exp 
"mental health services"/ or exp "self care"/ OR exp "self help"/ OR exp teletherapy/ OR exp "computer 
assisted therapy"/ OR psychotherap*.tw. OR psychological-therapy.tw. OR psychological-
treatment.tw. OR psychological-intervention.tw. OR counsel*.tw. OR cbt.tw. OR behavio?r-therapy.tw. 
OR interpersonal-therapy.tw. OR coping.tw. OR peer-support.tw. OR social-support.tw. OR problem-
solving.tw. OR stress-management.tw. OR self-help.tw. OR internet-therap*.tw. OR online-therap*.tw. 
OR psychoed*.tw. OR training.tw. OR exposure.tw. OR relaxation.tw. OR mindfulness.tw. OR 
reinforcement.tw. OR risk-reduction.tw. OR commitment-therap*.tw. OR case-manage*.tw.) AND 
(exp "patient compliance"/ OR adher*.tw. OR compliance.tw. OR exp "highly active antiretroviral 
therapy"/ OR exp "antiviral therapy"/ OR antiretroviral-therapy.tw.)  
 
Filters used: Human subjects, Aged ≥ 18 (‘Adult’ and ‘Aged’ catagories), English Language, Article, 
Randomized Controlled Trial or Controlled Clinical Trial, Post 1996.  
 
PsycInfo Search Term 
(DE (hiv OR aids) OR TX (hiv OR aids)) AND (DE (psychotherapy OR psychotherapeutic techniques OR 
mental health programs OR Counseling OR Stress management OR case management OR self 
management OR Telemedicine OR Computer Assisted Therapy OR Psychoeducation) OR TX 
(psychotherap* OR psychological-therap* OR psychological-treatment OR psychological-intervention 
OR counsel* OR cbt OR behavio#r-therap* OR interpersonal-therap* OR coping OR peer-support OR 
social-support OR problem-solving OR stress-manage* OR self-help OR internet-therap* OR online-
therap* OR psychoed* OR training OR exposure OR relaxation OR mindfulness OR reinforcement OR 
risk-reduction OR commitment-therap* OR case-manage*)) AND (DE (treatment compliance OR 
antiviral drugs OR drug therapy) OR TX (adher* OR compliance OR antiretroviral-therapy)) 
 
Filters used: Aged ≥ 18 (Adulthood), Article or Dissertation, Treatment Outcome/Clinical Trial or 





Medline Search Term 
(hiv [mesh] OR hiv infection [mesh] OR hiv [tiab] or aids [tiab]) AND (psychotherapy [mesh] OR mental 
health services [mesh] OR self-care [mesh] OR self-help groups [mesh] OR telemedicine [mesh] OR 
therapy, computer-assisted [mesh] OR psychotherap* [tiab] OR psychological therap* [tiab] OR 
psychological treatment* [tiab] OR psychological intervention* [tiab] OR counsel* [tiab] OR cbt [tiab] 
OR behavior therap* [tiab] OR behaviour therap* [tiab] OR interpersonal therap* [tiab] OR coping [tiab] 
OR peer support [tiab] OR social support [tiab] OR problem solving [tiab] OR stress manage* [tiab] OR 
self-help [tiab] OR internet therap* [tiab] OR online therap* [tiab] OR psychoed* [tiab] OR training 
[tiab] OR exposure [tiab] OR relaxation [tiab] OR mindfulness [tiab] OR reinforcement [tiab] OR risk 
reduction [tiab] OR commitment therap* [tiab] OR case manage* [tiab]) AND (patient compliance 
[mesh] OR adher* [tiab] OR compliance [tiab] OR HAART [mesh] OR antiretroviral therapy [tiab]) 
 
Filters used: Human Subjects, English language, Controlled Clinical Trial or Randomized Controlled Trial, 
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Appendix 
Appendix 1. Search Strategy 
 
Embase Search Term 
(exp "Human immunodeficiency virus"/ OR exp "Human immunodeficiency virus infection"/ OR exp 
"Acquired immune deficiency syndrome"/ OR hiv.tw. OR aids.tw. ) AND (exp psychotherapy/ or exp 
"mental health services"/ or exp "self care"/ OR exp "self help"/ OR exp teletherapy/ OR exp "computer 
assisted therapy"/ OR psychotherap*.tw. OR psychological-therapy.tw. OR psychological-
treatment.tw. OR psychological-intervention.tw. OR counsel*.tw. OR cbt.tw. OR behavio?r-therapy.tw. 
OR interpersonal-therapy.tw. OR coping.tw. OR peer-support.tw. OR social-support.tw. OR problem-
solving.tw. OR stress-management.tw. OR self-help.tw. OR internet-therap*.tw. OR online-therap*.tw. 
OR psychoed*.tw. OR training.tw. OR exposure.tw. OR relaxation.tw. OR mindfulness.tw. OR 
reinforcement.tw. OR risk-reduction.tw. OR commitment-therap*.tw. OR case-manage*.tw.) AND 
(exp "patient compliance"/ OR adher*.tw. OR compliance.tw. OR exp "highly active antiretroviral 
therapy"/ OR exp "antiviral therapy"/ OR antiretroviral-therapy.tw.)  
 
Filters used: Human subjects, Aged ≥ 18 (‘Adult’ and ‘Aged’ catagories), English Language, Article, 
Randomized Controlled Trial or Controlled Clinical Trial, Post 1996.  
 
PsycInfo Search Term 
(DE (hiv OR aids) OR TX (hiv OR aids)) AND (DE (psychotherapy OR psychotherapeutic techniques OR 
mental health programs OR Counseling OR Stress management OR case management OR self 
management OR Telemedicine OR Computer Assisted Therapy OR Psychoeducation) OR TX 
(psychotherap* OR psychological-therap* OR psychological-treatment OR psychological-intervention 
OR counsel* OR cbt OR behavio#r-therap* OR interpersonal-therap* OR coping OR peer-support OR 
social-support OR problem-solving OR stress-manage* OR self-help OR internet-therap* OR online-
therap* OR psychoed* OR training OR exposure OR relaxation OR mindfulness OR reinforcement OR 
risk-reduction OR commitment-therap* OR case-manage*)) AND (DE (treatment compliance OR 
antiviral drugs OR drug therapy) OR TX (adher* OR compliance OR antiretroviral-therapy)) 
 
Filters used: Aged ≥ 18 (Adulthood), Article or Dissertation, Treatment Outcome/Clinical Trial or 





Medline Search Term 
(hiv [mesh] OR hiv infection [mesh] OR hiv [tiab] or aids [tiab]) AND (psychotherapy [mesh] OR mental 
health services [mesh] OR self-care [mesh] OR self-help groups [mesh] OR telemedicine [mesh] OR 
therapy, computer-assisted [mesh] OR psychotherap* [tiab] OR psychological therap* [tiab] OR 
psychological treatment* [tiab] OR psychological intervention* [tiab] OR counsel* [tiab] OR cbt [tiab] 
OR behavior therap* [tiab] OR behaviour therap* [tiab] OR interpersonal therap* [tiab] OR coping [tiab] 
OR peer support [tiab] OR social support [tiab] OR problem solving [tiab] OR stress manage* [tiab] OR 
self-help [tiab] OR internet therap* [tiab] OR online therap* [tiab] OR psychoed* [tiab] OR training 
[tiab] OR exposure [tiab] OR relaxation [tiab] OR mindfulness [tiab] OR reinforcement [tiab] OR risk 
reduction [tiab] OR commitment therap* [tiab] OR case manage* [tiab]) AND (patient compliance 
[mesh] OR adher* [tiab] OR compliance [tiab] OR HAART [mesh] OR antiretroviral therapy [tiab]) 
 
Filters used: Human Subjects, English language, Controlled Clinical Trial or Randomized Controlled Trial, 
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Background: Many people living with HIV suffer from depressive symptoms. In a previous pilot study, 
self‐help cognitive behavioral therapy (in booklet format) was found to be effective in treating 
depressive symptoms in people with HIV. We developed an online self‐help program in Dutch and 
English (based on the booklet) for people with HIV and depressive symptoms. Besides the main 
question regarding the effectiveness of the program aimed at lowering depressive symptoms, sub‐
questions will focus on the moderators of treatment success (for which patients is the program 
especially beneficial?) and the mechanisms of change underlying the treatment outcome (which 
mediators affect the outcome of treatment?). In this paper, the protocol of the study will be described. 
Methods/design: The effectiveness of the program will be investigated by comparing the intervention 
group with a waiting list‐control group in a randomized controlled design, by including a pretest and 
three post‐tests. The self‐help program contains four main components: activation, relaxation, 
changing maladaptive cognitions, and goal attainment. Participants with mild to moderate depressive 
symptoms will work on the program for six to ten weeks, during which a coach will provide 
motivational support by telephone once a week. Participants in the control condition will receive 
weekly minimal support from a coach for eight weeks, and after the second post‐test, they can gain 
access to the self‐help program. Depressive symptoms and possible mediators (e.g., activation, 
cognitive coping, self‐efficacy, and goal adjustment) will be assessed by self‐report three times during 
the intervention/waiting period and at the pretest and first post‐test. 
Discussion: The proposed study aims to evaluate the effectiveness of an online self‐help intervention 
for people with HIV and depressive symptoms. If the intervention is shown to be effective, the program 
will be implemented. 
Consequently, many patients with HIV could be reached, and their psychological care may be improved. 
Trial registration: Netherlands Trial Register: NTR5407 





Currently, HIV is a chronic disease that requires the use of medication. Along with the physical 
problems that people living with HIV (PLWH) may experience (e.g., linked to the side effects of 
medication or comorbidities), psychological symptoms are also prevalent (1, 2). Specifically, depressive 
symptoms are often reported by PLWH. Many PLWH struggle, for example, with the daily use of 
medication and thinking about whom to tell about their HIV (3). This and more general life stressors 
may lead to depressive symptoms in PLWH. In turn, PLWH with depressive symptoms have a higher 
chance of non‐ adherence to their medication (4). This can result in more physical symptoms and illness. 
Therefore, the treatment of depressive symptoms in PLWH is important. 
Various treatments are available for PLWH with depressive symptoms. Group and individual 
therapies exist, and many of these contain cognitive behavioral components (see review studies (5‐9). 
These treatments are effective in decreasing depressive symptoms and improving the quality of life in 
PLWH (2, 5, 7‐9). Furthermore, beneficial effects were also found for medication adherence (6). 
These group and individual therapies have some disadvantages. First, patients and therapists 
should meet in person during office hours for the treatment. Second, the costs of these treatments 
are high. Third, for HIV‐ specific programs, the stigma is a significant barrier to service delivery and 
utilization (10). A self‐help program could be a way to overcome these disadvantages and barriers. The 
evidence base for low‐intensity interventions has been growing in recent years, with high‐quality trials 
supporting the effectiveness of self‐help cognitive behavioral therapy (CBT) for depression (11‐13). 
A low‐cost CBT self‐help booklet for PLWH was developed based on prior research and a needs 
assessment (14‐17). The self‐help booklet contains three main components: relaxation, changing 
maladaptive cognitions, and goal attainment. The effectiveness of this booklet was tested in a pilot 
randomized controlled trial (RCT) (18). The results indicated that this intervention was effective in 
reducing the depressive symptoms in PLWH, compared to waiting list controls. However, in this RCT, 
25% of the participants dropped out during the intervention phase. Elements should therefore be 
added to retain more PLWH in the program and to increase the effectiveness. In addition, several 
participants indicated they were worried that having the booklet in their home would disclose their 
HIV‐positive status. They would have valued a less stigmatizing mode. 
Therefore, the self‐help booklet was converted into an Internet version. The online program 
contains eight lessons, which can be completed in six to ten weeks. An online program has a lower 
stigma, is easily accessible, can reach more people, and has lower long‐term costs. Previous studies 
showed that online self‐help therapy for depression in people with chronic illness was effective (19). 
In addition to being converted from a booklet into an Internet version, the program was expanded in 
three ways in the proposed study: 
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1. An activation component was added, in which participants will be stimulated to perform 
(small) activities (e.g., wake up on time). Activation is often used in CBT for depression as a 
first step (20). 
2. Minimal coaching with motivational interviewing will be offered. A meta‐analysis (12) showed 
a greater effectiveness of the Internet therapy when coaching was included, also when given 
in a minimal format. In addition, our recent studies including minimal coaching showed 
attrition rates between 10 and 15% (21). 
3. Finally, in the current study, the online intervention will be available in Dutch and English to 
reach more PLWH in the Netherlands (and possibly in other countries in the future). 
 
In 2014, the development of the online program was finalized, and we asked a focus group (four 
volunteers from the Dutch HIV Association) to evaluate the program. Thereafter, we adapted the 
program, and we conducted a pilot study with 20 PLWH with depressive symptoms (14 males; mean 
age = 48.65 years, SD = 10.86) to test the feasibility of the program. Participants were approached via 
advertisements on the website and in the magazine of the Dutch HIV Association and were 
representative of the Dutch HIV population. The results of the pilot study showed that the program 
was effective in this small group; depressive symptoms decreased from pre‐test to post‐test. 
Furthermore, participants thought the program was easy to use and helpful to them. These results 
encouraged us to execute a large study on the effectiveness of the online self‐help program. 
The aim of the present paper is to describe the study protocol. The proposed study is a randomized 
controlled trial; the online self‐help program will be compared with a waiting list control condition. 
The study will include a pretest and three post‐tests for the intervention condition (directly after the 
intervention and three and six months afterward) and a pretest and two post‐tests (directly after the 
eight week waiting period and three months afterward) for the control condition. After the second 
post‐test (five months after the pretest), the participants in the control group can also begin the 
program. Concluding, we will investigate the effectiveness of the online self‐help program in 
decreasing depressive symptoms in the short and long term. In addition, the moderators (for which 
patients is the program especially beneficial?) and mediators (which mechanisms affect the outcome 




The study is a randomized controlled trial; participants will be randomly allocated to the intervention 
or the control group. Stratified randomization by treatment center and sex will be conducted. 
 
Stratification by sex is conducted, as there will be more male participants in the study, and the 
allocation of approximately the same number of females to the intervention group as to the control 
group is preferred. In addition, stratification by treatment center is being conducted because the 
number of (included) patients will differ among the treatment centers. Approximately equal allocation 
to each of the groups also in the small treatment centers, is important. This will be realized by creating 
random number tables for each treatment center, divided by sex. Randomization will take place in 
blocks of 12 participants for each treatment center. Males and females will represent separate blocks, 
with six males and six females for each treatment center, of which half will be randomly allocated to 
the intervention group, and half will be allocated to the control group. Participants, coaches, and 
researchers cannot be blind for allocation to conditions. Participants will be allocated to one of the 
conditions after the pretest. The random number tables will be created by an independent researcher, 
and the allocation sequence will be concealed from the main researcher, who enrolls and informs 
participants. 
The design consists of multiple measurements, one pretest, three post‐tests (two in the control 
group), and three assessments during the intervention/waiting period. Figure 1 shows a flow chart of 
the study design, and the SPIRIT Checklist is presented in Additional file 1. The study is approved by 
the medical ethics committee of the Leiden University Medical Center (LUMC; nr. P14.091). Online 
informed consent will be obtained from all participants. 
 
Participants 
At least 200 participants who are PLWH with mild to moderate depressive symptoms will be included. 
Participants will be approached in 23 of the 27 HIV treatment centers throughout the Netherlands 
during their regular visits to the HIV nursing consultants and doctors. To be eligible to participate in 
the study, a participant must meet all of the following criteria: being HIV positive, exhibiting mild to 
moderate depressive symptoms (defined as Patient Health Questionnaire 9 (PHQ‐9) (22) score > 4 and 
< 20), age 18 and older, having sufficient knowledge of the Dutch or English language, able to access 
the Internet, having an e‐mail address, and available for the next eight weeks to work on the 
intervention. 
An eligible participant who meets any of the following criteria will be excluded from 
participation in the study: being in the first half year following HIV diagnosis, having severe cognitive 
impairments (e.g., forgetfulness), exhibiting severe depressive symptoms (defined as PHQ‐ 9 score of 
20 or higher), experiencing suicidal ideation (indicated by a score > 1 on the suicide item of the PHQ‐
9), showing an absence of depressive symptoms (indicated by a PHQ‐9 score of four or lower), 
undergoing treatment presently by a psychologist or psychiatrist, or on antidepressants for less than 
three months or has experienced a change of type or dose of antidepressants in the past three months. 
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In case of severe depressive symptoms (using the set criterion) and/or suicide ideation, patients will 


































A power analysis was performed (with the program Power Analysis and Sample Size Software: PASS; 
(23)) to determine the sample size needed to assess the long‐ term effect of the intervention on the 
primary outcome depressive symptoms. Based on a medium effect size of 0.50, which proved to be 
realistic according to the previous pilot RCT, and assuming an alpha of 0.05 and a power of 0.80, both 
groups should consist of 64 participants who complete the four measurements. This sample size is also 
large enough to detect moderate pre‐defined two‐way cross‐product interactions, such as the 
interactions of group by sex. Taking into account a drop‐ out rate of 15% during working on the self‐
help program (based on our recent studies, which included coaching (21)), at least 150 patients should 
 
  
Figure 1. Flow chart of study design 
 
be allocated to the two groups at baseline (n = 75 in each group). We will aim for at least 200 
participants because dropout will also occur during the follow‐up. 
 
Procedure 
HIV nursing consultants and doctors in the treatment centers will screen as many PLWH as possible for 
the level of depression at regular check‐ups by means of the PHQ‐2 (24). In some of the treatment 
centers, the Hospital Anxiety and Depression Scale (HADS (25)) will be used instead of the PHQ‐2 
because this scale was already in use in these centers. HIV treatment centers will receive information 
about the study and a guideline for the screening. A form will be used for the screening, and the forms 
will be sent to the researchers. Patients will be screened over approximately six months; most patients 
visit the HIV treatment center once every six months. If the PHQ‐2 score is > 0, patients may be referred 
to the researchers. Patients will receive written information about the study and permission will be 
asked to provide the researchers with their e‐mail addresses and telephone numbers, so the 
researchers may contact the patients. The researchers will provide additional information to the 
patients and screen them more extensively with the PHQ‐9. If the depression score is mild (PHQ‐9 > 4) 
to moderate (PHQ‐9 < 20), patients are eligible for the study and will be invited to participate. After 
giving online informed consent, participants will be asked for permission to inform their general 
practitioner and the HIV treatment center about participation in the study. Thereafter, all participants 
will complete the pretest via online questionnaires (T0). Next, participants will be randomly allocated 
to either the intervention or the control condition. At the start of the intervention, the personal coach 
will contact the participant by telephone in order to check and improve motivation by using the 
technique of motivational interviewing. 
Subsequently, participants in the intervention group will follow the self‐help program for six 
to ten weeks and receive support from a coach (see study conditions). They will be asked to fill out 
online questionnaires three times during the intervention, after they complete the program (T1, a 
maximum of ten weeks after T0), three months later (T2), and again three months later (T3). 
Participants who are allocated to the control condition will receive minimal support for eight weeks 
(for details see study conditions). They will also be asked to fill out the questionnaires, including the 
T2. After the T2 (which is completed approximately five months after T0), the participants will also 
receive the online intervention. Coaches will monitor the well‐being of participants in both groups (see 
ethical precautions). We will raffle off gift cards and iPods among the participants who completed all 
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Subsequently, participants in the intervention group will follow the self‐help program for six 
to ten weeks and receive support from a coach (see study conditions). They will be asked to fill out 
online questionnaires three times during the intervention, after they complete the program (T1, a 
maximum of ten weeks after T0), three months later (T2), and again three months later (T3). 
Participants who are allocated to the control condition will receive minimal support for eight weeks 
(for details see study conditions). They will also be asked to fill out the questionnaires, including the 
T2. After the T2 (which is completed approximately five months after T0), the participants will also 
receive the online intervention. Coaches will monitor the well‐being of participants in both groups (see 
ethical precautions). We will raffle off gift cards and iPods among the participants who completed all 







Online self-help intervention 
The self‐help intervention is grounded in the theories of self‐regulation and stress‐coping, 
incorporating techniques of CBT and stress‐management. The content of the program reflects four 
main components covered in eight lessons: activation, relaxation, changing maladaptive cognitions, 
and goal attainment. The program contains a combination of psycho‐education, exercises, and 
assignments, all strengthened by motivation and support to increase the effectiveness and to minimize 
the attrition over time. 
The intervention is offered through a secured website that contains the complete work 
program. Participants work on the intervention one to two hours a week for a period of six to ten 
weeks. The program starts with an introduction, and participants are asked to think of a small activity 
to perform (e.g., taking a short walk; lesson 1). They are stimulated to perform this activity in the 
following weeks and to expand this to other activities. Furthermore, participants will be instructed to 
do relaxation exercises and to continue these exercises in the coming weeks (lesson 2). Thereafter, 
participants learn to identify and change irrational cognitions (by challenging negative thoughts) and 
to evoke a strong and positive feeling when they experience negative feelings (lessons 3‐5). 
Furthermore, participants are guided to formulate a new, realistic, concrete goal (such as quit smoking) 
and work on the stepwise attainment of this goal (lessons 6‐7). Finally, the participant will work on a 
concluding and summarizing lesson (lesson 8). All participants will receive support from a coach during 
the intervention (see below). 
 
Waiting list control condition 
Participants randomized to the control group will be placed on a waiting list and will receive the 
intervention after T2. They will receive an initial phone call to explain the procedures (to minimize 
attrition). Participants will receive minimal support from a coach (see below). 
 
Support from a coach 
Participants in the intervention group will be allocated to a coach, who will provide motivation and 
support throughout the program. During the first telephone contact, the coach will introduce the 
program, motivate the participant, and address technical aspects. Once a week, a prescheduled 
telephone call of approximately 15 minutes will be arranged between the participant and the allocated 
coach. Coaching will be provided through queries about the participant’s progress, motivational 
remarks, support in case problems are encountered, and encouragement to continue the program. 
Coaching will not include formal psychotherapy and will be provided until the participant completes 
 
the program or for a maximum of ten weeks. If the participant is not finished with the program after 
ten weeks, the coaching will end, but the participant can continue the program. 
Participants in the control group will also be allocated to a coach, who will provide minimal 
support over eight weeks. Participants will have a pre-scheduled weekly telephone call of 
approximately five minutes with the coach. The coach will address the well-being of the participant. 
Coaches will try to prevent participant dropout and monitor their depressive symptoms. When 
depressive symptoms or suicidal thoughts increase, the coach will act appropriately (see ethical 
precautions). 
A protocol for coaching will be used, with guidelines available for the provision of support. 
Coaches will receive a short training to inform them about the study and the coaching procedures. 
After each telephone call, coaches will note the elements that were used during the call (e.g., 
motivation, support) to monitor treatment integrity. Coaches will be Master students in clinical 
psychology or individuals with a Master’s degree in the field of psychology. The coaches will have 
completed clinical courses during their Master’s degree program in which they learned communication 
skills, interview techniques, and treatment strategies. In addition, coaches will be selected in a 
personal interview on the basis of adequate communication skills for the support and motivation of 
participants. Coaches will be supervised by the researchers and a psychotherapist. Once every two 
weeks (every week during the first month of the study), the coaches and the main researcher will hold 
an intervision meeting. Coaches can discuss difficulties and questions with each other and the 
researcher. If a problem arises between intervision sessions, the coach may contact the researcher. 
The researcher and the coach can consult a psychotherapist if necessary. 
 
Ethical precautions 
Coaches will monitor the well-being of participants in both the intervention and control groups. Each 
week, they will ask how the participant is doing. When depressive symptoms worsen or when suicidal 
thoughts increase, the coach will discuss this with the participant. The coach can refer the participant 
to the general practitioner or the HIV treatment center, if necessary. The coach can discuss this with 
the researcher and the psychotherapist. When a participant is referred for more intensive treatment 
from a psychologist or psychiatrist, the participant may continue with the study. As this may influence 
the outcomes, the referral will be added as a covariate in the analysis. 
Participants will complete questionnaires to assess depressive symptoms during the course of 
the study. When depressive symptoms of a participant increase, the researcher will notify the coach 
about this. The coach will discuss this increase of symptoms with the participant and will act 
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from a psychologist or psychiatrist, the participant may continue with the study. As this may influence 
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All assessments are self-reports and will be conducted online (except for the PHQ-2, which will be on 
paper for screening by the HIV nursing consultants and doctors and the PHQ-9, which will be used by 
the researchers for screening by telephone). Table 1 depicts all the assessment instruments that will 
be used in each stage of the study. The primary outcome is depression severity, as measured by the 
PHQ-9 (22) and the Center for Epidemiologic Studies Depression Scale (CES-D (26)). Secondary 
outcomes are physical tension, activation (Behavioral Activation for Depression Scale (BADS) (27)), 
cognitive reappraisal (Emotion Regulation Questionnaire (ERQ) (28)), cognitive coping (Cognitive 
Emotion Regulation Questionnaire (CERQ) (29)), depressive thoughts (Crandell Cognitions Inventory 
(CCI) (30)), behavioral coping (Behavioral Emotion Regulation Questionnaire (BERQ) Kraaij & Garnefski, 
unpublished questionnaire), coping self-efficacy (Kraaij & Garnefski, unpublished questionnaire), goal 
adjustment (Goal Disengagement and Reengagement Scale (31)), personal growth (Garnefski & Kraaij, 
unpublished questionnaire), symptoms of anxiety (Generalized Anxiety Disorder 7 (GAD-7) (32)), 
negative life events (Life Events Scale, (33)), motivation to start with the intervention, compliance, 
dropout and reasons for dropout, medical data, and user satisfaction. 
As potential moderators of treatment outcome demographic variables (sex, age, education, 
and nationality), clinical and psychological characteristics (severity of depressive symptoms at baseline, 
anxiety symptoms at baseline, coping self-efficacy, physical health, HIV status, motivation, and alcohol 
and drug use) will be tested at first. Previous research indicated that some of these moderators (e.g., 
sex and baseline depression severity) might be important in online CBT for depression (34, 35). In 
addition, other possible moderators will be investigated exploratory. 
The mediator variables and the dependent variable will be measured three times during the 
intervention/waiting period, at the pretest, and at the first post-test. The following mediator variables 
will be assessed in the study: activation (two items of the BADS), physical tension (two items), cognitive 
reappraisal (two items of the ERQ), cognitive coping (12 items of the CERQ), goal adjustment (two 
items of the Goal Disengagement and Reengagement Scale), symptoms of anxiety (PHQ-4 (36)), and 
coping self-efficacy (two items). The dependent variable in the mediational analysis is the depressive 
symptoms (PHQ-4). The questions (regarding, for example, symptoms and cognitions) that will be 
asked during the intervention/waiting period will refer to the last week. The assessments will be 
administered three times during the intervention/waiting period because, at these moments, we 
expect change in the mediating variables. The assessments are linked to the lessons of the self-help 
program for participants in the intervention group. At the first measurement, we expect a change in 
the behavioral activation; at the second measurement, we expect a change in the physical tension; at 
the third measurement, we expect a change in the cognitive reappraisal and cognitive coping; and at 
 
the post-test, we expect a change in the goal adjustment. Coping self-efficacy and anxiety are expected 
to change over the entire course of the treatment. 
 
Patient Health Questionnaire 9 (PHQ-9) 
Depressive symptoms will be measured with the PHQ-9 at the pre- and post-tests (22). The 
questionnaire consists of nine items and includes the DSM-V criteria for a major depressive disorder. 
The items are rated on a four-point scale ranging from zero “not at all” to three “nearly every day,” 
e.g., “Over the last two weeks, how often have you been bothered by: little interest or pleasure in 
doing things?” Scores range from 0 to 27, and cutpoints of 5, 10, 15, and 20 represent mild, moderate, 
moderately severe, and severe levels of depressive symptoms. The PHQ-9 is sensitive to change, has 
good sensitivity and specificity for detecting depressive disorders, and has adequate psychometric 
properties (37). Furthermore, the questionnaire is often used with PLWH (38). This questionnaire will 
be used to screen participants on depressive symptoms and to measure change in depressive 
symptoms from baseline to the post-tests. 
 
Center of Epidemiologic Studies Depression Scale (CES-D)  
The CES-D (26) will be used to measure depressive symptoms during the past week. The questionnaire 
consists of 20 items, such as “During the past week: I felt sad.” Items are rated on a four-point scale 
ranging from zero “rarely or none of the time (less than 1 day)” to three “most or all of the time (5-7 
days).” Total scores can range from 0 to 60, and the cut-off score for clinical depression is 16. The 
internal consistency, reliability, and convergent validity of the CES-D are adequate (26, 39), and 
sensitivity and specificity are high (40). Furthermore, the questionnaire is often used with PLWH (41). 
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and drug use) will be tested at first. Previous research indicated that some of these moderators (e.g., 
sex and baseline depression severity) might be important in online CBT for depression (34, 35). In 
addition, other possible moderators will be investigated exploratory. 
The mediator variables and the dependent variable will be measured three times during the 
intervention/waiting period, at the pretest, and at the first post-test. The following mediator variables 
will be assessed in the study: activation (two items of the BADS), physical tension (two items), cognitive 
reappraisal (two items of the ERQ), cognitive coping (12 items of the CERQ), goal adjustment (two 
items of the Goal Disengagement and Reengagement Scale), symptoms of anxiety (PHQ-4 (36)), and 
coping self-efficacy (two items). The dependent variable in the mediational analysis is the depressive 
symptoms (PHQ-4). The questions (regarding, for example, symptoms and cognitions) that will be 
asked during the intervention/waiting period will refer to the last week. The assessments will be 
administered three times during the intervention/waiting period because, at these moments, we 
expect change in the mediating variables. The assessments are linked to the lessons of the self-help 
program for participants in the intervention group. At the first measurement, we expect a change in 
the behavioral activation; at the second measurement, we expect a change in the physical tension; at 
the third measurement, we expect a change in the cognitive reappraisal and cognitive coping; and at 
 
the post-test, we expect a change in the goal adjustment. Coping self-efficacy and anxiety are expected 
to change over the entire course of the treatment. 
 
Patient Health Questionnaire 9 (PHQ-9) 
Depressive symptoms will be measured with the PHQ-9 at the pre- and post-tests (22). The 
questionnaire consists of nine items and includes the DSM-V criteria for a major depressive disorder. 
The items are rated on a four-point scale ranging from zero “not at all” to three “nearly every day,” 
e.g., “Over the last two weeks, how often have you been bothered by: little interest or pleasure in 
doing things?” Scores range from 0 to 27, and cutpoints of 5, 10, 15, and 20 represent mild, moderate, 
moderately severe, and severe levels of depressive symptoms. The PHQ-9 is sensitive to change, has 
good sensitivity and specificity for detecting depressive disorders, and has adequate psychometric 
properties (37). Furthermore, the questionnaire is often used with PLWH (38). This questionnaire will 
be used to screen participants on depressive symptoms and to measure change in depressive 
symptoms from baseline to the post-tests. 
 
Center of Epidemiologic Studies Depression Scale (CES-D)  
The CES-D (26) will be used to measure depressive symptoms during the past week. The questionnaire 
consists of 20 items, such as “During the past week: I felt sad.” Items are rated on a four-point scale 
ranging from zero “rarely or none of the time (less than 1 day)” to three “most or all of the time (5-7 
days).” Total scores can range from 0 to 60, and the cut-off score for clinical depression is 16. The 
internal consistency, reliability, and convergent validity of the CES-D are adequate (26, 39), and 
sensitivity and specificity are high (40). Furthermore, the questionnaire is often used with PLWH (41). 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Demographic variables and other information 
A self-designed questionnaire will be used to ask participants about sex, age, educational level, 
nationality, marital status, sexual orientation, social support, disclosure of HIV positive status, alcohol 
and drug use, previous depressive and anxiety episodes, treatment of psychological symptoms, and 
physical health. This information will be used to describe the demographic and clinical characteristics 
of the sample. In the follow-up assessments, questions will be asked about the use of medication for 
psychological problems and treatment received from a psychologist or a psychiatrist since the start of 
the study. The use of medication and treatment received will be added as covariates in the analysis. 
Furthermore, participants will complete a self-designed questionnaire about information 
regarding the HIV infection. Questions include time since the HIV diagnosis, how the infection occurred, 
symptoms of the infection, cluster of differentiation 4 (CD4) cell count, viral load, use of antiretroviral 
therapy (ART), medication adherence, and side effects of the medication. This information will be used 
to describe the HIV status and use of ART by the sample. 
 
Physical tension questionnaire 
Physical tension will be measured with a self-designed ten item questionnaire. Questions include 
difficulty to relax, ways to relax, and symptoms of physical tension (e.g., trembling hands, tense neck 
and shoulder muscles, and increased heart rate). Items can be answered on a three-point scale (no, 
sometimes, and yes). Higher scores reflect less physical tension. 
 
Behavioral Activation for Depression Scale (BADS) 
The subscale activation of the BADS (27) will be used to measure activation during the past week. The 
subscale consists of seven items that will be measured on a seven-point scale ranging from zero “not 
at all” to six “completely,” e.g., “I am content with the amount and types of things I did.” Higher scores 
reflect greater levels of activation. The psychometric properties of the Dutch BADS are adequate (42). 
 
Emotion Regulation Questionnaire (ERQ) 
The reappraisal subscale of the ERQ (28) will be used to measure the cognitive reappraisal. The six 
items are rated on a scale ranging from one “strongly disagree” to seven “strongly agree,” e.g., “When 
I want to feel less negative emotion, I change the way I’m thinking about the situation.” Higher scores 
indicate that cognitive reappraisal is often used to regulate emotions. The convergent and discriminant 





Cognitive Emotion Regulation Questionnaire (CERQ) 
The subscales rumination, catastrophizing, positive refocusing, refocus on planning, positive 
reappraisal, and putting into perspective of the CERQ (29) will be used to measure the use of these 
cognitive coping strategies when thinking about having HIV. The subscales consist of four items each, 
which will be rated on a five-point scale ranging from one “(almost) never,” to five “(almost) always.” 
Higher scores on a subscale indicate that this cognitive coping strategy is often used when thinking 
about having HIV. Examples of items include “I keep thinking about how terrible it is that I have HIV” 
(catastrophizing) and “I think about pleasant experiences” (positive refocusing). The psychometric 
properties of the CERQ are adequate (43). 
 
Crandell Cognitions Inventory (CCI) 
The hopelessness subscale of the CCI (30) will be used to measure black and white depressive thoughts. 
The subscale consists of seven items that are rated on a five-point scale ranging from one “(almost) 
never” to five “(almost) always,” e.g., “I’ll never feel good again.” Higher scores indicate a higher 
frequency of black and white depressive thinking. The reliability and validity of the CCI are good (30, 
44). 
 
Coping self-efficacy questionnaire 
Self-efficacy to cope with having HIV will be measured with a self-designed eight-item questionnaire 
(Kraaij & Garnefski, unpublished questionnaire). The questionnaire is based on the Generalized Self-
Efficacy Scale, which has a good reliability and validity (45). Items will be measured on a five-point scale 
ranging from one “totally disagree” to five “totally agree,” e.g., “I have the necessary skills to deal with 
having HIV.” High scores reflect more self-efficacy to cope with having HIV. 
 
Goal Disengagement and Reengagement Scale 
Goal adjustment will be measured with the Goal Disengagement and Reengagement Scale (31). We 
slightly adapted the scale so that questions will be asked regarding the disengagement and 
reengagement of goals that one has to stop pursuing because of having HIV. The scale consists of four 
items that measure goal disengagement (e.g., “If I have to stop pursuing an important goal in my life 
because I have HIV, it’s easy for me to reduce my effort toward the goal”) and six items that measure 
goal reengagement (e.g., “If I have to stop pursuing an important goal in my life because I have HIV, I 
start working on other new goals”). Items are measured on a five-point scale ranging from one “totally 
disagree” to five “totally agree.” Higher scores indicate more goal disengagement and reengagement. 
A question about new goals that have already been found will be added: “I have already found new 
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Demographic variables and other information 
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and drug use, previous depressive and anxiety episodes, treatment of psychological symptoms, and 
physical health. This information will be used to describe the demographic and clinical characteristics 
of the sample. In the follow-up assessments, questions will be asked about the use of medication for 
psychological problems and treatment received from a psychologist or a psychiatrist since the start of 
the study. The use of medication and treatment received will be added as covariates in the analysis. 
Furthermore, participants will complete a self-designed questionnaire about information 
regarding the HIV infection. Questions include time since the HIV diagnosis, how the infection occurred, 
symptoms of the infection, cluster of differentiation 4 (CD4) cell count, viral load, use of antiretroviral 
therapy (ART), medication adherence, and side effects of the medication. This information will be used 
to describe the HIV status and use of ART by the sample. 
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difficulty to relax, ways to relax, and symptoms of physical tension (e.g., trembling hands, tense neck 
and shoulder muscles, and increased heart rate). Items can be answered on a three-point scale (no, 
sometimes, and yes). Higher scores reflect less physical tension. 
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at all” to six “completely,” e.g., “I am content with the amount and types of things I did.” Higher scores 
reflect greater levels of activation. The psychometric properties of the Dutch BADS are adequate (42). 
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The reappraisal subscale of the ERQ (28) will be used to measure the cognitive reappraisal. The six 
items are rated on a scale ranging from one “strongly disagree” to seven “strongly agree,” e.g., “When 
I want to feel less negative emotion, I change the way I’m thinking about the situation.” Higher scores 
indicate that cognitive reappraisal is often used to regulate emotions. The convergent and discriminant 





Cognitive Emotion Regulation Questionnaire (CERQ) 
The subscales rumination, catastrophizing, positive refocusing, refocus on planning, positive 
reappraisal, and putting into perspective of the CERQ (29) will be used to measure the use of these 
cognitive coping strategies when thinking about having HIV. The subscales consist of four items each, 
which will be rated on a five-point scale ranging from one “(almost) never,” to five “(almost) always.” 
Higher scores on a subscale indicate that this cognitive coping strategy is often used when thinking 
about having HIV. Examples of items include “I keep thinking about how terrible it is that I have HIV” 
(catastrophizing) and “I think about pleasant experiences” (positive refocusing). The psychometric 
properties of the CERQ are adequate (43). 
 
Crandell Cognitions Inventory (CCI) 
The hopelessness subscale of the CCI (30) will be used to measure black and white depressive thoughts. 
The subscale consists of seven items that are rated on a five-point scale ranging from one “(almost) 
never” to five “(almost) always,” e.g., “I’ll never feel good again.” Higher scores indicate a higher 
frequency of black and white depressive thinking. The reliability and validity of the CCI are good (30, 
44). 
 
Coping self-efficacy questionnaire 
Self-efficacy to cope with having HIV will be measured with a self-designed eight-item questionnaire 
(Kraaij & Garnefski, unpublished questionnaire). The questionnaire is based on the Generalized Self-
Efficacy Scale, which has a good reliability and validity (45). Items will be measured on a five-point scale 
ranging from one “totally disagree” to five “totally agree,” e.g., “I have the necessary skills to deal with 
having HIV.” High scores reflect more self-efficacy to cope with having HIV. 
 
Goal Disengagement and Reengagement Scale 
Goal adjustment will be measured with the Goal Disengagement and Reengagement Scale (31). We 
slightly adapted the scale so that questions will be asked regarding the disengagement and 
reengagement of goals that one has to stop pursuing because of having HIV. The scale consists of four 
items that measure goal disengagement (e.g., “If I have to stop pursuing an important goal in my life 
because I have HIV, it’s easy for me to reduce my effort toward the goal”) and six items that measure 
goal reengagement (e.g., “If I have to stop pursuing an important goal in my life because I have HIV, I 
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disagree” to five “totally agree.” Higher scores indicate more goal disengagement and reengagement. 




goals.” This last question will be handled separately, with higher scores indicating that more new goals 
were found. 
 
Behavioral Emotion Regulation Questionnaire (BERQ) 
The subscales seeking distraction, actively approaching, seeking social support, and withdrawal from 
the BERQ (Kraaij & Garnefski, unpublished questionnaire) will be used to measure the use of these 
behavioral strategies to cope with having HIV. Each subscale consists of four items that will be 
measured on a five-point scale ranging from one “never/hardly ever” to five “(nearly) always,” e.g., “I 
do other things to distract myself.” Higher scores on a subscale indicate that the strategy is often used 
to cope with having HIV. A previous study (Kraaij & Garnefski, in preparation) has shown a good 
reliability of this questionnaire. 
 
Personal growth questionnaire 
Personal growth due to having HIV will be measured with a self-designed five-item questionnaire 
(Garnefski & Kraaij, unpublished questionnaire). Items will be rated on a five-point scale ranging from 
one “not at all” to five “certainly,” e.g., “Because of having HIV I appreciate life more.” High scores 
indicate personal growth due to having HIV. In a previous study, the reliability of this questionnaire 
was adequate (15). 
 
Generalized Anxiety Disorder 7 (GAD-7) 
The severity of symptoms of anxiety will be investigated with the GAD-7 (32). The questionnaire 
consists of seven items that are rated on a four-point scale ranging from zero “not at all” to three 
“nearly every day,” e.g., “Over the last two weeks, how often have you been bothered by: feeling 
nervous, anxious or on edge.” Higher scores indicate more anxiety symptoms. The psychometric 
properties of the GAD-7 are adequate, and the scale also may be used as a screener for panic, social 
anxiety, and post-traumatic stress disorder (37). 
 
Patient Health Questionnaire 2 and Patient Health Questionnaire 4 (PHQ-2 and PHQ-4) 
The PHQ-4 (36) will be used to assess depressive and anxiety symptoms during the intervention or 
waiting period (for the mediational analysis). It consists of the first two questions of the PHQ-9 and the 
first two questions of the GAD-7. Items are rated on a four-point scale ranging from zero “not at all” 
to three “nearly every day.” Higher scores indicate more pathology. The internal reliability, construct 
validity, and factorial validity are adequate (36). The PHQ-2 (24) consists of the first two questions of 
the PHQ-9 and will be used by the HIV treatment centers to screen for depressive symptoms. 
 
 
Hospital Anxiety and Depression Scale (HADS) 
The HADS (25) will be used by some of the HIV treatment centers to screen for depressive symptoms. 
The HADS consists of an anxiety and a depression subscale, and each subscale consists of seven 
questions, e.g., “I still enjoy the things I used to enjoy.” Items are rated on a four-point scale, and the 
response categories are different for each question. Higher scores indicate more anxiety and 
depressive symptoms. The HADS is widely used and is a reliable and valid questionnaire to screen for 
anxiety and depressive symptoms (25, 46). 
 
Life Events Scale 
Life events will be assessed with the Life Events Scale (33). The scale consists of 17 negative life events 
(e.g., divorce of parents), and participants indicate if they have not experienced the life event, 
experienced it longer than one year ago, or experienced it last year. For each of the two periods, a 
total score of negative life events will be calculated. 
 
Motivation to start with the intervention 
Three questions will be used to measure the motivation to start the intervention. Two questions will 
be asked regarding the expected usefulness of the intervention, and one question about the 
motivation to start with the intervention. Questions will be answered on a five-point scale, and the 
scores on the items will be summed. 
 
Compliance 
Two measures of program adherence will be used in this study. During the intervention, program 
adherence will be measured three times by asking participants whether they read the information on 
the website and performed the exercises. Furthermore, we will monitor whether the participant calls 
with the coach. These two measures will be handled separately. 
 
Dropout and reasons for dropout 
Two types of dropout will be investigated three times during the intervention and at T1, T2, and T3. 
We will register the participants who stopped using the intervention and the participants who did not 
complete the questionnaires. We will remind participants to fill in the questionnaires. When they drop 
out, we will ask them why they do not wish to participate anymore to investigate the reasons for 
dropout. We will examine the difference in dropout between groups and differences between 





An Internet-based self-help intervention for people with HIV and depressive symptoms: Study protocol for an RCT
 
goals.” This last question will be handled separately, with higher scores indicating that more new goals 
were found. 
 
Behavioral Emotion Regulation Questionnaire (BERQ) 
The subscales seeking distraction, actively approaching, seeking social support, and withdrawal from 
the BERQ (Kraaij & Garnefski, unpublished questionnaire) will be used to measure the use of these 
behavioral strategies to cope with having HIV. Each subscale consists of four items that will be 
measured on a five-point scale ranging from one “never/hardly ever” to five “(nearly) always,” e.g., “I 
do other things to distract myself.” Higher scores on a subscale indicate that the strategy is often used 
to cope with having HIV. A previous study (Kraaij & Garnefski, in preparation) has shown a good 
reliability of this questionnaire. 
 
Personal growth questionnaire 
Personal growth due to having HIV will be measured with a self-designed five-item questionnaire 
(Garnefski & Kraaij, unpublished questionnaire). Items will be rated on a five-point scale ranging from 
one “not at all” to five “certainly,” e.g., “Because of having HIV I appreciate life more.” High scores 
indicate personal growth due to having HIV. In a previous study, the reliability of this questionnaire 
was adequate (15). 
 
Generalized Anxiety Disorder 7 (GAD-7) 
The severity of symptoms of anxiety will be investigated with the GAD-7 (32). The questionnaire 
consists of seven items that are rated on a four-point scale ranging from zero “not at all” to three 
“nearly every day,” e.g., “Over the last two weeks, how often have you been bothered by: feeling 
nervous, anxious or on edge.” Higher scores indicate more anxiety symptoms. The psychometric 
properties of the GAD-7 are adequate, and the scale also may be used as a screener for panic, social 
anxiety, and post-traumatic stress disorder (37). 
 
Patient Health Questionnaire 2 and Patient Health Questionnaire 4 (PHQ-2 and PHQ-4) 
The PHQ-4 (36) will be used to assess depressive and anxiety symptoms during the intervention or 
waiting period (for the mediational analysis). It consists of the first two questions of the PHQ-9 and the 
first two questions of the GAD-7. Items are rated on a four-point scale ranging from zero “not at all” 
to three “nearly every day.” Higher scores indicate more pathology. The internal reliability, construct 
validity, and factorial validity are adequate (36). The PHQ-2 (24) consists of the first two questions of 
the PHQ-9 and will be used by the HIV treatment centers to screen for depressive symptoms. 
 
 
Hospital Anxiety and Depression Scale (HADS) 
The HADS (25) will be used by some of the HIV treatment centers to screen for depressive symptoms. 
The HADS consists of an anxiety and a depression subscale, and each subscale consists of seven 
questions, e.g., “I still enjoy the things I used to enjoy.” Items are rated on a four-point scale, and the 
response categories are different for each question. Higher scores indicate more anxiety and 
depressive symptoms. The HADS is widely used and is a reliable and valid questionnaire to screen for 
anxiety and depressive symptoms (25, 46). 
 
Life Events Scale 
Life events will be assessed with the Life Events Scale (33). The scale consists of 17 negative life events 
(e.g., divorce of parents), and participants indicate if they have not experienced the life event, 
experienced it longer than one year ago, or experienced it last year. For each of the two periods, a 
total score of negative life events will be calculated. 
 
Motivation to start with the intervention 
Three questions will be used to measure the motivation to start the intervention. Two questions will 
be asked regarding the expected usefulness of the intervention, and one question about the 
motivation to start with the intervention. Questions will be answered on a five-point scale, and the 
scores on the items will be summed. 
 
Compliance 
Two measures of program adherence will be used in this study. During the intervention, program 
adherence will be measured three times by asking participants whether they read the information on 
the website and performed the exercises. Furthermore, we will monitor whether the participant calls 
with the coach. These two measures will be handled separately. 
 
Dropout and reasons for dropout 
Two types of dropout will be investigated three times during the intervention and at T1, T2, and T3. 
We will register the participants who stopped using the intervention and the participants who did not 
complete the questionnaires. We will remind participants to fill in the questionnaires. When they drop 
out, we will ask them why they do not wish to participate anymore to investigate the reasons for 
dropout. We will examine the difference in dropout between groups and differences between 







Medical data will be obtained from the Athena/SHM Cohort Study after consent from the participant. 
The ATHENA Cohort Study is maintained by Stichting HIV Monitoring, which is supported by the Dutch 
Ministry of Health via the National Institute for Public Health and Environment (RIVM). The data that 
will be used include the time since HIV diagnosis, medication use, CD4 cell count, and viral load. 
 
User satisfaction questionnaire 
At T1, we will ask participants about their satisfaction with the self-help program and the coach with a 
self-designed questionnaire. The questionnaire consists of 31 items to evaluate the intervention, for 
example, the components of the self-help program and the support from the coach. Open-ended and 
closed-ended questions will be used in the questionnaire. The questions for participants in the control 
group will concern the support from the coach (13 questions). The answers to these questions will be 
used to adjust the self-help program before implementing it. 
 
Statistical analyses 
A two-tailed alpha of 0.05 will be used for significance testing. All analyses will be based on an 
intention-to-treat (ITT) analysis, which includes all participants who were randomized to one of the 
groups at the beginning of the study (47). Baseline differences between conditions will be investigated 
with chi-square tests for categorical variables and ANOVAs for continuous variables.  
To examine the effect of condition on the depressive symptoms at the post-tests, longitudinal 
multilevel regression analysis (LMRA) will be conducted (48). A two- level model will be studied: time 
at level 1 and participants at level 2. The variable time will have four categories indicating the four time 
points (T0–T3). The baseline (T0) will be used as reference category. The independent variable is 
condition, the dependent variable is the score on the PHQ-9 or the CES-D, and several covariates will 
be included in the model (e.g., sex and age). Multiple imputation for missing data is not necessary in 
LMRA because it can include participants with missing data on one or more time points (48). The 
existence of an effect of HIV treatment center will be investigated exploratory. 
Furthermore, Cohen’s d will be calculated to indicate within- and between-group effect sizes 
(49). In addition, clinically important differences for individual change in depressive symptoms will be 
examined. Change scores of five or more from the pretest to the post-tests will be considered as clinical 
important differences for the PHQ-9 (50). 
With regard to all secondary outcomes, we will study the pre-treatment versus post-treatment 
changes by using the analyses described above for the PHQ-9 and the CES-D. To examine moderators 
of the treatment outcome, LMRA will be conducted. Potential moderators will be entered individually. 
Interaction effects will be investigated (e.g., time x condition x moderator). A limited number of cross-
 
product interactions will be examined, and we will correct for multiple testing. Furthermore, the 
QUINT (Qualitative Interaction Trees (51) method will be used to identify subgroups for which the 
intervention is most effective, by exploratory investigation of the multiple moderators. 
Mediation will be tested by examining the indirect effect of the independent variable 
(condition) on the dependent variable (depressive symptoms) through the proposed mediators. 
Mediation analysis will be conducted by using latent difference score models, which are recommended 
with repeated measurements and multiple mediators (52). These models focus on intra-individual 
change and individual differences in that change. 
 
Discussion 
In the proposed study, we will investigate the effectiveness of an online self-help intervention for 
PLWH with depressive symptoms in a randomized controlled trial. Additionally, moderators and 
mediators of the treatment outcome will be assessed. This study has some strengths and limitations 
that will be discussed in the following section. First, a strength of this study is that the self-help program 
is online, so many people can be reached. Only PLWH without Internet or an e-mail address cannot 
participate, but most people in The Netherlands have access to the Internet. Second, participants can 
work on the program when and where they want and at their own pace. Third, the content of the 
program is based on prior research and a needs assessment among PLWH (14-18); that is, the program 
is designed especially for PLWH. Fourth, moderators of the treatment outcome will be studied; we will 
investigate for whom the program is especially beneficial. Investigations of the effect of personal 
characteristics on the treatment outcome are useful, so patients could receive the treatment that is 
most likely to decrease their depressive symptoms. Fifth, mediators of the treatment outcome will be 
assessed; the mechanisms of change of the intervention will be studied. Knowing more about exactly 
how the invention works is important. Knowing what is effective would allow the adaptation of the 
treatment to make it more efficient (53). Sixth, the support participants receive from the coach is also 
a strength in this study. The coach will motivate participants to continue with the program, and this 
will probably decrease the dropout. Lastly, most HIV treatment centers in the Netherlands agreed to 
screen patients for the study. This means that we will have PLWH from across the country participating 
in the study. 
Furthermore, some limitations are present in the study. Patients with severe depressive 
symptoms and/or suicidal ideation will be excluded from the study. We argue that these patients 
should be closely monitored by a therapist. We expect that these patients would benefit from the self-
help program, as has also been found in previous research (54), but more intense treatment is 
desirable for these patients. In addition, the follow-up period of participants in the control group is 
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Medical data 
Medical data will be obtained from the Athena/SHM Cohort Study after consent from the participant. 
The ATHENA Cohort Study is maintained by Stichting HIV Monitoring, which is supported by the Dutch 
Ministry of Health via the National Institute for Public Health and Environment (RIVM). The data that 
will be used include the time since HIV diagnosis, medication use, CD4 cell count, and viral load. 
 
User satisfaction questionnaire 
At T1, we will ask participants about their satisfaction with the self-help program and the coach with a 
self-designed questionnaire. The questionnaire consists of 31 items to evaluate the intervention, for 
example, the components of the self-help program and the support from the coach. Open-ended and 
closed-ended questions will be used in the questionnaire. The questions for participants in the control 
group will concern the support from the coach (13 questions). The answers to these questions will be 
used to adjust the self-help program before implementing it. 
 
Statistical analyses 
A two-tailed alpha of 0.05 will be used for significance testing. All analyses will be based on an 
intention-to-treat (ITT) analysis, which includes all participants who were randomized to one of the 
groups at the beginning of the study (47). Baseline differences between conditions will be investigated 
with chi-square tests for categorical variables and ANOVAs for continuous variables.  
To examine the effect of condition on the depressive symptoms at the post-tests, longitudinal 
multilevel regression analysis (LMRA) will be conducted (48). A two- level model will be studied: time 
at level 1 and participants at level 2. The variable time will have four categories indicating the four time 
points (T0–T3). The baseline (T0) will be used as reference category. The independent variable is 
condition, the dependent variable is the score on the PHQ-9 or the CES-D, and several covariates will 
be included in the model (e.g., sex and age). Multiple imputation for missing data is not necessary in 
LMRA because it can include participants with missing data on one or more time points (48). The 
existence of an effect of HIV treatment center will be investigated exploratory. 
Furthermore, Cohen’s d will be calculated to indicate within- and between-group effect sizes 
(49). In addition, clinically important differences for individual change in depressive symptoms will be 
examined. Change scores of five or more from the pretest to the post-tests will be considered as clinical 
important differences for the PHQ-9 (50). 
With regard to all secondary outcomes, we will study the pre-treatment versus post-treatment 
changes by using the analyses described above for the PHQ-9 and the CES-D. To examine moderators 
of the treatment outcome, LMRA will be conducted. Potential moderators will be entered individually. 
Interaction effects will be investigated (e.g., time x condition x moderator). A limited number of cross-
 
product interactions will be examined, and we will correct for multiple testing. Furthermore, the 
QUINT (Qualitative Interaction Trees (51) method will be used to identify subgroups for which the 
intervention is most effective, by exploratory investigation of the multiple moderators. 
Mediation will be tested by examining the indirect effect of the independent variable 
(condition) on the dependent variable (depressive symptoms) through the proposed mediators. 
Mediation analysis will be conducted by using latent difference score models, which are recommended 
with repeated measurements and multiple mediators (52). These models focus on intra-individual 
change and individual differences in that change. 
 
Discussion 
In the proposed study, we will investigate the effectiveness of an online self-help intervention for 
PLWH with depressive symptoms in a randomized controlled trial. Additionally, moderators and 
mediators of the treatment outcome will be assessed. This study has some strengths and limitations 
that will be discussed in the following section. First, a strength of this study is that the self-help program 
is online, so many people can be reached. Only PLWH without Internet or an e-mail address cannot 
participate, but most people in The Netherlands have access to the Internet. Second, participants can 
work on the program when and where they want and at their own pace. Third, the content of the 
program is based on prior research and a needs assessment among PLWH (14-18); that is, the program 
is designed especially for PLWH. Fourth, moderators of the treatment outcome will be studied; we will 
investigate for whom the program is especially beneficial. Investigations of the effect of personal 
characteristics on the treatment outcome are useful, so patients could receive the treatment that is 
most likely to decrease their depressive symptoms. Fifth, mediators of the treatment outcome will be 
assessed; the mechanisms of change of the intervention will be studied. Knowing more about exactly 
how the invention works is important. Knowing what is effective would allow the adaptation of the 
treatment to make it more efficient (53). Sixth, the support participants receive from the coach is also 
a strength in this study. The coach will motivate participants to continue with the program, and this 
will probably decrease the dropout. Lastly, most HIV treatment centers in the Netherlands agreed to 
screen patients for the study. This means that we will have PLWH from across the country participating 
in the study. 
Furthermore, some limitations are present in the study. Patients with severe depressive 
symptoms and/or suicidal ideation will be excluded from the study. We argue that these patients 
should be closely monitored by a therapist. We expect that these patients would benefit from the self-
help program, as has also been found in previous research (54), but more intense treatment is 




only three months (they may start with the intervention after the three month follow-up), while this 
period is six months for the participants in the intervention group. However, we argue that it is not 
ethical to let people in the control group wait for approximately eight months before providing the 
intervention (eight weeks plus six months of follow-up). Therefore, the intervention will be offered to 
the control group after the second post-test. The last limitation concerns the screening of participants 
for depressive symptoms. We will use a questionnaire with nine items to measure depressive 
symptoms in PLWH. One could argue that a diagnostic interview will screen depressive symptoms 
more extensively and allow the identification of a possible depressive disorder. However, this approach 
would be time consuming, and the PHQ-9 is a reliable and valid measure of severity of depressive 
symptoms (37). Furthermore, the program is designed for people with mild to moderate depressive 
symptoms, so a diagnosis of depression is not an inclusion criterion for participation in the study. 
To conclude, in the proposed study, we will evaluate an online self-help program for PLWH 
with depressive symptoms. Since depressive symptoms exist frequently in PLWH, low-cost and low-
stigmatizing interventions are needed for these individuals. The proposed study offers an online self-
help program that complies with this request. If the self-help program proves to be effective in the 
proposed study, implementation of the website will be done in cooperation with the Dutch patient 
organization (HIV Vereniging Nederland) and HIV treatment centers. Furthermore, the program may 
be implemented in other countries as well. 
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only three months (they may start with the intervention after the three month follow-up), while this 
period is six months for the participants in the intervention group. However, we argue that it is not 
ethical to let people in the control group wait for approximately eight months before providing the 
intervention (eight weeks plus six months of follow-up). Therefore, the intervention will be offered to 
the control group after the second post-test. The last limitation concerns the screening of participants 
for depressive symptoms. We will use a questionnaire with nine items to measure depressive 
symptoms in PLWH. One could argue that a diagnostic interview will screen depressive symptoms 
more extensively and allow the identification of a possible depressive disorder. However, this approach 
would be time consuming, and the PHQ-9 is a reliable and valid measure of severity of depressive 
symptoms (37). Furthermore, the program is designed for people with mild to moderate depressive 
symptoms, so a diagnosis of depression is not an inclusion criterion for participation in the study. 
To conclude, in the proposed study, we will evaluate an online self-help program for PLWH 
with depressive symptoms. Since depressive symptoms exist frequently in PLWH, low-cost and low-
stigmatizing interventions are needed for these individuals. The proposed study offers an online self-
help program that complies with this request. If the self-help program proves to be effective in the 
proposed study, implementation of the website will be done in cooperation with the Dutch patient 
organization (HIV Vereniging Nederland) and HIV treatment centers. Furthermore, the program may 
be implemented in other countries as well. 
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Background Many people living with HIV have depressive symptoms, but some individuals do not 
receive adequate treatment. We developed an online self-help intervention for people with HIV with 
depressive symptoms on the basis of previous research. The aim of this study was to investigate 
the effectiveness of the intervention on depressive symptoms in individuals with HIV. 
Methods In this randomized controlled trial, participants recruited from 23 HIV treatment centers in 
the Netherlands were eligible if they were aged 18 years and older, had been diagnosed with HIV at 
least 6 months before the study, and had mild to moderate depressive symptoms (Patient Health 
Questionnaire-9 [PHQ-9] score > 4 and < 20). Individuals also had to speak English or Dutch and 
have internet access and an email address. Participants were randomly assigned (1:1) to an internet-
based intervention (Living positive with HIV) or an attention-only waiting-list control condition. 
Randomization was done using random number tables, with permuted blocks of 12, stratified by 
treatment center and sex. Participants, researchers, and coaches were not masked to group 
allocation. The primary outcome was depressive symptoms assessed with the PHQ-9 and the Center 
for Epidemiologic Studies Depression Scale (CES-D) at pretest, eight weeks after baseline, and three 
months after completion of the intervention or control condition (post-test 2). The primary analysis 
was done by intention to treat. Between group effect size was assessed with Cohen’s d. This trial 
is registered with the Netherlands Trial Registry, number NTR5407. 
Findings Between Feb 1, and Dec 31, 2015, we randomly assigned 188 participants to the intervention 
group (n = 97) or the control group (n = 91). Mean pretest PHQ-9 score was 11.74 (SD 2.49) in the 
intervention group and 11.11 (2.37) in the control group; at the post-test visits it was 6.73 (3.00) and 
6.62 (3.03) in the intervention group and 8.60 (3.12) and 8.06 (3.17) in the control group. Mean 
pretest CES-D score was 24.91 (5.93) in the intervention group and 22.94 (6.48) in the control group; 
at the post-test visits it was 13.94 (6.39) and 15.71 (6.39) in the intervention group and 19.09 (7.05) 
and 18.43 (7.05) in the control group. The reduction in depressive symptoms was significantly 
larger in the intervention group than in the control group (d = –0.56 95% CI [–0.85, –0.27] for PHQ-
9 and –0.72 [–1.02, –0.42] for CES-D at post-test 1; –0.46 [–0.75, –0.17] for PHQ-9 and –0.47 [–0.76, 
–0.18] for CES-D at post-test 2). No adverse events were reported. 
Interpretation This guided internet-based intervention might be effective for the treatment of 
depressive symptoms. Future research should focus on the effectiveness of online psychological 







Depressive symptoms occur in around 33% of people with HIV (1). A possible consequence of 
depression in people with HIV is reduced adherence to antiretroviral therapy (2). Although several 
psychological interventions have been found to effectively reduce depressive symptoms (3, 4) and 
improve antiretroviral therapy adherence (5) and quality of life (4), many individuals with HIV do not 
seek treatment when they feel depressed because of factors such as perceived stigma (6). Internet-
based interventions might increase the accessibility of treatment for people with HIV who have 
depression. Additionally, these interventions have the potential to reach a large number of people, 
can be followed anonymously at preferred times and places, and might be more cost-effective than 
face-to-face interventions. Previous studies found that internet-based treatments are effective for the 
treatment of depression in the general population (7), and in people with chronic somatic conditions 
(8). Furthermore, face-to-face and guided internet-based interventions for depression were found to 
be equally effective (9). 
Only four studies (10-13) have assessed the effectiveness of computerised or internet 
treatments for depressive symptoms in people with HIV. Three of these interventions did not improve 
mood (10-12). An online support group intervention for individuals with HIV reduced depressive 
symptoms, but this study did not include a control condition (13). The other studies investigated a 
metacognitive therapy and positive psychology intervention (11), a cognitive behavioural intervention 
(12), and stress-management training (10). These interventions might have been ineffective because 
they did not meet the needs of people with HIV who have depressive symptoms (10, 12). For example, 
one of the interventions focused more on adherence than on depression (12). Therefore, the 
development of online interventions for people with HIV that effectively reduce depressive symptoms 
is needed. 
We designed an internet-based treatment termed Living positive with HIV (14). The 
intervention is based on a booklet self-help programme for people with HIV who have depression (15). 
The booklet was designed specifically for individuals with HIV, to meet their needs and preferences 
(16). A randomized controlled trial (15) showed that the booklet was effective in decreasing depressive 
symptoms, compared with a waiting-list control condition. On the basis of these findings, we adapted 
the self-help booklet and converted it into the current internet-based self-help intervention. 
Thereafter, a focus group evaluated the intervention and we adjusted it accordingly. In a pilot study 
(14) in 2014, 20 individuals with HIV completed the intervention with telephone coaching. Depressive 
symptoms decreased after the intervention and user satisfaction was high (14). 
The aim of this study was to investigate the effectiveness of the guided internet-based self-
help intervention in decreasing depressive symptoms in people with HIV compared with an attention-
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(14) in 2014, 20 individuals with HIV completed the intervention with telephone coaching. Depressive 
symptoms decreased after the intervention and user satisfaction was high (14). 
The aim of this study was to investigate the effectiveness of the guided internet-based self-





only waiting-list control condition. We also investigated the effect of the intervention on anxiety and 
user satisfaction with the intervention. 
 
Research in context 
Evidence before this study 
In a previous study, we did a meta-analysis of 62 randomized controlled trials published up to Sept 29, 
2014, to investigate the effectiveness of psychosocial interventions for people with HIV in improving 
mental health. The meta-analysis included one internet-based intervention for people with HIV that 
investigated effects on mood. On Augustus 30, 2017, our search was updated; we searched PubMed, 
PsycINFO, and Embase using terms related to “HIV”, “Internet-based therapy”, and “depression”. One 
additional study was found. To date, only two studies have investigated the use of internet-based 
interventions for people with HIV who have depressive symptoms and both found that the 
interventions did not improve mood. 
 
Added value of this study 
Our results show that the guided internet-based intervention, Living positive with HIV, might be 
effective in improving depressive symptoms in people with HIV compared with an attention-only 
waiting-list control condition. 
This improvement was sustained over time, and anxiety was significantly reduced in patients who 
followed the intervention compared with the control. Online interventions have advantages, such as 
large potential reach and accessibility. Additionally, this intervention is available in Dutch and English 
and could be adapted for use in other countries. 
 
Implications of all the available evidence 
People with HIV who have depressive symptoms should be referred to effective psychological 
treatments. eHealth interventions are emerging and have been shown to be as effective as face-to-
face interventions. Therefore, treatment providers might refer people with HIV who have depressive 
symptoms to an online intervention, such as the intervention used in this study. More research on 
moderators, mediators, and the cost-effectiveness of internet-based interventions is needed. 
 
Methods 
Study design and participants 
In this randomized controlled trial, participants were recruited from 23 HIV treatment centers in the 
Netherlands. Patients at these centers underwent a two-step screening for depressive symptoms. 
 
 
Nursing consultants and doctors in HIV treatment centers initially screened patients with HIV for 
depressive symptoms during regular check-ups using the Patient Health Questionnaire-2 (PHQ-2) (17). 
Patients with PHQ-2 scores higher than zero who were interested in participating in the study were 
referred to the researchers for a second screening with the Patient Health Questionnaire-9 (PHQ-9), 
using established cutoff scores (18). One HIV treatment center screened patients with the Hospital 
Anxiety and Depression Scale (19), because this questionnaire was already in use. Patients with total 
scores higher than 2 and less than 16 on the Hospital Anxiety and Depression Scale were deemed 
eligible for referral to the researchers. The study was also advertised by the Dutch HIV Association. 
Researchers contacted all interested patients to provide more information and to screen for eligibility. 
Eligible individuals were aged 18 years and older, had been diagnosed with HIV at least six 
months before the study, and had mild to moderate depressive symptoms (PHQ-9 score of > 4 and < 
20). Eligible patients were also required to speak Dutch or English, have internet access and an email 
address, and to be available for eight weeks to work on the intervention. We excluded individuals with 
severe cognitive impairments, severe depressive symptoms (PHQ-9 score ≥ 20), or severe suicidal 
ideation (score > 1 on the suicide item of the PHQ-9), and those who were receiving treatment from a 
psychologist or psychiatrist, had been on antidepressants for less than three months, or had changed 
type or dose of antidepressants in the past three months. The study was approved by the medical 
ethics committee of Leiden University Medical Center. The study protocol has been published 
elsewhere (14). All participants provided online informed consent. 
 
Randomization and masking 
Participants were randomly assigned (1:1) to the internet-based intervention or the attention-only 
waiting-list control condition. Randomization was done using random number tables to generate the 
randomization sequence with block sizes of 12, stratified by treatment center and sex, and concealed 
from the main researcher. The main researcher allocated participants to conditions, but the characters 
in the randomization file were white until assignment of a participant was carried out (then the letters 
on one line in the file were made visible). Participants, researchers, and coaches were not masked to 
the participant’s assigned treatment condition. 
 
Procedures 
Medical data (e.g., viral load) were obtained from the AIDS Therapy Evaluation in the Netherlands 
(ATHENA) cohort study after obtaining consent from the participant. The ATHENA cohort study is 
maintained by Stichting HIV Monitoring, which is supported by the Dutch Ministry of Health via the 
National Institute for Public Health and Environment. A self-designed questionnaire, included in the 
pretest, was used to obtain information about patient demographics. 
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All participants completed the pretest and were randomly assigned to one of two conditions. 
Participants in the intervention group did the first post-test after they had completed the intervention 
(duration six to ten weeks), followed by two further post-tests three and six months after completion 
of the intervention. Participants in the control group received two post-tests: the first post-test was 
sent eight weeks after the pretest and the second post-test was sent three months after the first post-
test was completed (Appendix 1). Participants who completed all questionnaires received €25. The last 
post-test was completed on October 14, 2016. All assessments were completed online via a secured 
website, with the exception of screening with the PHQ-9, which was completed via telephone 
conversations. 
The internet-based self-help intervention consisted of cognitive behavioural therapy. 
Psychoeducation was alternated with exercises and assignments. The intervention was based on a self-
help booklet for people with HIV with depressive symptoms (15), which was extended to include an 
activation component and minimal coaching with motivational interviewing, and the programme was 
translated into English to reach more people with HIV. The intervention included four main 
components covered in eight lessons. The first component was activation, in which participants were 
encouraged to do pleasant activities. The second component contained relaxation exercises. The third 
component included assignments to identify and change negative thoughts. The fourth component 
included goal setting and increasing confidence to attain goals. Participants received login details for 
the secured website of the intervention. Participants did the intervention for one to two hours per 
week for a period of around eight weeks, and received telephone coaching. 
Participants in the control condition were put on a waiting list and received attention only via 
telephone calls from a coach. After the second post-test, participants in the control condition were 
invited to start the intervention. Participants in the control group who started the intervention 
received one post-test, the results of which are not reported in this paper and will not be reported 
elsewhere. 
All participants received minimal telephone coaching. Participants in the intervention group 
were called weekly for approximately 15 minutes by a personal coach, who asked the participants how 
they were doing and how they were progressing with the intervention. Furthermore, motivational 
interviewing was used to prevent attrition. Formal psychotherapy was not included in the coaching, 
but depressive symptoms and suicidal thoughts were monitored. Coaching was offered until 
participants completed the intervention (maximum duration ten weeks). After ten weeks, participants 
could complete the intervention independently and ask questions via email. Participants in the control 
group were called weekly for around five minutes by a personal coach, for a period of eight weeks. The 
coach asked participants how they were doing and motivated individuals to stay in the study. Coaches 
monitored depressive symptoms and suicidal thoughts in both the intervention and control groups and 
 
 
patients with severe depressive symptoms or suicidal ideation were referred to their general 
practitioner or HIV treatment center. 
All coaches were clinical psychology Masters students or graduates with an MSc in Psychology 
who had attended several clinical courses during their Masters, in which they learned communication 
skills and therapeutic strategies. Coaches were trained by the main researcher. During training, 
coaching procedures and motivational interviewing were explained and practiced. Coaches received a 
coaching manual with additional information about motivational interviewing, the study, the 
procedures, and content of coaching (e.g., what to do when depressive symptoms of a participant 
increase). At the beginning of the study, weekly supervision sessions were arranged with all coaches 
and the main researcher to discuss difficulties and questions. After a few months, these supervision 
sessions were phased out, but coaches and researchers could contact each other directly via telephone 
or email when needed. 
 
Outcomes 
The primary outcome was depressive symptoms, assessed with the PHQ-9 (18) and the Center for 
Epidemiologic Studies Depression Scale (CES-D; (20)) at pretest (baseline), immediately after the 
intervention (or eight weeks after baseline in the control group; post-test 1), and at three months after 
the first post-test. As a secondary outcome, in the intervention group only, we also assessed the PHQ-
9 and CES-D scores six months after completion of the intervention. Total scores ranged between 0 
and 27 for the PHQ-9 and 0 and 60 for the CES-D, with higher scores indicating increasing symptom 
severity. The secondary outcomes were anxiety symptoms, assessed with the Generalized Anxiety 
Disorder-7 (GAD-7) scale (21) (total score 0–21) at all assessment time points, with higher scores 
indicating increasing symptom severity, and user satisfaction, measured with a self-designed 
questionnaire at the first post-test. In the intervention group, participants were asked to grade the 
intervention (0–10; a higher score indicated higher user satisfaction) and whether they would 
recommend the intervention (yes, maybe, or no). In both groups, participants were also asked to grade 
the coach (0–10; a higher score indicated higher satisfaction with the coach). 
Other secondary outcomes not reported in this paper were physical tension, activation 
(Behavioral Activation for Depression Scale; (22)), cognitive reappraisal (Emotion Regulation 
Questionnaire; (23)), cognitive coping (Cognitive Emotion Regulation Questionnaire; (24)), depressive 
thoughts (Crandell Cognitions Inventory; (25)), behavioral coping (Kraaij & Garnefski, Behavioral 
Emotion Regulation Questionnaire, unpublished questionnaire), coping self-efficacy (Kraaij & 
Garnefski, unpublished questionnaire), goal adjustment (Goal Disengagement and Reengagement 
Scale; (26)), personal growth (Garnefski & Kraaij, unpublished questionnaire), negative life events (Life 
Events Scale), motivation to start with the intervention, compliance, and dropout and reasons for 
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dropout. These outcomes were used in moderator and mediator analyses. The results of these 
outcomes will be reported elsewhere. 
There was no data safety monitoring board. Participants were assessed multiple times during 
the intervention and the study, and the results regarding their symptoms were monitored by the 
researcher. Additionally, coaches monitored the participants. 
 
Statistical analysis 
A power analysis with the program Power Analysis and Sample Size Software (PASS) was performed. 
On the basis of the randomized controlled trial on the effectiveness of the self-help booklet (15), and 
an expected dropout of 15% at the first post-test, a sample size of 150 participants was required to 
detect an effect size of 0.50 with 0.80 power at the 5% significance level. We aimed to include 
200 participants because attrition was expected during follow-up (14). 
Statistical analysis was done with SPSS software (version 23.0), and a p value of less than 0.05 
was considered to indicate statistical significance. Primary and secondary analyses were done by 
intention to treat. 
χ² tests and ANOVA were used to investigate differences between participants who dropped 
out and those who completed the intervention. We did longitudinal multilevel regression analyses (27) 
using the maximum likelihood estimation method to investigate differences between the groups in 
changes in depressive and anxiety symptoms from the pretest to the post-tests. Time and group were 
included as fixed effects and slopes for time and the intercept as random effects. Pretest, post-test 1, 
and post-test 2 scores were included in the between-group analyses. Pretest and the three post-test 
scores for the intervention group were included in the within-group analyses to assess the long- term 
effects of the intervention. The variance components variance–covariance matrix was used for 
between-group analyses and the heterogeneous autoregressive matrix was used for within-group 
analyses. Additionally, all outcomes were analysed in the per-protocol sample, which included all 
randomly assigned participants who completed at least five lessons of the intervention (indicated by 
self-report); using this minimum ensured that at least three of the four main intervention components 
were completed. The effect of HIV treatment center on the random intercept was investigated in an 
exploratory analysis, by adding treatment center as an extra level in the analysis. 
Cohen’s d was calculated to assess effect size. For the between-group effect sizes, the mean 
difference scores for the control group were subtracted from the mean difference scores for the 
intervention group and divided by the pooled SD of the raw scores at pretest (28). For the effect size 
of time (i.e., long-term effect of the intervention), we used the formula unstandardized coefficient 
(b)/SD (28), using the SD of the raw scores of the intervention group at pretest. Effect sizes were 
calculated using the estimated values from the longitudinal multilevel regression analyses. The formula 
 
 
used by de Zeeuw and colleagues (29) was used to calculate the SE of the between-group effect size 
and 95% CIs. 
Clinically significant differences, deterioration, and number needed to treat from pretest to 
the first post-test were assessed for the PHQ-9 and the CES-D. A reliable change index was calculated 
for each individual to determine improvement and their pretest score was subtracted from their first 
post-test score and divided by the SE of difference between the two scores (30). To calculate the SE of 
difference, test–retest reliability (rxx) was used, where rxx was equal to 0.84 for both the PHQ-9 (18) 
and the CES-D. Reliable change index scores of less than –1.96 indicated symptom improvement. 
Recovery was calculated by examining whether a cutoff for depression (score 10 on the PHQ-9 (31) 
and 22 on the CES-D (32)) was reached at the first post-test. Recovery was only assessed in participants 
who scored above this cutoff at pretest (clinical cases), because participants who scored below this 
cutoff at pretest had already reached the criterion (30). For participants who scored above the cutoff 
at pretest, we assessed both improvement and recovery; in cases of both, the criteria for clinically 
significant change according to Jacobson and Truax (30) were met. Deterioration was also assessed, 
whereby a reliable change index score higher than 1.96 indicated deterioration. The number needed 
to treat was calculated using the percentage of participants who met the criteria for clinically 
significant change. Clinically significant change, deterioration, and number needed to treat were 
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Figure 1. Trial profile 
 
Results 
Between February 1, and December 31, 2015, 3642 people with HIV were screened for depressive 
symptoms in HIV treatment centers, of whom 445 were screened for eligibility. One hundred eighty-
eight participants were randomly assigned to the intervention group (n = 97) or the control group (n = 
91; Figure 1). Of the 91 participants in the control group, 77 (85%) completed the first post-test and 67 
(74%) completed the second post- test. Forty-six (51%) of 91 participants started the intervention after 
the second post-test. Of the 97 participants in the intervention group, 88 (91%) started the 
intervention, 75 (77%) completed the first post-test, 64 (66%) completed the second post-test, and 60 
(62%) completed the third post-test. All participants in the intervention group who dropped out (i.e., 
did not complete the first post-test) stopped the intervention before completion of the fifth lesson. 
 
 
Fourteen participants did not finish the intervention in ten weeks. We identified no significant 
differences in the proportion of participants who did not complete the first post-test between the two 
groups. Additionally, no significant differences in the baseline characteristics were identified between 
participants who completed the first post-test and those who did not. 
Most participants were men, homosexual, and educated to a medium or high level, with a 
mean age of about 46 years (Table 1). Mean time since HIV diagnosis was about 10 years and most 
participants were on antiretroviral therapy. Participants in the intervention group received a mean of 
6.38 telephone calls from the coach compared with a mean of 6.23 telephone calls in the control group, 
with no significant differences identified between groups (p = 0.67). The mean duration of phone calls 
per participant was significantly higher in the intervention group than the control group (90.74 minutes 
(SD = 60.32) vs 60.52 minutes (SD = 42.30); p < 0.0001). 
 
Table 1. Baseline characteristics of the intervention and control group 
Characteristic Intervention group  
(n = 97) 
Control group  
(n = 91) 
Total sample  
(n = 188) 
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Time since HIV diagnosis (years)a 9.35 (6.46) 10.41 (6.70) 9.87 (6.58) 
Diagnosis of AIDS    
Screened by HIV treatment centers (n = 3642) 
Screened by researchers (n = 445) 
Did not meet inclusion criteria/not interested in participating (n = 3197) 
Completed pretest and randomised (n = 188) 
Excluded (n = 257) 
- No depressive symptoms/PHQ-9 score < 5 (n = 109) 
- Not interested (n = 55) 
- No time (n = 27) 
- Already receiving treatment from psychologist/psychiatrist (n = 21) 
- PHQ-9 score > 19 (n = 18) 
- PHQ-9 score question 9 > 1 (n = 12) 
- Could not be reached (n = 10) 
- No computer/internet (n = 4) 
- Died (n = 1) 
Allocated to intervention group (n = 97) 
Started with intervention (n = 88;  91%) 
Did not start (n = 9) 
- Program did not fit/preferred psychologist (n = 4) 
- Unknown (n = 2) 
- No time (n=1) 
- Depressive symptoms decreased (n = 1) 
- Computer was broken (n = 1) 
Allocated to control group (n = 91) 
Started with coaching (n = 87; 96%) 
Did not start (n = 4) 
- Did not want to be in control group (n = 2) 




First post-test  (+/- 8 weeks after baseline) 
Assessed (n = 77; 85%) 
Lost to follow-up (n = 10) 
- Did not want to complete questionnaires (n = 5) 
- Depressive symptoms decreased (n = 3) 
- Preferred treatment from psychologist (n = 1) 
- Unknown (n = 1) 
Second post-test (3-month follow-up)  
Assessed (n = 64; 66%) 
Lost to follow-up (n = 11) 
- Unknown (n = 10) 
- Depressive symptoms decreased (n = 1) 
 
First post-test (after intervention) 
Assessed (n = 75; 77%) 
Lost to follow-up (n = 13) 
- Program did not fit/preferred psychologist (n = 7) 
- No time (n = 3) 
- Program was too confronting (n = 2) 
- Unknown (n = 1) 
Second post-test (3-month follow-up)  
Assessed (n = 67; 74%) 
Lost to follow-up (n = 10) 
- Unknown (n = 7) 
- Did not want to start with program (n = 2) 
- Did not want to complete questionnaires (n = 1) 
Intervention 
Started with intervention (n = 46; 51%) 
Lost to follow-up (n = 21) 
- No depressive symptoms (n = 7) 
- Unknown (n = 7) 
- Received psychological treatment (n = 5) 
- No time (n = 1) 
- No longer interested (n = 1) 
Third post-test (6-month follow-up)  
Assessed (n = 60; 62%) 
Lost to follow-up (n = 4) 





Analysed (n = 97) Analysed (n = 91) 
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Results 
Between February 1, and December 31, 2015, 3642 people with HIV were screened for depressive 
symptoms in HIV treatment centers, of whom 445 were screened for eligibility. One hundred eighty-
eight participants were randomly assigned to the intervention group (n = 97) or the control group (n = 
91; Figure 1). Of the 91 participants in the control group, 77 (85%) completed the first post-test and 67 
(74%) completed the second post- test. Forty-six (51%) of 91 participants started the intervention after 
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intervention, 75 (77%) completed the first post-test, 64 (66%) completed the second post-test, and 60 
(62%) completed the third post-test. All participants in the intervention group who dropped out (i.e., 
did not complete the first post-test) stopped the intervention before completion of the fifth lesson. 
 
 
Fourteen participants did not finish the intervention in ten weeks. We identified no significant 
differences in the proportion of participants who did not complete the first post-test between the two 
groups. Additionally, no significant differences in the baseline characteristics were identified between 
participants who completed the first post-test and those who did not. 
Most participants were men, homosexual, and educated to a medium or high level, with a 
mean age of about 46 years (Table 1). Mean time since HIV diagnosis was about 10 years and most 
participants were on antiretroviral therapy. Participants in the intervention group received a mean of 
6.38 telephone calls from the coach compared with a mean of 6.23 telephone calls in the control group, 
with no significant differences identified between groups (p = 0.67). The mean duration of phone calls 
per participant was significantly higher in the intervention group than the control group (90.74 minutes 
(SD = 60.32) vs 60.52 minutes (SD = 42.30); p < 0.0001). 
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mL) 






















Data are mean (SD), n (%), or n/N (%). Some percentages do not sum to 100% because of rounding.  
a available for 187 participants, b available for 86 participants, c available for 136 participants. 
 
Mean pretest PHQ-9 score was 11.74 (SD = 2.49) in the intervention group and 11.11 (2.37) in 
the control group; at the post-test visits it was 6.73 (3.00) and 6.62 (3.03) in the intervention group 
and 8.60 (3.12) and 8.06 (3.17) in the control group. Mean pretest CES-D score was 24.91 (5.93) in the 
intervention group and 22.94 (6.48) in the control group; at the post-test visits it was 13.94 (6.39) and 
15.71 (6.39) in the intervention group and 19.09 (7.05) and 18.43 (7.05) in the control group (Appendix 
2). A group-by-time interaction effect was identified for the PHQ-9 and CES-D: the reduction in 
depressive symptoms between pretest and post-test 1 was significantly larger in the intervention 
group than in the control group (Table 2 and Figure 2). The effect sizes for the differences in scores at 
post-test 1 (corrected for baseline) were d = –0.56, 95% CI [–0.85, –0.27] for the PHQ-9 and d = –0.72, 
95% CI [–1.02, –0.42] for the CES-D. Furthermore, time had a significant effect on the PHQ-9 and CES-
D: depressive symptoms decreased significantly between pretest and post-test 1 in both groups (Table 
2). For the GAD-7, the time effect was not significant, but a significant group-by-time interaction effect 
was identified: the reduction in anxiety symptoms between pretest and post-test 1 was significantly 
larger in the intervention group than in the control group (d = –0.75, 95% CI [–1.05, –0.45]). No time 
effect or group-by-time interaction effect was identified between post-test 1 and post-test 2 for PHQ-
9, CES-D, or GAD-7 (Table 2). The effect sizes for the differences in scores at post-test 2 (corrected for 
baseline) were smaller than those for the differences in scores at post-test 1 for the PHQ-9 (d = –0.46, 






Figure 2. Estimated mean PHQ-9, CES-D, and GAD-7 scores over time in both groups. 
Error bars show 95% CI. 
 
In the intervention group, time had a significant effect on all outcomes. Depressive and anxiety 
symptoms decreased from pretest to post-test 1 and remained low at post-tests 2 and 3 (Table 3). No 
significant time effect was identified from post-test 1 to post-test 2 or from post-test 2 to post-test 3 
for PHQ-9, CES-D, and GAD-7. Within- group effect sizes were moderate between the pretest and post-
test 1 and around zero between post-test 1 and post-test 2; and between post-test 2 and post-test 3. 
In an exploratory analysis, we assessed the effect of HIV treatment center by use of an 
unconditional means model with three levels. The intraclass correlation was estimated to be 
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effect or group-by-time interaction effect was identified between post-test 1 and post-test 2 for PHQ-
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In the intervention group, time had a significant effect on all outcomes. Depressive and anxiety 
symptoms decreased from pretest to post-test 1 and remained low at post-tests 2 and 3 (Table 3). No 
significant time effect was identified from post-test 1 to post-test 2 or from post-test 2 to post-test 3 
for PHQ-9, CES-D, and GAD-7. Within- group effect sizes were moderate between the pretest and post-
test 1 and around zero between post-test 1 and post-test 2; and between post-test 2 and post-test 3. 
In an exploratory analysis, we assessed the effect of HIV treatment center by use of an 





approximately zero in all models, indicating that treatment center had no effect; therefore we did not 
include it in the analyses. Furthermore, per-protocol analyses confirmed the findings of the intention-
to-treat analyses (data not shown). 
 
Table 2. Mixed model analyses comparing the differences in depressive and anxiety symptom scores 
over time in the intervention and control groups 
 Time effect   Time-by-group effect 




      
Pretest to post-test 1 -2.51 (0.56) -4.48  <0.0001 -2.50 (0.80) -3.14 0.002 
Post-test 1 to post-test 2 -0.54 (0.55) -0.98 0.33 0.42 (0.79) 0.53 0.59 
CES-Dd       
Pretest to post-test 1 -4.21 (1.11) -3.81 0.0002 -6.76 (1.57) -4.31 <0.0001 




      
Pretest to post-test 1 -0.90 (0.51) -1.77 0.08 -3.42 (0.72) -4.75 <0.0001 
Post-test 1 to post-test 2 -0.43 (0.52) -0.83 0.41 0.86 (0.73) 1.17 0.24 
a b = unstandardized coefficient b t-test statistic, c PHQ-9 = Patient Health Questionnaire 9, d CES-D = Center for Epidemiologic 
Studies Depression Scale, e GAD-7 = Generalized Anxiety Disorder 7.  
 
In the intervention group, significantly more participants improved (reliable change index 
score less than –1.96) than in the control group (p = 0.003 for PHQ-9; p = 0.001 for the CES-D; Appendix 
3). Sixty-two percent of participants scored above the cutoff on the PHQ-9 at pretest and were 
considered to be clinically depressed and 55% of participants scored above the cutoff on the CES-D. 
The proportion of participants who scored above the cutoff at pretest and recovered was significantly 
higher in the intervention group than in the control group (p = 0.005 for PHQ-9; p = 0.001 for the CES-
D). A higher proportion of participants reached the criteria for clinically significant change (both 
recovery and improvement) in the intervention group than in the control group on PHQ-9 (p = 0.005) 
and CES-D (p < 0.0001; Appendix 3). Deterioration was rare and no significant differences were 
identified between the groups for the PHQ-9 (χ² 1.35, p = 0.25) or CES-D (χ² 3.42, p = 0.06). The number 
needed to treat was 3.30 for the PHQ-9 and 2.20 for the CES-D (Appendix 3). 
Most participants were satisfied with the intervention (mean overall score 7.34 (SD = 1.62); n 
= 74). Of the 74 patients who graded the intervention at post-test 1, 55 participants (74%) would 
definitely recommend the intervention to others, 18 (24%) would maybe recommend it, and one (2%) 
 
 
would not recommend the intervention. The mean score for the coach was 7.62 (SD = 1.52; n = 146): 
7.92 (SD = 1.31) in the intervention group compared with 7.32 (1.66) in the control group (p = 0.02). 
No adverse events were reported. 
 
Table 3. Mixed model analyses investigating the effects of the intervention on short-term and long-
term depressive and anxiety symptoms in the intervention group 
 ba (SE) tb P Cohen’s d (95%CI) 
Primary outcome measures 
PHQ-9c 
    
Pretest to post-test 1 -3.75 (0.41) -9.17 <0.0001 -0.79 (-1.02, -0.56) 
Post-test 1 to post-test 2 -0.30 (0.37) -0.80 0.43 -0.06 (-0.26, 0.14) 
Post-test 2 to post-test 3 0.20 (0.46) 0.44 0.66 0.04 (-0.16, 0.24) 
CES-Dd     
Pretest to post-test 1 -7.56 (0.84) -9.03 <0.0001 -0.72 (-0.94, -0.50) 
Post-test 1 to post-test 2 0.60 (0.74) 0.81 0.42 0.06 (-0.14, 0.26) 
Post-test 2 to post-test 3 0.02 (0.91) 0.02 0.99 0.002 (-0.20, 0.20) 
Secondary outcome measure 
GAD-7e 
    
Pretest to post-test 1 -2.63 (0.38) -6.91 <0.0001 -0.56 (-0.77, -0.34) 
Post-test 1 to post-test 2 0.04 (0.34) 0.12 0.91 0.01 (-0.19, 0.21) 
Post-test 2 to post-test 3 -0.22 (0.42) -0.53 0.60 -0.05 (-0.25, 0.15) 
a b = unstandardized coefficient b t-test statistic, c PHQ-9 = Patient Health Questionnaire 9, d CES-D = Center for Epidemiologic 
Studies Depression Scale, e GAD-7 = Generalized Anxiety Disorder 7. 
 
Discussion 
We found that a guided internet-based self-help intervention was effective for decreasing depressive 
symptoms in people with HIV compared with an attention-only control condition. Significantly more 
participants in the intervention group than in the control group had a clinically significant reduction in 
depressive symptoms. Additionally, anxiety symptoms decreased in the intervention group compared 
with the control group and user satisfaction was high. The results of this study are important, since 
only four previous studies have investigated the effectiveness of computerised or internet-based 
interventions for people with HIV, and three (10-12) of those studies found that the intervention had 
no effect on mood. This is the first randomized controlled trial to show that an internet-based 
intervention for people with HIV can significantly reduce depressive symptoms. Our results add to 
previous findings that online interventions for depression could be effective for the general population 
(7) and for people with a chronic somatic disease (8). In this study, the between-group effect sizes for 
depressive symptoms on the first post-test were larger than reported in previous research (7, 8). 
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approximately zero in all models, indicating that treatment center had no effect; therefore we did not 
include it in the analyses. Furthermore, per-protocol analyses confirmed the findings of the intention-
to-treat analyses (data not shown). 
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over time in the intervention and control groups 
 Time effect   Time-by-group effect 
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Studies Depression Scale, e GAD-7 = Generalized Anxiety Disorder 7.  
 
In the intervention group, significantly more participants improved (reliable change index 
score less than –1.96) than in the control group (p = 0.003 for PHQ-9; p = 0.001 for the CES-D; Appendix 
3). Sixty-two percent of participants scored above the cutoff on the PHQ-9 at pretest and were 
considered to be clinically depressed and 55% of participants scored above the cutoff on the CES-D. 
The proportion of participants who scored above the cutoff at pretest and recovered was significantly 
higher in the intervention group than in the control group (p = 0.005 for PHQ-9; p = 0.001 for the CES-
D). A higher proportion of participants reached the criteria for clinically significant change (both 
recovery and improvement) in the intervention group than in the control group on PHQ-9 (p = 0.005) 
and CES-D (p < 0.0001; Appendix 3). Deterioration was rare and no significant differences were 
identified between the groups for the PHQ-9 (χ² 1.35, p = 0.25) or CES-D (χ² 3.42, p = 0.06). The number 
needed to treat was 3.30 for the PHQ-9 and 2.20 for the CES-D (Appendix 3). 
Most participants were satisfied with the intervention (mean overall score 7.34 (SD = 1.62); n 
= 74). Of the 74 patients who graded the intervention at post-test 1, 55 participants (74%) would 
definitely recommend the intervention to others, 18 (24%) would maybe recommend it, and one (2%) 
 
 
would not recommend the intervention. The mean score for the coach was 7.62 (SD = 1.52; n = 146): 
7.92 (SD = 1.31) in the intervention group compared with 7.32 (1.66) in the control group (p = 0.02). 
No adverse events were reported. 
 
Table 3. Mixed model analyses investigating the effects of the intervention on short-term and long-
term depressive and anxiety symptoms in the intervention group 
 ba (SE) tb P Cohen’s d (95%CI) 
Primary outcome measures 
PHQ-9c 
    
Pretest to post-test 1 -3.75 (0.41) -9.17 <0.0001 -0.79 (-1.02, -0.56) 
Post-test 1 to post-test 2 -0.30 (0.37) -0.80 0.43 -0.06 (-0.26, 0.14) 
Post-test 2 to post-test 3 0.20 (0.46) 0.44 0.66 0.04 (-0.16, 0.24) 
CES-Dd     
Pretest to post-test 1 -7.56 (0.84) -9.03 <0.0001 -0.72 (-0.94, -0.50) 
Post-test 1 to post-test 2 0.60 (0.74) 0.81 0.42 0.06 (-0.14, 0.26) 
Post-test 2 to post-test 3 0.02 (0.91) 0.02 0.99 0.002 (-0.20, 0.20) 
Secondary outcome measure 
GAD-7e 
    
Pretest to post-test 1 -2.63 (0.38) -6.91 <0.0001 -0.56 (-0.77, -0.34) 
Post-test 1 to post-test 2 0.04 (0.34) 0.12 0.91 0.01 (-0.19, 0.21) 
Post-test 2 to post-test 3 -0.22 (0.42) -0.53 0.60 -0.05 (-0.25, 0.15) 
a b = unstandardized coefficient b t-test statistic, c PHQ-9 = Patient Health Questionnaire 9, d CES-D = Center for Epidemiologic 
Studies Depression Scale, e GAD-7 = Generalized Anxiety Disorder 7. 
 
Discussion 
We found that a guided internet-based self-help intervention was effective for decreasing depressive 
symptoms in people with HIV compared with an attention-only control condition. Significantly more 
participants in the intervention group than in the control group had a clinically significant reduction in 
depressive symptoms. Additionally, anxiety symptoms decreased in the intervention group compared 
with the control group and user satisfaction was high. The results of this study are important, since 
only four previous studies have investigated the effectiveness of computerised or internet-based 
interventions for people with HIV, and three (10-12) of those studies found that the intervention had 
no effect on mood. This is the first randomized controlled trial to show that an internet-based 
intervention for people with HIV can significantly reduce depressive symptoms. Our results add to 
previous findings that online interventions for depression could be effective for the general population 
(7) and for people with a chronic somatic disease (8). In this study, the between-group effect sizes for 





Furthermore, the long term effect of the intervention on mental health was found to be enduring. The 
follow-up period in the present study was six months in the intervention group and three months in 
the control group; thus longer follow-up measurements are necessary. 
Depressive symptoms were also reduced in the control group, and participants appreciated 
the coaching and graded the coaches highly. The weekly telephone contact with coaches might lead 
to a decrease in depressive symptoms, as reported previously (33). Furthermore, the coach also 
seemed important in the intervention group. Participants were satisfied with the coaching and this 
component of the intervention was made feasible because the coaches were Masters students and 
graduates in clinical psychology. Thus, this method of coaching could be used when implementing the 
intervention. Additionally, nurses in HIV treatment centers could also be trained to provide the 
coaching to increase scalability of the intervention. 
The current study has important strengths and limitations. This randomized controlled trial 
was well designed and included a large sample of people with HIV treated at 23 of 26 HIV treatment 
centers in the Netherlands. Additionally, the intervention was designed specifically for individuals with 
HIV and was done online, which has advantages compared with face-to-face treatment, such as more 
people can be reached and stigma might be lessened. Furthermore, the intervention is available in 
Dutch and English and could be translated into other languages for use in other countries. Both the 
PHQ-9 and CES-D questionnaires were used to increase the strength of the findings and because they 
were recommended for people with HIV (34). The results of the PHQ-9 and CES-D questionnaires were 
comparable, which increases confidence in our results. The primary outcome was analysed in the 
intention-to-treat population. The number of patients who had not started or had dropped out at the 
first post-test was high (22 individuals in the intervention group and 14 individuals in the control group), 
which is a limitation of the study. However, internet-based interventions often have high dropout rates 
(7, 8). In the current study, no differences in baseline characteristics were identified between 
participants who dropped out and those who completed the intervention, which indicates that none 
of the characteristics assessed in this study were associated with dropout and that the results might 
be generalised. Only self-report measures were used, instead of other measures such as interviews, 
which can be used for diagnostic purposes. However, a diagnosis of depression was not an inclusion 
criterion in the current study and interviews would have been time consuming. Additionally, 
participants in the intervention group might have met participants in the control group and shared 
their experiences. However, since participants lived in various locations across the Netherlands we 
expect that this would be unlikely. Waiting-list control conditions might inflate the effects of 
interventions in studies and it is possible that this occurred in the current study. We used an attention-
only waiting-list control condition, which is more active than a waiting-list only control and might have 
reduced the inflation. An additional limitation is that the intervention was developed by the 
 
 
researchers. Every effort was made to avoid contact with participants after allocation to conditions. 
We recommend independent replication of this study. Our findings might not be generalizable to all 
people with HIV in the Netherlands. However, given that almost all HIV treatment centers in the 
Netherlands participated and there were no baseline differences between patients who dropped out 
and those who completed the study, the HIV population in our study is representative of the HIV 
population in the Netherlands (regarding characteristics such as sex, sexual orientation, and education). 
Study generalizability to non-western, low-income countries deserves further study. 
For future research, it is important to investigate moderators and mediators of treatment 
effect to identify the subgroups for whom this intervention is the most optimal and the mechanisms 
that make this intervention effective. It would be valuable to investigate the cost-effectiveness of the 
intervention. Furthermore, the intervention could be implemented and the long-term effectiveness 
should be studied. HIV is highly prevalent in other parts of the world, such as Africa, and the 
intervention could be adapted to the local culture of these countries and its effectiveness could be 
investigated there.  
In conclusion, this randomized controlled trial found that the guided internet-based 
intervention Living positive with HIV might be effective in decreasing depressive symptoms in the 
short-term and the long-term up to six months. Anxiety was reduced after the intervention, and the 
intervention and the coach were mostly positively evaluated. This new, online intervention might 
represent a clinically meaningful enhancement to psychological care for individuals with HIV who have 
depressive symptoms. Our findings suggest that implementation of the intervention including coaching 
might be justified in the Netherlands. 
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Appendix 1. Overview of assessments during the study 





Pretest Post-test 1 Post-test 2 Post-test 3a 
PHQ-2b or HADSc X      
PHQ-9d  X X X X X 
CES-De   X X X X 
GAD-7f   X X X X 
Demographics and 
HIV questionnaire 
  X    
User satisfaction    X   
a Not sent to participants in the control group, b PHQ-2 = Patient Health Questionnaire-2, c HADS = Hospital Anxiety and 
Depression Scale, d PHQ-9 = Patient Health questionnaire-9, e CES-D = Center of Epidemiologic Studies Depression Scale, f 





Appendix 2. Estimated means and standard deviations on the PHQ-9, CES-D and GAD-7 over time in 
the intervention and control group 
Measure and time 
point 
Intervention group (n = 97) Control group (n = 91) 
 M SD M SD 
PHQ-9a     
 Pretest 11.74 2.49 11.11 2.37 
 Post-test 1 6.73 3.00 8.60 3.12 
 Post-test 2 6.62 3.03 8.06 3.17 
 Post-test 3b 7.18 3.45   
CES-Dc     
 Pretest 24.91 5.93 22.94 6.48 
 Post-test 1 13.94 6.39 19.09 7.05 
 Post-test 2 15.71 6.39 18.43 7.05 
 Post-test 3b 16.26 7.22   
GAD-7d     
 Pretest 9.44 2.59 8.24 2.90 
 Post-test 1 5.12 2.77 7.34 3.27 
 Post-test 2 5.55 2.77 6.91 3.27 
 Post-test 3b 5.69 3.18   
a = PHQ-9 = Patient Health Questionnaire 9, b Intervention group only, c CES-D = Center for Epidemiologic Studies Depression 
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Objective: The goal of the study was to investigate moderators of intervention effect of a guided 
Internet‐based self‐help intervention for people with HIV and depressive symptoms. This study was 
part of a randomized controlled trial where the intervention was found to be effective in reducing 
depressive symptoms compared to an attention‐only control group. 
Methods: The intervention consisted of guided online cognitive behavioral therapy. Demographic 
characteristics (e.g. age), HIV characteristics (e.g. duration of HIV), and psychological characteristics 
(e.g. coping self‐efficacy) were investigated as potential moderators of intervention effect. 
Results: In 2015, 188 people with HIV and depressive symptoms were included in the study: 97 were 
randomized to the intervention group and 91 to the control group. One moderator of intervention 
effect was found: coping self‐efficacy. Participants with low coping self‐efficacy improved more in the 
intervention group than in the control group, and participants with high coping self‐efficacy improved 
in both groups. 
Conclusions: The results indicate that the intervention may be provided to all people with HIV and 
depressive symptoms. It may be especially important for people with HIV and low coping self‐efficacy 
to start with the intervention, since they do not improve in the control group with only minimal 
attention. 
Trial registration: Nederlands Trialregister NTR5407, September 11, 2015. 
 






Cognitive behavioral therapy (CBT) is frequently used to treat depressive symptoms in people living 
with HIV (PLWH). Numerous studies have found that it is an effective therapy for PLWH (1‐5). Online 
treatments may be an alternative to face‐to‐face CBT, and may be more easily accessible, more cost‐
effective, and reach more people. A large body of research has found that Internet‐based CBT was 
effective to treat depressive symptoms (6‐9). In the last years, we have developed an Internet‐based 
intervention for PLWH with depressive symptoms: Living positive with HIV (10). This CBT intervention 
was found to be effective in decreasing depressive symptoms in PLWH, compared to a control 
condition that received attention only (11). 
 However, we did not examine yet for whom the online intervention is especially effective. It is 
important to investigate this, as it may inform us which PLWH may benefit most from the treatment 
and for which PLWH it may be more beneficial to refer them to another treatment (12). Consequently, 
PLWH may be referred to a treatment that is more likely to decrease their symptoms and this may lead 
to lower costs, reduced therapy duration, and personalised care. For whom the intervention is most 
effective can be investigated by examining moderators: factors that influence the effectiveness of 
treatment (13). For example, it is possible that the intervention works better for men than for women, 
while in the control condition both men and women do not improve. In this case, sex is the moderator 
that affects outcome of treatment. Moderators have to be distinguished from general predictors: 
factors that have an effect on the outcome irrespective of treatment condition (12). A factor can be 
both moderator and general predictor. 
 As far as we know, no studies have been conducted in PLWH with depressive symptoms 
regarding moderators of effects of (online) CBT. Though, moderators of change in face‐to‐face CBT 
have been investigated in other patient groups with depression. Marriage, unemployment, and 
experience of more recent life events predicted superior response to cognitive therapy, compared to 
antidepressants (14). In a recent meta‐analysis, gender was not found to be a moderator of CBT versus 
pharmacotherapy (15), just as baseline depression severity (16). 
 There are few studies into moderators of treatment outcome in online CBT for depressive 
symptoms. One study has found that baseline depression severity was a moderator: for participants 
with severe depressive symptoms online CBT resulted in a larger improvement than the waiting list 
control group and for participants with less severe depressive symptoms the differences in 
improvement between both groups were smaller (17). The same result was found for marital status, 
where widowed/divorced participants that received online CBT showed the largest improvement (17). 
Age was also found to be a moderator: for older participants online CBT was more effective, while 
online interpersonal psychotherapy was more effective for younger participants (18). 
165
6




Objective: The goal of the study was to investigate moderators of intervention effect of a guided 
Internet‐based self‐help intervention for people with HIV and depressive symptoms. This study was 
part of a randomized controlled trial where the intervention was found to be effective in reducing 
depressive symptoms compared to an attention‐only control group. 
Methods: The intervention consisted of guided online cognitive behavioral therapy. Demographic 
characteristics (e.g. age), HIV characteristics (e.g. duration of HIV), and psychological characteristics 
(e.g. coping self‐efficacy) were investigated as potential moderators of intervention effect. 
Results: In 2015, 188 people with HIV and depressive symptoms were included in the study: 97 were 
randomized to the intervention group and 91 to the control group. One moderator of intervention 
effect was found: coping self‐efficacy. Participants with low coping self‐efficacy improved more in the 
intervention group than in the control group, and participants with high coping self‐efficacy improved 
in both groups. 
Conclusions: The results indicate that the intervention may be provided to all people with HIV and 
depressive symptoms. It may be especially important for people with HIV and low coping self‐efficacy 
to start with the intervention, since they do not improve in the control group with only minimal 
attention. 
Trial registration: Nederlands Trialregister NTR5407, September 11, 2015. 
 






Cognitive behavioral therapy (CBT) is frequently used to treat depressive symptoms in people living 
with HIV (PLWH). Numerous studies have found that it is an effective therapy for PLWH (1‐5). Online 
treatments may be an alternative to face‐to‐face CBT, and may be more easily accessible, more cost‐
effective, and reach more people. A large body of research has found that Internet‐based CBT was 
effective to treat depressive symptoms (6‐9). In the last years, we have developed an Internet‐based 
intervention for PLWH with depressive symptoms: Living positive with HIV (10). This CBT intervention 
was found to be effective in decreasing depressive symptoms in PLWH, compared to a control 
condition that received attention only (11). 
 However, we did not examine yet for whom the online intervention is especially effective. It is 
important to investigate this, as it may inform us which PLWH may benefit most from the treatment 
and for which PLWH it may be more beneficial to refer them to another treatment (12). Consequently, 
PLWH may be referred to a treatment that is more likely to decrease their symptoms and this may lead 
to lower costs, reduced therapy duration, and personalised care. For whom the intervention is most 
effective can be investigated by examining moderators: factors that influence the effectiveness of 
treatment (13). For example, it is possible that the intervention works better for men than for women, 
while in the control condition both men and women do not improve. In this case, sex is the moderator 
that affects outcome of treatment. Moderators have to be distinguished from general predictors: 
factors that have an effect on the outcome irrespective of treatment condition (12). A factor can be 
both moderator and general predictor. 
 As far as we know, no studies have been conducted in PLWH with depressive symptoms 
regarding moderators of effects of (online) CBT. Though, moderators of change in face‐to‐face CBT 
have been investigated in other patient groups with depression. Marriage, unemployment, and 
experience of more recent life events predicted superior response to cognitive therapy, compared to 
antidepressants (14). In a recent meta‐analysis, gender was not found to be a moderator of CBT versus 
pharmacotherapy (15), just as baseline depression severity (16). 
 There are few studies into moderators of treatment outcome in online CBT for depressive 
symptoms. One study has found that baseline depression severity was a moderator: for participants 
with severe depressive symptoms online CBT resulted in a larger improvement than the waiting list 
control group and for participants with less severe depressive symptoms the differences in 
improvement between both groups were smaller (17). The same result was found for marital status, 
where widowed/divorced participants that received online CBT showed the largest improvement (17). 
Age was also found to be a moderator: for older participants online CBT was more effective, while 





 The current exploratory study investigated moderators of outcome of the online intervention 
Living positive with HIV. The first research question of the study was: which factors moderate the 
effectiveness of the intervention? Since moderators were not previously explored in CBT interventions 
for PLWH and depressive symptoms, a large selection of moderators was investigated: demographic 
characteristics (e.g. age), HIV characteristics (e.g. duration of HIV), and psychological characteristics 
(e.g. coping self‐efficacy). The second research question of the study was: which subgroups of 
participants benefit most from the intervention? To answer this question, interactions between 
multiple moderators and the treatment variable were examined. 
 
Methods 
Participants and procedure 
This study is based on a randomized controlled trial (RCT) on the effectiveness of the CBT‐based online 
self‐help intervention ‘Living positive with HIV’. The methods of the RCT are explained in more detail 
elsewhere (10). In 2015, nursing consultants and doctors in 23 of 26 HIV treatment centers in the 
Netherlands screened PLWH during regular consultations on depressive symptoms with the Patient 
Health Questionnaire‐2 (PHQ‐2; (19)). When the PHQ‐2 score was > zero, patients interested in the 
study were informed and their contact information was transferred to the researchers. The 
researchers called the patients and screened them on the inclusion criteria: being HIV positive for > six 
months, age > 17 years, mastery of Dutch or English language, available for eight weeks, having 
Internet and an e‐mail address, no use of antidepressants or use for > three months and no change of 
type or dose in the past three months, absence of severe cognitive impairments, not currently treated 
by psychologist or psychiatrist, mild to moderate depressive symptoms (Patient Health Questionnaire‐
9 (PHQ‐9 (20) score > 4 and < 20), and no severe suicide ideation (score < 2 on question 9 of PHQ‐9). 
 When patients were eligible for the study and agreed to participate, online informed consent 
was signed. Thereafter, the pretest was completed and participants were randomly allocated to the 
intervention or control condition. Stratified randomization by treatment center and sex was conducted. 
Random number tables were used and the randomization sequence was generated by an independent 
researcher and concealed from the main researcher. There were multiple measurement moments; the 
pretest, first post‐test (approximately eight weeks after pretest), and second post‐test (approximately 
five months after pretest) were used in the current analyses. Participants received €25 when they 
completed all questionnaires. The study was approved by the medical ethics committee of Leiden 






Guided online self-help intervention 
The online self-help intervention was based on CBT. Four main components were included in the 
intervention: activation, relaxation, changing negative cognitions, and goal attainment. Participants 
worked approximately eight weeks on the intervention, one to two hours a week. In addition, they 
were supported by a personal coach, who called them each week for about 15 minutes until they had 
finished the intervention (maximum ten weeks). The coach motivated participants to continue with 
the intervention by using motivational interviewing. Well-being of participants was checked by the 
coach, as well as progress with the intervention. Coaches were Master students in clinical psychology 
or graduates with an MSc in psychology. They received a training concerning coaching procedures and 
they followed a coaching manual. Supervision sessions were arranged with coaches and the researcher 
in the beginning of the study (later via e-mail and phone). 
 
Control condition 
Participants in the control condition were put on a waiting list and received attention only. They were 
called by a personal coach for about five minutes per week during the first eight weeks of the waiting 
period. The coach asked how the participant was doing, enhanced motivation to stay in the study, and 
monitored depressive symptoms. Part of the protocol was to refer the participant to the HIV treatment 
center or general practitioner when symptoms deteriorated and became severe. Participants gained 
access to the intervention after post-test 2. 
 
Assessments 
All assessments were completed online. Potential moderating variables were measured at pretest and 
the outcome variable was measured at pretest, post-test 1 and post-test 2. For more information on 
the assessments, see (10). 
 
Outcome variable 
Depressive symptoms in the last two weeks, measured by the PHQ-9 (20), was the outcome variable. 





The following questions were asked regarding demographic characteristics: sex, age, education, 
marital status, and employment status. 
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Regarding HIV characteristics the following questions were asked: physical symptoms in last two weeks, 
diagnosis of AIDS, use of antiretroviral therapy (ART) known to have depression as side effect based 
on the Farmacotherapeutisch Kompas (Farmacotherapeutic Compass (21)). Data on the duration of 
HIV of participants was obtained from the Athena/SHM Cohort Study (22) after consent from the 
participant. The ATHENA Cohort Study is maintained by the Stichting HIV Monitoring, which is 




Treatment for psychological symptoms. Two questions were asked about treatment for psychological 
symptoms: use of psychotropic medication and treatment for psychological symptoms in last five years. 
 
Depressive symptoms at pretest. The PHQ-9 score at pretest was included as potential moderating 
variable. 
 
Anxiety symptoms. The Generalized Anxiety Disorder-7 (GAD-7) (23) was used to measure symptoms 
of anxiety in the last two weeks. Total scores range from 0 to 21 and higher scores represent more 
anxiety symptoms. 
 
Coping self-efficacy. Self-efficacy to cope with having HIV was measured with an adapted version of 
the Generalized Self-Efficacy scale, which has good reliability and validity (24). The scale was adjusted 
for PLWH, Cronbach’s α at pretest for the adjusted scale was 0.92. Total scores range from 8 to 40 and 
higher scores indicate more self-efficacy to cope with having HIV. 
 
Use of alcohol, soft drugs, hard drugs, and sedatives. The Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST) (25) was used to measure psychoactive substance use (alcohol, soft drugs, hard 
drugs, and sedatives/sleeping pills) and related problems. Total scores for each substance range from 
0 to 39. For alcohol, a total score of zero to ten indicates that no intervention is needed (i.e. no 
problematic alcohol use), and a score > ten indicates that an intervention is needed (i.e. problematic 
alcohol use). For soft drugs, hard drugs, and sedatives, a total score of zero to three indicates that no 
intervention is needed (i.e. no problematic drug use), and a score higher than three indicates that an 
intervention is needed (i.e. problematic drug use). The categorical variables with two categories (no 




Depressive thoughts. The hopelessness subscale of the Crandell Cognitions Inventory (CCI) (26) was 
used to measure depressive thoughts. Total scores range from 7 to 35 and higher scores reflect more 
black and white depressive thinking. 
 
Physical tension. Physical tension was measured with a self-designed 10 item questionnaire. Questions 
were asked regarding difficulty to relax, ways to relax, and symptoms of physical tension. Total scores 
range from 10 to 30 and higher scores indicate less physical tension. 
 
Behavioral activation. The subscale activation of the Behavioral Activation for Depression Scale (BADS) 
(27) was used to measure behavioral activation during the past week. Total scores range from 0 to 42 
and higher scores reflect higher levels of activation. 
 
Life events. The number of life events that a participant had ever experienced was measured with the 
Life Events Scale (28). The scale consists of 17 negative life events and it was counted how many life 
events (e.g. divorce, dead of a loved one) a participant experienced during life. 
 
Statistical analysis 
Analyses were conducted in SPSS version 23 and R version 3.2.2. SPSS was used to answer the first 
research question regarding moderators 1  of intervention effect. In SPSS, longitudinal multilevel 
moderated regression analyses (LMRA) (31) were conducted. Time, Group, moderators, and 
interactions were included as fixed effects and slopes for Time and the intercept were included as 
random effects. Two time contrasts were created: short term (pretest to post-test 1) and long term 
(pretest to post-test 2). Continuous moderator variables were grand mean centered and moderators 
were individually included in the model. All two-way and three-way interactions were included in the 
model. When the interaction Time x Group x Moderator was significant, this indicated a moderator 
effect. The moderator depressive symptoms at pretest was not included in the SPSS analysis, because 
it was part of the dependent variable. Maximum likelihood estimation was used to estimate the effects 
in the model. The variance components covariance structure provided the best fit and was chosen for 
the analyses. The analysis was intention-to-treat (ITT) and α = 0.05 was used for significance testing. 
 The second research question regarding subgroups of participants that benefit most from the 
intervention was answered with an analysis in R. It was conducted with the method Qualitative 
Interaction Trees (QUINT), using the corresponding R-package QUINT (32, 33). The aim of QUINT is to 
                                                          
1 Moderators are called predictive factors in medicine and general predictors are called prognostic 
factors (29, 30). 
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identify three subgroups of participants, based on different combinations of certain participant 
characteristics at baseline (i.e. moderators). For the first subgroup the intervention is more effective 
than the control condition, for the second subgroup the control condition is more effective than the 
intervention, and for the optional third subgroup both conditions are equally effective. The subgroups 
are to be found by splitting on values of moderators. QUINT has some advantages; multiple 
moderators can be included in the analysis at the same time, without a priori specifying which 
moderators interact and which type of interaction (as opposed to linear regression, where interactions 
are pre-specified and usually only first order interactions, also called two-way interactions, are 
included). In this way, higher order interactions can be detected, and QUINT may identify subgroups 
for which the direction of the intervention effect is different. The created subgroups are graphically 
represented in a binary tree with nodes and leaves that is easy to interpret. The QUINT algorithm starts 
with all participants in the root node. Then a moderator is searched that has the largest intervention-
subgroup interaction. All moderators, possible split points on moderators, and possible assignments 
of leaves to the subgroups are considered. Then, the node splits into two child nodes (leaves) based 
on the best combination of moderator, split point, and assignment. Thereafter, the child nodes split 
again, etc. QUINT uses some criteria to stop the tree building process, e.g. the number of participants 
in a leaf should be large enough (for more information see (32)). The whole procedure may result in a 
large and complex tree which also models noise in the data, and may not fit future data. QUINT reduces 
this overfitting by pruning the tree back to an optimal subtree, using bias-corrected bootstrapping. 
 In QUINT analyses, type of partitioning criterion was set at effect size criterion, and the 
minimum absolute value of d (effect size) in each of two leaves after the first split (dmin) was set at 0.40 
(as suggested by (32)). Minimal sample size of a group in a leaf was 10, and number of bootstrap 
samples was 1000. Two analyses were conducted. First, PHQ-9 pretest minus PHQ-9 post-test 1 was 
used as outcome variable, and Group and all moderators were included in the formula. Second, PHQ-
9 pretest minus PHQ-9 post-test 2 was used as outcome variable, and Group and all moderators were 
included. The analysis in QUINT was based on participants that completed questionnaires at post-test 




In HIV treatment centers 3642 PLWH were screened on depressive symptoms, of which 445 were 
referred to and screened by the researchers. One hundred and eighty eight PLWH participated in the 
study: 97 in the intervention group and 91 in the control group. The first post-test was completed by 
75 participants (77%) in the intervention group and 77 (85%) in the control group and the second post-
 
 
test was completed by 64 participants (66%) in the intervention group and 67 (74%) in the control 
group. A flow chart of participants through the study including reasons for drop-out is available 
elsewhere (11). 
 The majority of participants was male, around 46 years, and had HIV for about ten years, see 
Table 1. The mean PHQ-9 score was 11.44 at pretest, which indicates moderate depressive symptoms. 
 
Table 1. Baseline characteristics of the intervention and control group. Data are provided as M (SD) or 
n (%). 
Characteristic Intervention group  
(n = 97) 
Control group  
(n = 91) 
Total sample  






























 Married or cohabiting 














Employment status    
 Employed 52 (54%) 43 (47%) 95 (51%) 
 Not employed 45 (46%) 48 (53%) 93 (49%) 
























































 Yes 50 (52%) 50 (55%) 100 (53%) 
Age (years) 45.53 (10.32) 47.12 (10.94) 46.30 (10.63) 
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in a leaf should be large enough (for more information see (32)). The whole procedure may result in a 
large and complex tree which also models noise in the data, and may not fit future data. QUINT reduces 
this overfitting by pruning the tree back to an optimal subtree, using bias-corrected bootstrapping. 
 In QUINT analyses, type of partitioning criterion was set at effect size criterion, and the 
minimum absolute value of d (effect size) in each of two leaves after the first split (dmin) was set at 0.40 
(as suggested by (32)). Minimal sample size of a group in a leaf was 10, and number of bootstrap 
samples was 1000. Two analyses were conducted. First, PHQ-9 pretest minus PHQ-9 post-test 1 was 
used as outcome variable, and Group and all moderators were included in the formula. Second, PHQ-
9 pretest minus PHQ-9 post-test 2 was used as outcome variable, and Group and all moderators were 
included. The analysis in QUINT was based on participants that completed questionnaires at post-test 




In HIV treatment centers 3642 PLWH were screened on depressive symptoms, of which 445 were 
referred to and screened by the researchers. One hundred and eighty eight PLWH participated in the 
study: 97 in the intervention group and 91 in the control group. The first post-test was completed by 
75 participants (77%) in the intervention group and 77 (85%) in the control group and the second post-
 
 
test was completed by 64 participants (66%) in the intervention group and 67 (74%) in the control 
group. A flow chart of participants through the study including reasons for drop-out is available 
elsewhere (11). 
 The majority of participants was male, around 46 years, and had HIV for about ten years, see 
Table 1. The mean PHQ-9 score was 11.44 at pretest, which indicates moderate depressive symptoms. 
 
Table 1. Baseline characteristics of the intervention and control group. Data are provided as M (SD) or 
n (%). 
Characteristic Intervention group  
(n = 97) 
Control group  
(n = 91) 
Total sample  
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Employment status    
 Employed 52 (54%) 43 (47%) 95 (51%) 
 Not employed 45 (46%) 48 (53%) 93 (49%) 
























































 Yes 50 (52%) 50 (55%) 100 (53%) 





Characteristic Intervention group  
(n = 97) 
Control group  
(n = 91) 
Total sample  
(n = 188) 
Number of physical symptoms last 2 weeks 9.09 (3.57) 9.44 (3.66) 9.26 (3.61) 
Time since HIV diagnosis (years) c 9.35 (6.46) 10.41 (6.70) 9.87 (6.58) 
Depressive symptoms (PHQ-9d) 11.74 (4.74) 11.11 (4.22) 11.44 (4.50) 
Anxiety symptoms (GAD-7e) 9.44 (4.72) 8.24 (4.41) 8.86 (4.60) 
Coping self-efficacy 28.63 (6.38) 28.75 (6.02) 28.69 (6.20) 
Alcohol use (ASSISTf) g 10.29 (8.83) 7.11 (6.74) 8.75 (8.02) 
Soft drugs use (ASSISTf) h 7.73 (9.19) 6.27 (6.80) 7.00 (8.09) 
Hard drugs use (ASSISTf) i 8.06 (8.70) 7.96 (9.16) 8.01 (8.87) 
Sedatives use (ASSISTf) j 6.20 (6.75) 8.64 (9.21) 7.38 (8.09) 
Depressive thoughts (CCIk) 15.27 (6.44) 15.09 (6.46) 15.18 (6.43) 
Physical tension 21.14 (3.64) 21.58 (3.77) 21.36 (3.70) 
Behavioral activation (BADSl) 18.88 (8.93) 17.90 (8.15) 18.40 (8.55) 
Number of life events 5.66 (3.32) 5.18 (3.42) 5.43 (3.37) 
a ART = antiretroviral therapy, b = based on 184 participants that use ART, c = available for 187 participants, d PHQ-9 = Patient 
Health Questionnaire-9, e GAD-7 = Generalized Anxiety Disorder-7, f ASSIST = Alcohol, Smoking and Substance Involvement 
Screening Test, g = based on 169 participants that ever used alcohol, h = based on 120 participants that ever used soft drugs; 
i = based on 98 participants that ever used hard drugs; j = based on 97 participants that ever used sedatives, k CCI = Crandell 
Cognitions Inventory, l BADS = Behavioral Activation for Depression Scale. 
 
Moderators of intervention effect: results of multilevel moderated regression analyses 
Coping self-efficacy was found to be a significant moderator on the short term. Figure 1 displays the 
moderator effect, with coping self-efficacy based on a median split (i.e. value of 29) for illustrative 
purposes. The graph shows that participants in the intervention group improved, regardless of level of 
coping self-efficacy. However, in the control group, participants improved less when they have low 
coping self-efficacy, compared to high coping self-efficacy. In other words, participants with low coping 
self-efficacy seem to benefit more in the intervention group than in the control group. No other 
significant moderators were found, see Table 2. 
In addition, to obtain more insight in the influence of coping self-efficacy on the development 
of depressive symptoms over time, we also inspected whether coping self-efficacy was a general 
predictor (Time x coping self-efficacy effect). It was not found to be a general predictor on the short 






Figure 1. Coping self-efficacy as moderator of intervention effect. 
 
Interactions between moderators: results of QUINT analyses 
The results of the QUINT analyses show that no higher order interactions (e.g. three-way or four-way) 
between moderators and the treatment variable were present. The final pruned tree had two leaves 
and was split on the variable coping self-efficacy. The results indicate that participants with 
low/average coping self-efficacy (≤ 33.5) showed larger reductions in PHQ-9 score from pretest to post-
test 1 in the intervention group than in the control group (d = 0.68, 95% CI [0.31, 1.05]). Furthermore, 
for participants with high coping self-efficacy (> 33.5), there were no differences between groups (d = 
-0.40, 95% CI [-1.28, 0.48]). The analysis with the change score from pretest to post-test 2 as outcome 







Moderators of change in guided online self-help for people with HIV and depressive symptoms
 
 
Characteristic Intervention group  
(n = 97) 
Control group  
(n = 91) 
Total sample  
(n = 188) 
Number of physical symptoms last 2 weeks 9.09 (3.57) 9.44 (3.66) 9.26 (3.61) 
Time since HIV diagnosis (years) c 9.35 (6.46) 10.41 (6.70) 9.87 (6.58) 
Depressive symptoms (PHQ-9d) 11.74 (4.74) 11.11 (4.22) 11.44 (4.50) 
Anxiety symptoms (GAD-7e) 9.44 (4.72) 8.24 (4.41) 8.86 (4.60) 
Coping self-efficacy 28.63 (6.38) 28.75 (6.02) 28.69 (6.20) 
Alcohol use (ASSISTf) g 10.29 (8.83) 7.11 (6.74) 8.75 (8.02) 
Soft drugs use (ASSISTf) h 7.73 (9.19) 6.27 (6.80) 7.00 (8.09) 
Hard drugs use (ASSISTf) i 8.06 (8.70) 7.96 (9.16) 8.01 (8.87) 
Sedatives use (ASSISTf) j 6.20 (6.75) 8.64 (9.21) 7.38 (8.09) 
Depressive thoughts (CCIk) 15.27 (6.44) 15.09 (6.46) 15.18 (6.43) 
Physical tension 21.14 (3.64) 21.58 (3.77) 21.36 (3.70) 
Behavioral activation (BADSl) 18.88 (8.93) 17.90 (8.15) 18.40 (8.55) 
Number of life events 5.66 (3.32) 5.18 (3.42) 5.43 (3.37) 
a ART = antiretroviral therapy, b = based on 184 participants that use ART, c = available for 187 participants, d PHQ-9 = Patient 
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Cognitions Inventory, l BADS = Behavioral Activation for Depression Scale. 
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self-efficacy seem to benefit more in the intervention group than in the control group. No other 
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Interactions between moderators: results of QUINT analyses 
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The first aim of this study was to investigate moderators of intervention effect of an online CBT 
intervention for PLWH with depressive symptoms. It has been found previously that this intervention 
may be effective in decreasing depressive symptoms among PLWH, compared to a control condition 
that received minimal attention (11). One moderator of intervention effect was found in the current 
study: coping self-efficacy. Participants with high coping self-efficacy improved on average in both 
groups, and participants with low coping self-efficacy improved more in the intervention group than 
in the control group. These results indicate that especially for PLWH with low coping self-efficacy it is 
important to start with this intervention to decrease their depressive symptoms. The second aim of 
this study was to investigate which subgroups of participants benefit most from the intervention by 
examining higher order interactions between moderators and treatment group, and none were found. 
As coping self-efficacy was found to be a moderator in this analysis, the two analyses yielded similar 
results. 
This study shows that no moderators of intervention effect other than coping self-efficacy 
were found. The study was conducted to find factors that influence the effect of the intervention, to 
find out who benefits the most (12). Subgroups of participants that would not benefit from the 
intervention or would be harmed by the intervention, could be referred to other treatments in the 
future. Since we only found one moderator of intervention effect and based on the value of this 
moderator the treatment effect only differed in strength and not in sign, it can be concluded that the 
intervention could be beneficial for all participants, irrespective of certain demographic characteristics, 
HIV characteristics, or psychological characteristics. This knowledge is relevant for implementation; 
the intervention can be offered to all PLWH with mild to moderate depressive symptoms. 
Previous studies did not investigate (coping) self-efficacy as moderator, but it has been 
investigated as general predictor of outcome of CBT for people with depression in three uncontrolled 
studies (34-36). Two studies have found that self-efficacy is not a general predictor of outcome (34, 
35). However, another study has found that coping self-efficacy is a general predictor of outcome of 
face-to-face and telephone CBT for depression: participants with moderate or high coping self-efficacy 
were more likely to improve than participants with low coping self-efficacy (36). The current study 
investigated coping self-efficacy as moderator and general predictor and found that it was a moderator, 
but not a general predictor.  
Some limitations of the study have to be mentioned. This was an exploratory post hoc analysis, 
so findings need to be interpreted with caution and replicated in future studies. Many possible 
moderators were investigated in SPSS, which is a strength, but the disadvantage is that some 
moderators may be found which may not all be ‘real’ moderators (type I error). However, the analysis 
 
 
was exploratory and an additional analysis was conducted in QUINT where all moderators were 
included in one model. Furthermore, the analysis in SPSS was ITT, but the analysis in QUINT was with 
participants that completed questionnaires at the post-tests and there was some drop-out. Yet the 
results of both analyses support each other. In addition, there was no follow-up more than three 
months in the current study. It is possible that moderator effects will be evident on the long term, this 
needs to be investigated in future research. 
To conclude, this study found one factor that influenced the effectiveness of the intervention: 
coping self-efficacy. PLWH with high coping self-efficacy improved in both groups, and PLWH with low 
coping self-efficacy improved more in the intervention group than in the control group. This indicates 
that it may be particularly important to provide the intervention to PLWH with low coping self-efficacy, 
as they do not improve with minimal attention only. When these findings are confirmed in future 
studies, it may be recommended to screen PLWH with depressive symptoms on coping self-efficacy 
before referral to an intervention. The results suggest that the intervention may be provided to all 
PLWH with mild to moderate depressive symptoms. 
 
Acknowledgements 
This work was supported by the Aidsfonds (file number 2013027).  
177
6




The first aim of this study was to investigate moderators of intervention effect of an online CBT 
intervention for PLWH with depressive symptoms. It has been found previously that this intervention 
may be effective in decreasing depressive symptoms among PLWH, compared to a control condition 
that received minimal attention (11). One moderator of intervention effect was found in the current 
study: coping self-efficacy. Participants with high coping self-efficacy improved on average in both 
groups, and participants with low coping self-efficacy improved more in the intervention group than 
in the control group. These results indicate that especially for PLWH with low coping self-efficacy it is 
important to start with this intervention to decrease their depressive symptoms. The second aim of 
this study was to investigate which subgroups of participants benefit most from the intervention by 
examining higher order interactions between moderators and treatment group, and none were found. 
As coping self-efficacy was found to be a moderator in this analysis, the two analyses yielded similar 
results. 
This study shows that no moderators of intervention effect other than coping self-efficacy 
were found. The study was conducted to find factors that influence the effect of the intervention, to 
find out who benefits the most (12). Subgroups of participants that would not benefit from the 
intervention or would be harmed by the intervention, could be referred to other treatments in the 
future. Since we only found one moderator of intervention effect and based on the value of this 
moderator the treatment effect only differed in strength and not in sign, it can be concluded that the 
intervention could be beneficial for all participants, irrespective of certain demographic characteristics, 
HIV characteristics, or psychological characteristics. This knowledge is relevant for implementation; 
the intervention can be offered to all PLWH with mild to moderate depressive symptoms. 
Previous studies did not investigate (coping) self-efficacy as moderator, but it has been 
investigated as general predictor of outcome of CBT for people with depression in three uncontrolled 
studies (34-36). Two studies have found that self-efficacy is not a general predictor of outcome (34, 
35). However, another study has found that coping self-efficacy is a general predictor of outcome of 
face-to-face and telephone CBT for depression: participants with moderate or high coping self-efficacy 
were more likely to improve than participants with low coping self-efficacy (36). The current study 
investigated coping self-efficacy as moderator and general predictor and found that it was a moderator, 
but not a general predictor.  
Some limitations of the study have to be mentioned. This was an exploratory post hoc analysis, 
so findings need to be interpreted with caution and replicated in future studies. Many possible 
moderators were investigated in SPSS, which is a strength, but the disadvantage is that some 
moderators may be found which may not all be ‘real’ moderators (type I error). However, the analysis 
 
 
was exploratory and an additional analysis was conducted in QUINT where all moderators were 
included in one model. Furthermore, the analysis in SPSS was ITT, but the analysis in QUINT was with 
participants that completed questionnaires at the post-tests and there was some drop-out. Yet the 
results of both analyses support each other. In addition, there was no follow-up more than three 
months in the current study. It is possible that moderator effects will be evident on the long term, this 
needs to be investigated in future research. 
To conclude, this study found one factor that influenced the effectiveness of the intervention: 
coping self-efficacy. PLWH with high coping self-efficacy improved in both groups, and PLWH with low 
coping self-efficacy improved more in the intervention group than in the control group. This indicates 
that it may be particularly important to provide the intervention to PLWH with low coping self-efficacy, 
as they do not improve with minimal attention only. When these findings are confirmed in future 
studies, it may be recommended to screen PLWH with depressive symptoms on coping self-efficacy 
before referral to an intervention. The results suggest that the intervention may be provided to all 
PLWH with mild to moderate depressive symptoms. 
 
Acknowledgements 






1. Crepaz N, Passin WF, Herbst JH, Rama SM, Malow RM, Purcell DW, et al. Meta-analysis of cognitive-behavioral 
interventions on HIV-positive persons' mental health and immune functioning. Health Psychol. 2008;27(1):4-14. 
2. Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-
infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDS. 2007;21(10):732-9. 
3. Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression--a systematic review of interventions. Psychol 
Health Med. 2011;16(5):493-527. 
4. Spies G, Asmal L, Seedat S. Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic 
review. J Affect Disord. 2013;150(2):171-80. 
5. van Luenen S, Garnefski N, Spinhoven P, Spaan P, Dusseldorp E, Kraaij V. The Benefits of Psychosocial Interventions 
for Mental Health in People Living with HIV: A Systematic Review and Meta-analysis. AIDS Behav. 2018;22(1):9-42. 
6. Andersson G, Carlbring P, Ljótsson B, Hedman E. Guided internet-based CBT for common mental disorders. Journal 
of Contemporary Psychotherapy. 2013;43(4):223-33. 
7. Newby JM, Twomey C, Li SSY, Andrews G. Transdiagnostic computerised cognitive behavioural therapy depression 
and anxiety: A systematic review and meta-analysis. J Affect Disord. 2016;199:30-41. 
8. Spek V, Cuijpers P, Nyklicek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of 
depression and anxiety: a meta-analysis. Psychol Med. 2007;37(3):319-28. 
9. van Beugen S, Ferwerda M, Hoeve D, Rovers MM, Spillekom-van Koulil S, van Middendorp H, et al. Internet-Based 
Cognitive Behavioral Therapy for Patients With Chronic Somatic Conditions: A Meta-Analytic Review. J Med Internet 
Res. 2014;16(3):e88. 
10. van Luenen S, Kraaij V, Spinhoven P, Garnefski N. An Internet-based self-help intervention for people with HIV and 
depressive symptoms: study protocol for a randomized controlled trial. Trials. 2016;17(1):1-12. 
11. Van Luenen S, Garnefski N, Spinhoven P, Kraaij V. Guided Internet-based intervention for people with HIV and 
depressive symptoms: A randomised controlled trial. The Lancet HIV. 2018;in press. 
12. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized 
clinical trials. Arch Gen Psychiatry. 2002;59(10):877-83. 
13. Baron RM, Kenny DA. The moderator mediator variable distinction in social psychological-research - Conceptual, 
strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-82. 
14. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and 
cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol. 2009;77(4):775. 
15. Cuijpers P, Weitz E, Twisk J, Kuehner C, Cristea I, David D, et al. Gender as predictor and moderator of outcome in 
cognitive behavior therapy and pharmacotherapy for adult depression: An "individual patient data" meta-analysis. 
Depress Anxiety. 2014;31(11):941-51. 
16. Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, et al. Baseline depression severity as moderator 
of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data 
meta-analysis. JAMA psychiatry. 2015;72(11):1102-9. 
17. Button KS, Wiles NJ, Lewis G, Peters TJ, Kessler D. Factors associated with differential response to online cognitive 
behavioural therapy. Soc Psychiatry Psychiatr Epidemiol. 2012;47(5):827-33. 
18. Donker T, Batterham PJ, Warmerdam L, Bennett K, Bennett A, Cuijpers P, et al. Predictors and moderators of 
response to internet-delivered Interpersonal Psychotherapy and Cognitive Behavior Therapy for depression. J Affect 
Disord. 2013;151(1):343-51. 
19. Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2 - Validity of a two-item depression 
screener. Med Care. 2003;41(11):1284-92. 
20. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 - Validity of a brief depression severity measure. J Gen Intern Med. 
2001;16(9):606-13. 
21. Nederland Z. Farmacotherapeutisch Kompas 2018. Available from: www.farmacotherapeutischkompas.nl. 
22. Stichting HIV monitoring 2017. Available from: www.hiv-monitoring.nl. 
23. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder - The GAD-
7. Arch Intern Med. 2006;166(10):1092-7. 
24. Schwarzer R, Jerusalem M. Generalized Self-Efficacy Scale. In: Weinman J, Wright S, Johnston M, editors. Measures 
in Health Psychology: a user's portfolio. Causal and control beliefs. Windsor, UK: NFER-NELSON; 1995. 
25. WHO Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and 
feasibility. Addiction. 2002;97(9):1183-94. 
 
 
26. Crandell CJ, Chambless DL. The validation of an inventory for measuring depressive thoughts - The Crandell 
Cognitions Inventory. Behav Res Ther. 1986;24(4):403-11. 
27. Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral Activation for Depression Scale (BADS): 
Psychometric Properties and Factor Structure. Journal of Psychopathology and Behavioral Assessment. 
2007;29(3):191-202. 
28. Garnefski N, Kraaij V. Life Events Scale Leiden University2001. Available from: www.cerq.leidenuniv.nl. 
29. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 
2004;9(6):606-16. 
30. Italiano A. Prognostic or predictive? It’s time to get back to definitions. J Clin Oncol. 2011;29(35):4718. 
31. Stoel RD, van Den Wittenboer G, Hox J. Analyzing longitudinal data using multilevel regression and latent growth 
curve analysis. Metodologia de las Ciencias del Comportamiento. 2003;5(1):21-42. 
32. Dusseldorp E, Doove L, Van Mechelen I. Quint: An R package for identification of subgroups of clients who differ in 
which treatment alternative is best for them. Behav Res Methods. 2015;48(2):650-63. 
33. Dusseldorp E, Van Mechelen I. Qualitative interaction trees: a tool to identify qualitative treatment–subgroup 
interactions. Stat Med. 2014;33(2):219-37. 
34. Backenstrass M, Schwarz T, Fiedler P, Joest K, Reck C, Mundt C, et al. Negative mood regulation expectancies, self-
efficacy beliefs, and locus of control orientation: moderators or mediators of change in the treatment of 
depression? Psychotherapy Research. 2006;16(02):250-8. 
35. Kavanagh DJ, Wilson PH. Prediction of outcome with group cognitive therapy for depression. Behav Res Ther. 
1989;27(4):333-43. 
36. Stiles-Shields C, Corden ME, Kwasny MJ, Schueller SM, Mohr DC. Predictors of outcome for telephone and face-to-








1. Crepaz N, Passin WF, Herbst JH, Rama SM, Malow RM, Purcell DW, et al. Meta-analysis of cognitive-behavioral 
interventions on HIV-positive persons' mental health and immune functioning. Health Psychol. 2008;27(1):4-14. 
2. Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-
infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDS. 2007;21(10):732-9. 
3. Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression--a systematic review of interventions. Psychol 
Health Med. 2011;16(5):493-527. 
4. Spies G, Asmal L, Seedat S. Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic 
review. J Affect Disord. 2013;150(2):171-80. 
5. van Luenen S, Garnefski N, Spinhoven P, Spaan P, Dusseldorp E, Kraaij V. The Benefits of Psychosocial Interventions 
for Mental Health in People Living with HIV: A Systematic Review and Meta-analysis. AIDS Behav. 2018;22(1):9-42. 
6. Andersson G, Carlbring P, Ljótsson B, Hedman E. Guided internet-based CBT for common mental disorders. Journal 
of Contemporary Psychotherapy. 2013;43(4):223-33. 
7. Newby JM, Twomey C, Li SSY, Andrews G. Transdiagnostic computerised cognitive behavioural therapy depression 
and anxiety: A systematic review and meta-analysis. J Affect Disord. 2016;199:30-41. 
8. Spek V, Cuijpers P, Nyklicek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of 
depression and anxiety: a meta-analysis. Psychol Med. 2007;37(3):319-28. 
9. van Beugen S, Ferwerda M, Hoeve D, Rovers MM, Spillekom-van Koulil S, van Middendorp H, et al. Internet-Based 
Cognitive Behavioral Therapy for Patients With Chronic Somatic Conditions: A Meta-Analytic Review. J Med Internet 
Res. 2014;16(3):e88. 
10. van Luenen S, Kraaij V, Spinhoven P, Garnefski N. An Internet-based self-help intervention for people with HIV and 
depressive symptoms: study protocol for a randomized controlled trial. Trials. 2016;17(1):1-12. 
11. Van Luenen S, Garnefski N, Spinhoven P, Kraaij V. Guided Internet-based intervention for people with HIV and 
depressive symptoms: A randomised controlled trial. The Lancet HIV. 2018;in press. 
12. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized 
clinical trials. Arch Gen Psychiatry. 2002;59(10):877-83. 
13. Baron RM, Kenny DA. The moderator mediator variable distinction in social psychological-research - Conceptual, 
strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-82. 
14. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and 
cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol. 2009;77(4):775. 
15. Cuijpers P, Weitz E, Twisk J, Kuehner C, Cristea I, David D, et al. Gender as predictor and moderator of outcome in 
cognitive behavior therapy and pharmacotherapy for adult depression: An "individual patient data" meta-analysis. 
Depress Anxiety. 2014;31(11):941-51. 
16. Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, et al. Baseline depression severity as moderator 
of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data 
meta-analysis. JAMA psychiatry. 2015;72(11):1102-9. 
17. Button KS, Wiles NJ, Lewis G, Peters TJ, Kessler D. Factors associated with differential response to online cognitive 
behavioural therapy. Soc Psychiatry Psychiatr Epidemiol. 2012;47(5):827-33. 
18. Donker T, Batterham PJ, Warmerdam L, Bennett K, Bennett A, Cuijpers P, et al. Predictors and moderators of 
response to internet-delivered Interpersonal Psychotherapy and Cognitive Behavior Therapy for depression. J Affect 
Disord. 2013;151(1):343-51. 
19. Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2 - Validity of a two-item depression 
screener. Med Care. 2003;41(11):1284-92. 
20. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 - Validity of a brief depression severity measure. J Gen Intern Med. 
2001;16(9):606-13. 
21. Nederland Z. Farmacotherapeutisch Kompas 2018. Available from: www.farmacotherapeutischkompas.nl. 
22. Stichting HIV monitoring 2017. Available from: www.hiv-monitoring.nl. 
23. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder - The GAD-
7. Arch Intern Med. 2006;166(10):1092-7. 
24. Schwarzer R, Jerusalem M. Generalized Self-Efficacy Scale. In: Weinman J, Wright S, Johnston M, editors. Measures 
in Health Psychology: a user's portfolio. Causal and control beliefs. Windsor, UK: NFER-NELSON; 1995. 
25. WHO Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and 
feasibility. Addiction. 2002;97(9):1183-94. 
 
 
26. Crandell CJ, Chambless DL. The validation of an inventory for measuring depressive thoughts - The Crandell 
Cognitions Inventory. Behav Res Ther. 1986;24(4):403-11. 
27. Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral Activation for Depression Scale (BADS): 
Psychometric Properties and Factor Structure. Journal of Psychopathology and Behavioral Assessment. 
2007;29(3):191-202. 
28. Garnefski N, Kraaij V. Life Events Scale Leiden University2001. Available from: www.cerq.leidenuniv.nl. 
29. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 
2004;9(6):606-16. 
30. Italiano A. Prognostic or predictive? It’s time to get back to definitions. J Clin Oncol. 2011;29(35):4718. 
31. Stoel RD, van Den Wittenboer G, Hox J. Analyzing longitudinal data using multilevel regression and latent growth 
curve analysis. Metodologia de las Ciencias del Comportamiento. 2003;5(1):21-42. 
32. Dusseldorp E, Doove L, Van Mechelen I. Quint: An R package for identification of subgroups of clients who differ in 
which treatment alternative is best for them. Behav Res Methods. 2015;48(2):650-63. 
33. Dusseldorp E, Van Mechelen I. Qualitative interaction trees: a tool to identify qualitative treatment–subgroup 
interactions. Stat Med. 2014;33(2):219-37. 
34. Backenstrass M, Schwarz T, Fiedler P, Joest K, Reck C, Mundt C, et al. Negative mood regulation expectancies, self-
efficacy beliefs, and locus of control orientation: moderators or mediators of change in the treatment of 
depression? Psychotherapy Research. 2006;16(02):250-8. 
35. Kavanagh DJ, Wilson PH. Prediction of outcome with group cognitive therapy for depression. Behav Res Ther. 
1989;27(4):333-43. 
36. Stiles-Shields C, Corden ME, Kwasny MJ, Schueller SM, Mohr DC. Predictors of outcome for telephone and face-to-










Exploring mediators of a guided web-based self-help 






















Manuscript in revision for publication in Journal of Medical Internet Research Mental Health: 
Van Luenen, S., Kraaij, V., Spinhoven, P., Wilderjans, T.F. & Garnefski, N. Exploring mediators of a 







Exploring mediators of a guided web-based self-help 






















Manuscript in revision for publication in Journal of Medical Internet Research Mental Health: 
Van Luenen, S., Kraaij, V., Spinhoven, P., Wilderjans, T.F. & Garnefski, N. Exploring mediators of a 










Exploring mediators of a guided web-based self-help 






















Manuscript in revision for publication in Journal of Medical Internet Research Mental Health: 
Van Luenen, S., Kraaij, V., Spinhoven, P., Wilderjans, T.F. & Garnefski, N. Exploring mediators of a 







Exploring mediators of a guided web-based self-help 






















Manuscript in revision for publication in Journal of Medical Internet Research Mental Health: 
Van Luenen, S., Kraaij, V., Spinhoven, P., Wilderjans, T.F. & Garnefski, N. Exploring mediators of a 







Background: Cognitive behavior therapy is frequently used to treat depressive symptoms in people 
living with HIV. We developed an Internet-based cognitive behavioral intervention for people with HIV 
and depressive symptoms, which was previously found to be effective. 
Objective: In the current study, potential mediators of the online intervention were investigated. 
Methods: This study was part of a randomized controlled trial, in which the intervention was compared 
to an attention only waiting list control condition. Participants were 188 (97 in intervention group and 
91 in control group) people with HIV and mild to moderate depressive symptoms recruited in HIV 
treatment centers in the Netherlands. The intervention consisted of online cognitive behavioral 
therapy for eight weeks, including minimal telephone support from a coach. Participants were 
assessed with online questionnaires at pretest, three times during the intervention / waiting period, 
and post intervention. The outcome was depressive symptoms, factors that were tested as potential 
mediators were changes in behavioral activation, relaxation, the cognitive coping strategies 
catastrophizing and positive refocusing, goal reengagement, and coping self-efficacy. 
Results: Changes in behavioral activation (p = 0.006) and in goal reengagement (p = 0.009) were found 
to be significant mediators of the intervention effect. The mediation effect seems to occur between 
week 3 and 5 for behavioral activation, and between week 1 and 3 for goal reengagement. We found 
a return effect from depressive symptoms to goal reengagement, which could weaken the mediation 
effect. 
Conclusions: The results suggest that changes in behavioral activation and goal reengagement may 
mediate the effect of the online intervention for people with HIV and depressive symptoms. The results 
may lead to possible mechanisms of change of the intervention and improvement of therapy outcomes. 
Trial registration: Nederlands Trialregister NTR5407, September 11, 2015. 
 






Living positive with HIV is an Internet-based intervention that we have developed for people living with 
HIV (PLWH) and depressive symptoms (1). It has been found that this intervention was effective in 
treating depressive symptoms in PLWH, compared to a control group that received minimal coaching 
(2). However, we do not know which factors are mediators of the intervention effect. Mediators are 
factors that (partially) explain the relation between an independent and dependent variable. In this 
case, we look for treatment factors that may explain the relationship between receiving the online 
intervention and the decrease in depressive symptoms (3). When a mediator of intervention effect is 
found, it may provide us indications for possible mechanisms of change (4). A mechanism of change is 
defined as a process that leads to change, which may answer the important question: how does the 
intervention work? It is important to have more knowledge about the mechanisms of change to be 
able to adapt and improve the intervention in order to optimize the outcome (4). To investigate 
mediators of treatment outcome, at least three measurement moments are needed to establish a 
timeline of mediators and outcomes.  
 
Previous research 
Research on online CBT to treat depressive symptoms in PLWH is scarce. As far as we know, no studies 
were conducted on mediators of online CBT for depressive symptoms in PLWH. Though, potential 
mediators of CBT (face-to-face and online) for people with depressive symptoms in general have been 
investigated in the last decade. First of all, when we look at face-to-face CBT for depressive symptoms, 
the literature regarding changes in cognitions as a mediator is mixed. Three reviews have found that a 
change in cognitions was an important mediator (5-7), while another review has concluded that there 
is little evidence for cognitive mediation in CBT for depression (8). Therefore, the role of changing 
cognitions as a mediator in CBT for depressive symptoms is still unclear. Furthermore, the mediating 
role of behavioral factors such as changes in activation level, in CBT for depression was investigated in 
a review (7). Changes in behavioral factors were found to be a significant mediator in three out of six 
studies. 
Next to mediation studies of face-to-face CBT for depressive symptoms, mediators were also 
investigated in online CBT for depressive symptoms. It has been found that changes in dysfunctional 
attitudes, a negative problem orientation (9), repetitive negative thinking (9, 10), use of cognitive skills 
(11), and perceived control over things in life (9, 12) were mediators in the relation between online 
CBT and (a decrease in) depressive symptoms. Increasing activity levels was not found to be a mediator 
in online CBT for depression (11). Concluding, the results regarding mediators of change of (online) 
CBT are mixed and should be investigated further. Additionally, many previous mediation studies 
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correlated across subjects changes over time – using only two measurement moments (i.e., pretest 
and post-test) – in two variables, which does not allow to establish a timeline of mediators and 
outcomes (4, 7). More research with at least three measurement moments is needed in order to 
establish this timeline.  
 
Current study 
In this study, potential mediators of the effect of the online intervention Living positive with HIV on 
depressive symptoms were investigated. The intervention is based on CBT and contains four main 
components: behavioral activation, relaxation, changing negative thoughts into more balanced 
thoughts, and goal attainment. We statistically explored mediators for the decrease in depressive 
symptoms that might refer to causal mechanisms of change that may have been activated by the 
intervention components. The following potential mediators were investigated in the current study: 
changes in behavioral activation, relaxation, the cognitive coping strategies catastrophizing and 
positive refocusing, goal reengagement, and coping self-efficacy. We attempted to determine a 
temporal pattern of change: the mediators and the outcome (depressive symptoms) were investigated 
at pretest, three times during the intervention, and post-intervention. 
 
Methods 
Participants and procedure 
This study is part of a randomized controlled trial (RCT; Nederlands Trialregister NTR5407) investigating 
the effectiveness of the self-help intervention ‘Living positive with HIV’. More information about the 
procedure of the RCT can be found elsewhere (1). Nursing consultants and doctors in 23 of 26 HIV 
treatment centers in the Netherlands recruited participants during regular check-ups. Patients were 
screened with the Patient Health Questionnaire-2 (PHQ-2; (13)), and when their score was higher than 
zero, they were informed about the study and referred to the researchers when they were interested. 
Researchers called the patients and screened them on the inclusion criteria: being HIV positive for at 
least six months, age > 17 years, mastery of the Dutch or English language, available for the next eight 
weeks, having Internet and an e-mail address, no use of antidepressants or use for more than three 
months and no change of type or dose of antidepressants in the past three months, absence of severe 
cognitive impairments, not currently treated by a psychologist or psychiatrist, presence of mild to 
moderate depressive symptoms (determined by a Patient Health Questionnaire-9 -PHQ-9 (14)- score > 




When patients were eligible and agreed to participate, online informed consent was signed. 
Thereafter, participants completed the pretest and were randomly allocated to the intervention or 
control condition (waiting list and attention only from a coach). Stratified randomization by sex and 
HIV treatment center was performed. A random number table was used to create the sequence, which 
was done by an independent researcher and concealed from the main researcher. There were multiple 
measurement moments after randomization: three times during the intervention (lesson one, three, 
and five) or waiting period (week one, three, and five), a post-test when participants were finished 
with the intervention (experimental group) or eight weeks after pretest (control group), and a follow-
up at three and six months (the last follow-up was only completed in the intervention group). In the 
current study, the follow-up measurements were not used in the analyses. Participants received €25 
when they completed all questionnaires. The study was approved by the medical ethics committee of 
the Leiden University Medical Center (LUMC; nr. P14.091). 
 
Study conditions 
Guided online self-help intervention 
The intervention consists of CBT and contains four main components: 1) behavioral activation: 
conducting small positive activities (week 1); 2) relaxation exercises (week 2); 3) changing negative 
cognitions into more balanced cognitions and eliciting strong and positive feelings when negative 
feelings are experienced (week 3 to 5); and 4) goal attainment: setting important personal goals and 
working on attaining them (week 6 and 7). Participants received login details for the secured website 
of the intervention. No changes to the intervention were made during the RCT. The intervention exists 
of eight lessons with psychoeducation, exercises and assignments. Participants worked approximately 
eight weeks on the intervention, one to two hours a week. In addition, they were called by a personal 
coach each week for about 15 minutes. The coach checked the well-being of the participant and 
discussed the progress of the intervention. Coaches used motivational interviewing to motivate 
participants to continue with the intervention, to minimize attrition. Coaching was provided until the 
participant had finished the intervention, with a maximum of ten weeks. Coaches were Master 
students in clinical psychology or graduates with a Master’s degree in the field of psychology. Coaches 
received a training and followed a coaching manual. Supervision sessions with coaches and a 
researcher to discuss issues encountered during coaching were scheduled in the beginning of the study. 
There were less issues at the end of the study, therefore, they were handled via e-mail or phone. More 
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Participants that were allocated to the control condition were put on a waiting list and received 
attention only from a personal coach. Telephone coaching was provided for eight weeks, 
approximately five minutes per week. The coach addressed the well-being of the participant, 
monitored depressive symptoms, and motivated the participant to keep waiting and complete 
questionnaires. The participant was referred to the HIV treatment center or general practitioner when 
the depressive symptoms worsened and became severe. After the three month follow-up, participants 
were invited to start with the intervention. 
 
Assessments 
All assessments were completed online and administered at pretest, week 1, 3, and 5 during the 
intervention/waiting period, and at post-test. The questions that were asked during the 
intervention/waiting period concern the symptoms that were experienced during the last week. To 
reduce the time to complete the questionnaires, one or two items were chosen from each 
questionnaire (with the chosen items being the same across measurement moments). The authors 
jointly determined the items that represented the concept the best. The questionnaires are explained 
briefly below. More information on the specific questions that were used, and the scoring can be found 
in Appendix 1. 
 
Outcome measure 
The outcome measure for the mediational analysis was severity of depressive symptoms. This was 
measured with the PHQ-2 (13), which consists of the first two questions of the PHQ-9. The construct 
and criterion validity of the PHQ-2 are adequate (13), and the Spearman-Brown coefficient ranged 




Behavioral activation was measured by a sum score of two items from the subscale activation of the 
Behavioral Activation for Depression Scale (BADS) (15). The psychometric properties of the Dutch BADS 
are adequate (16), and the Spearman-Brown coefficient of the two items ranged from 0.79 to 0.84 
throughout the five measurement moments in the current study. 
 
Relaxation 
Relaxation was measured with one self-designed item concerning difficulty to relax. The reliability of 




Cognitive coping: catastrophizing and positive refocusing 
The subscales catastrophizing and positive refocusing of the Cognitive Emotion Regulation 
Questionnaire short version (CERQ-short) (17) were adopted to measure the use of these cognitive 
coping strategies when thinking about having HIV. The subscales consist of two items each. The 
psychometric properties of the CERQ-short are adequate (17). In the current study the Spearman-
Brown coefficient ranged from 0.84 to 0.94 throughout the five measurement moments for the 
catastrophizing subscale, and from 0.72 to 0.81 throughout the five measurement moments for the 
positive refocusing subscale. 
 
Goal reengagement 
One item of the Goal Disengagement and Goal Reengagement Scale (GDGRS) (18) was used to measure 
goal reengagement. For the current study, the item was specifically reformulated to measure goal 
reengagement in relation to having HIV. The reliability of the total instrument was previously found to 
be satisfactory (18).  
 
Coping self-efficacy 
A sum score of two self-designed items was used to measure self-efficacy to cope with having HIV. The 
items were based on the Generalized Self-Efficacy Scale, which has good reliability and validity (19). 
The Spearman-Brown coefficient of the two items in the current study ranged from 0.75 to 0.92 
throughout the five measurement moments. 
 
Statistical analysis 
The mediation analyses were conducted with the PHQ-2 score as dependent variable (Y), Group 
(intervention and control) as independent variable (X), and activation, relaxation, the cognitive coping 
strategies catastrophizing and positive refocusing, goal reengagement, and coping self-efficacy as 
potential mediators (M). Note that the PHQ-2 and all six mediator questionnaires were administered 
at all five measurement moments (pre-test, week 1, 3, 5, and post-test). 
The mediation analyses were performed in three steps. In step 1 all potential mediators were 
entered separately into a multilevel structural equation model (MSEM (20)). An MSEM model was 
chosen because Group (X) does not change over time (level 2: between subjects-level), whereas PHQ-
2 (Y) and the mediator (M) scores do change over time (level 1: within subjects-level). As Group (X) is 
constant over time, only mediation at the between level can take place. To test this, MSEM computes 
the product term a x b and evaluates its significance, with a being the between effect from X to M, and 
b the between effect from M to Y. Mediation is present when the product term significantly differs 
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from zero. The significant mediators that were found were thereafter all together included in a single 
model in order to investigate which mediation effects remain significant after controlling for the other 
mediators in the model. The analysis in step 1 was repeated for the per protocol sample, as a sensitivity 
analysis. The per protocol sample included participants in the intervention group that finished at least 
the first five lessons of the intervention, and participants in the control group that received at least 
five telephone calls from the coach. 
In step 2 an explorative analysis was conducted to investigate when the mediating effect(s) 
exactly occurred (i.e., in between which two measurement moments). To this end, for the significant 
mediators encountered in step 1, the same MSEM model was fitted as in step 1, however using 
different combinations of measurement moments. In particular, the timing of the mediation effect(s) 
was investigated by comparing for each measurement moment an MSEM model including only the 
measurements up to that moment (including the measurement moment in question) to an MSEM 
model including only subsequent measurement moments. For example, for week 1, an MSEM model 
including the pretest and week 1 was compared to an MSEM model including week 3, week 5, and the 
post-test. The first measurement moment for which in both associated MSEM models mediation is 
present, was considered as the moment when the mediation occurred. 
In step 3 return effects from the dependent variable to the significant mediators identified in 
step 1 (i.e., from Y to M) were studied. When return effects are present, this may indicate that the 
mediation effect is less strong. Return effects were investigated by means of a bivariate autoregressive 
latent trajectory analysis (ALT (21, 22)). In order to get a good fitting but not too complex ALT model 
(which generalizes well), some constraints on the parameters were imposed. In particular, for each 
variable, parameters representing auto-regressive paths were set equal to each other, with the same 
being true for cross-lagged parameters. Further, for each variable, residual variances for each 
measurement moment were kept equal (except for the first measurement moment as prescribed by 
the predetermined model parameterization, see (21)). Finally, time-specific correlations between 
residuals were set equal over time. To determine whether the ALT model fitted well to the data, the 
following model fit indices were evaluated: root mean square error of approximation (RMSEA) with its 
90% confidence interval (CI), comparative fit index (CFI) and Tucker Lewis Index (TLI). The model has a 
good fit when the RMSEA value is below 0.06, when the 90% CI for RMSEA has an upper bound < 0.08 
and a lower bound > 0.05, and when the CFI and TLI values are higher than 0.95 (23, 24). The analyses 
were based on full information maximum likelihood (FIML) techniques, which means that all available 
data - including participants with partially missing data - was used. 𝛼𝛼𝛼𝛼 = 0.05 was used for significance 





In the HIV treatment centers, 3642 patients were screened on depressive symptoms. Of these, 445 
were screened by the researchers and 188 patients were included in the study. Patients were 1:1 
randomized to the intervention group (n = 97) and the control group (n = 91). Note that due to the 
stratified randomization the intervention group contains a few more participants than the control 
group. The post-test was completed by 75 participants (77%) of the intervention group and 77 
participants (85%) of the control group. Figure 1 displays for each group separately the flow of 
participants through the study in terms of PHQ-2. 
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Figure 1. Flow of participants through the study. 
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- Unknown (n = 1)
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 Twenty-two participants (12%) in the study were female and 166 (88%) were male. The 
average age of participants was 46.30 years old (SD = 10.63). Thirty-two participants (17%) were 
heterosexual, 144 (77%) homosexual and 12 (6%) bisexual. Most participants had a medium education 
(n = 77; 41%) or a high education (n = 69, 37%), and a minority a low education (n = 42; 22%). 
Participants had HIV for 9.87 years on average (SD = 6.58). Twenty-three participants (12%) had AIDS 
and 165 (88%) did not have AIDS, and 184 participants (98%) used ART and 4 (2%) did not use ART. 
More information on the baseline characteristics of the sample can be found elsewhere (2). Mean 
scores on the questionnaires at different time points can be found in Table 1. 
 
Mediation analysis step 1 
Table 2 shows the results of the mediation analysis based on MSEM in which all mediators are 
investigated separately. Changes in BADS and GDGRS were found to be significant mediators. 
Subsequently, these two mediators were together included in a single model. Changes in BADS 
remained a significant mediator when changes in GDGRS was controlled for (a x b: 0.25, SE = 0.10, p = 
0.01), whereas changes in GDGRS was not a significant mediator anymore when changes in BADS was 
controlled for (a x b: 0.15, SE = 0.09, p = 0.10). Correlations between BADS and GDGRS varied across 
measurement moments (range from r = 0.07, p = 0.39 to r = 0.54, p < 0.001). The mediation analysis 
was repeated on the per protocol sample and the results were similar as for the whole sample. For 
illustrative purposes, Figure 2 displays the course of PHQ-2, BADS, and GDGRS scores over time in both 
groups. The intervention group shows a stronger reduction in PHQ-2 score over time than the control 
group, and at the same time BADS scores and GDGRS scores increase more over time in the 





Table 1. Mean scores on the questionnaires at different time points. Data are provided as M (SD). 
Characteristic Intervention group Control group 
Depressive symptoms (PHQ-2a) pretest 3.10 (1.47) 2.78 (1.26) 
 Week 1 2.13 (1.41) 2.27 (1.55) 
 Week 3 1.66 (1.20) 2.24 (1.56) 
 Week 5 1.24 (1.25) 2.05 (1.59) 
 Post-test 1.53 (1.41) 2.38 (1.59) 
Behavioral activation (BADSb) pretest 4.78 (3.15) 4.58 (3.05) 
 Week 1 5.90 (2.74) 5.30 (2.88) 
 Week 3 6.52 (2.88) 5.35 (2.82) 
 Week 5 7.35 (2.31) 5.78 (2.74) 
 Post-test 7.57 (2.99) 5.46 (3.07) 
Relaxation pretest 1.62 (0.60) 1.69 (0.68) 
 Week 1 1.66 (0.57) 1.74 (0.62) 
 Week 3 1.97 (0.59) 1.80 (0.65) 
 Week 5 2.13 (0.70) 1.81 (0.61) 
 Post-test 2.05 (0.66) 1.86 (0.70) 
Catastrophizing (CERQ-shortc) pretest 3.80 (2.36) 3.37 (1.74) 
 Week 1 3.44 (1.77) 3.61 (2.10) 
 Week 3 3.05 (1.58) 3.38 (2.04) 
 Week 5 2.75 (1.21) 3.24 (1.68) 
 Post-test 2.92 (1.75) 3.16 (1.69) 
Positive refocusing (CERQ-shortc) pretest 6.39 (2.23) 6.37 (2.03) 
 Week 1 6.13 (1.89) 5.96 (1.85) 
 Week 3 6.32 (1.96) 5.90 (1.97) 
 Week 5 6.91 (1.96) 6.39 (2.05) 
 Post-test 7.04 (2.17) 6.07 (2.19) 
Goal reengagement (GDGRSd) pretest 3.15 (0.86) 2.97 (0.82) 
 Week 1 3.42 (0.79) 3.12 (0.81) 
 Week 3 3.55 (0.75) 3.10 (0.94) 
 Week 5 3.71 (0.79) 3.26 (0.97) 
 Post-test 3.55 (0.79) 3.08 (0.99) 
Coping self-efficacy pretest 7.08 (1.78) 7.24 (1.66) 
 Week 1 7.51 (1.59) 7.15 (1.78) 
 Week 3 8.03 (1.60) 7.14 (1.83) 
 Week 5 8.11 (1.40) 7.53 (1.69) 
 Post-test 7.93 (1.65) 7.20 (1.72) 
a PHQ-2 = Patient Health Questionnaire-2, b BADS = Behavioral Activation for Depression Scale, c CERQ-short = Cognitive 
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Behavioral activation (BADSb) pretest 4.78 (3.15) 4.58 (3.05) 
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Table 2. Mediation effects of six potential mediators (tested separately) with Group as independent 
variable and PHQ-2a score as dependent variable, based on MSEMb analysis on data containing all 5 
measurement moments. 
Potential mediator a x bc SE p 
Behavioral activation (BADSd) 0.31 0.11 0.006e 
Relaxation 0.05 0.08 0.55 
Catastrophizing (CERQ-shortf) -0.005 0.06 0.92 
Positive refocusing (CERQ-shortf) 0.10 0.08 0.17 
Goal reengagement (GDGRSg) 0.29 0.11 0.009e 
Coping self-efficacy 0.12 0.08 0.13 
a PHQ-2 = Patient Health Questionnaire-2, b MSEM = multilevel structural equation model, c coefficient for the product term 
testing the mediation effect, d BADS = Behavioral Activation for Depression Scale, e p < .05, f CERQ-short = Cognitive Emotion 
Regulation Questionnaire short version, g GDGRS = Goal Disengagement and Goal Reengagement Scale. 
 
Mediation analysis step 2: timing of mediation effects 
Table 3 shows the timing of the mediation effects of the significant mediators in step 1. The results 
show that for changes in BADS the mediation effect is not significant when the pretest, week 1 and 
week 3 measurements are combined. However, the mediation effect is significant when the week 5 
and post-test measurements are combined. Therefore, it seems likely that the BADS mediation effect 
occurs between week 3 and week 5. For changes in GDGRS, the results are almost similar. The 
mediation effect is not significant when the pretest and week 1 measurements are combined and is 
significant when the week 3, week 5, and post-test measurements are combined. Hence, it seems likely 
that the GDGRS mediation effect occurs between week 1 and week 3. 
 
Mediation analysis step 3: return effects 
Table 4 presents the results of the analysis on return effects from the dependent variable to the 
mediators. The values of the fit indices (RMSEA, CFI, and TLI) indicate that the model has an acceptable 
to good fit. The results show that there is no return effect from the PHQ-2 to the BADS, but there is a 
return effect from the PHQ-2 to the GDGRS. However, the standardized coefficient (𝛽𝛽𝛽𝛽) for the effect 
of the GDGRS on the PHQ-2 (𝛽𝛽𝛽𝛽 = -0.20) is higher -in absolute value- than the 𝛽𝛽𝛽𝛽 for the effect of the 
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Table 3. Timing of mediation effects: comparison of the mediation effect in MSEMa models fitted to 





BADSb a x bc BADSb SE BADSb p GDGRSd a x 
bc 
GDGRSd SE GDGRSd p 
Pretest 0.03 0.06 0.66 0.06 0.04 0.17 
Week 1 – post-test 0.44 0.13 0.001e 0.43 0.14 0.003e 
       
Pretest – week 1 0.10 0.10 0.30 0.20 0.12 0.09 
Week 3 – post-test 0.59 0.16 < 0.001e 0.50 0.18 0.005e 
       
Pretest – week 3 0.20 0.11 0.08 0.19 0.10 0.04e 
Week 5 – post-test 0.69 0.20 < 0.001e 0.60 0.27 0.03e 
       
Pretest – week 5 0.23 0.11 0.04e 0.22 0.10 0.02e 
Post-test 0.52 0.15 < 0.001e 0.24 0.10 0.02e 
 a MSEM = multilevel structural equation model, b BADS = Behavioral Activation for Depression Scale, c coefficient for the 
product term testing the mediation effect, d GDGRS = Goal Disengagement and Goal Reengagement Scale, e p < .05. 
 
Table 4. Results of the analysis on return effects from the dependent variable (PHQ-2a) to the 
mediators. 
Mediator bb 
Y  M 
(SE) 
𝜷𝜷𝜷𝜷c  
Y  M 
(SE) 





BADSg -0.12 (0.10) -.06 (0.05) 0.24 0.06 (0.04, 0.09) 0.94 0.94 
GDGRSh -0.08 (0.03) -.13 (0.06) 0.02i 0.06 (0.03, 0.08) 0.95 0.94 
a PHQ-2 = Patient Health Questionnaire-2, b b = unstandardized coefficient, c 𝛽𝛽𝛽𝛽  = standardized coefficient (using STDYX 
standardization), d RMSEA = Root Mean Square Error of Approximation, e CFI = Comparative Fit Index, f TLI = Tucker Lewis 




This study investigated potential mediators of a guided Internet-based intervention for PLWH with 
depressive symptoms, compared to a control group that received attention only. Changes in behavioral 
activation and goal reengagement were found to be significant mediators of the intervention effect. 
For changes in behavioral activation, the mediation effect seemed to occur between week 3 and 5 of 
the intervention and for changes in goal reengagement the mediation effect seemed to occur between 
 
 
week 1 and 3. The mediation effect of changes in behavioral activation seemed to be stronger than 
the effect of changes in goal reengagement since goal reengagement was not a significant mediator 
anymore when the model was controlled for behavioral activation. Moreover, a return effect (from 
the dependent variable to the mediator) was found for goal reengagement and not for behavioral 
activation. 
 In a review about CBT for depression, changes in behavioral activation were found to be a 
significant mediator in three out of six studies (7). More specifically, when only high quality studies 
were examined, three out of four studies concluded that changes in behavioral factors were a 
significant mediator. This is in line with our findings. However, a previous study into Internet CBT for 
depression investigated changes in behavioral activation as a mediator and has found that it was not 
a significant mediator of the intervention effect (11). An explanation for the difference in results 
between our study and this previous study may be the difference in timing of the intervention 
components and measurement moments. That is, the component behavioral activation was offered 
early in our intervention and late in the other intervention. We included three measurement moments 
during the intervention period in our study and there was only one measurement moment during the 
intervention in the previous study, and at that moment behavioral activation was not offered yet. 
Therefore, it is not surprising that no mediation effect of behavioral activation was found in the 
previous study. It is important to include multiple measurement moments of the dependent variable 
and possible mediators during the intervention period, in order to determine a timeline of the effects 
of mediators and outcome. As far as we know, changes in goal reengagement as a mediator of 
intervention effect for (online) CBT for depression was not investigated previously. More research is 
needed regarding the mediating role of changes in behavioral activation and goal reengagement in 
online CBT for depressive symptoms. 
The current study was conducted to find mediators of the intervention effect, which may 
provide us with suggestions for possible mechanisms of change underlying the intervention. Since 
changes in behavioral activation and goal reengagement were found to be mediators of the 
intervention, they may suggest possible mechanisms of change. It was previously found that reward 
processing and avoidance may be possible mechanisms of change of behavioral activation (25-27). 
That is, specific components of the intervention may activate these mechanisms, e.g. by activating 
participants, avoidance of (positive) activities may be reduced. In turn, this may lead to a reduction in 
depressive symptoms. However, it was previously found that there is no 1-to-1 relation between 
offering certain components of the intervention and the change in corresponding mediators (8, 28). 
For example, it was found that negative thinking decreased after CBT but also after behavioral 
activation. So, even when the focus was not on changing negative thoughts in the behavioral activation 
195
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mediators. 
Mediator bb 
Y  M 
(SE) 
𝜷𝜷𝜷𝜷c  
Y  M 
(SE) 





BADSg -0.12 (0.10) -.06 (0.05) 0.24 0.06 (0.04, 0.09) 0.94 0.94 
GDGRSh -0.08 (0.03) -.13 (0.06) 0.02i 0.06 (0.03, 0.08) 0.95 0.94 
a PHQ-2 = Patient Health Questionnaire-2, b b = unstandardized coefficient, c 𝛽𝛽𝛽𝛽  = standardized coefficient (using STDYX 
standardization), d RMSEA = Root Mean Square Error of Approximation, e CFI = Comparative Fit Index, f TLI = Tucker Lewis 




This study investigated potential mediators of a guided Internet-based intervention for PLWH with 
depressive symptoms, compared to a control group that received attention only. Changes in behavioral 
activation and goal reengagement were found to be significant mediators of the intervention effect. 
For changes in behavioral activation, the mediation effect seemed to occur between week 3 and 5 of 
the intervention and for changes in goal reengagement the mediation effect seemed to occur between 
 
 
week 1 and 3. The mediation effect of changes in behavioral activation seemed to be stronger than 
the effect of changes in goal reengagement since goal reengagement was not a significant mediator 
anymore when the model was controlled for behavioral activation. Moreover, a return effect (from 
the dependent variable to the mediator) was found for goal reengagement and not for behavioral 
activation. 
 In a review about CBT for depression, changes in behavioral activation were found to be a 
significant mediator in three out of six studies (7). More specifically, when only high quality studies 
were examined, three out of four studies concluded that changes in behavioral factors were a 
significant mediator. This is in line with our findings. However, a previous study into Internet CBT for 
depression investigated changes in behavioral activation as a mediator and has found that it was not 
a significant mediator of the intervention effect (11). An explanation for the difference in results 
between our study and this previous study may be the difference in timing of the intervention 
components and measurement moments. That is, the component behavioral activation was offered 
early in our intervention and late in the other intervention. We included three measurement moments 
during the intervention period in our study and there was only one measurement moment during the 
intervention in the previous study, and at that moment behavioral activation was not offered yet. 
Therefore, it is not surprising that no mediation effect of behavioral activation was found in the 
previous study. It is important to include multiple measurement moments of the dependent variable 
and possible mediators during the intervention period, in order to determine a timeline of the effects 
of mediators and outcome. As far as we know, changes in goal reengagement as a mediator of 
intervention effect for (online) CBT for depression was not investigated previously. More research is 
needed regarding the mediating role of changes in behavioral activation and goal reengagement in 
online CBT for depressive symptoms. 
The current study was conducted to find mediators of the intervention effect, which may 
provide us with suggestions for possible mechanisms of change underlying the intervention. Since 
changes in behavioral activation and goal reengagement were found to be mediators of the 
intervention, they may suggest possible mechanisms of change. It was previously found that reward 
processing and avoidance may be possible mechanisms of change of behavioral activation (25-27). 
That is, specific components of the intervention may activate these mechanisms, e.g. by activating 
participants, avoidance of (positive) activities may be reduced. In turn, this may lead to a reduction in 
depressive symptoms. However, it was previously found that there is no 1-to-1 relation between 
offering certain components of the intervention and the change in corresponding mediators (8, 28). 
For example, it was found that negative thinking decreased after CBT but also after behavioral 





treatment, they did decrease (28). More research should be conducted into the relation between 
offering certain components of the intervention and the change in corresponding mediators. 
Goal reengagement and behavioral activation as components of the intervention are related, 
as both are trying to increase the amount of (positive) activities to improve one’s mood. In addition, in 
interventions that include behavioral activation, goal setting is often included as a first step of 
activation (29, 30). Since behavioral activation and goal reengagement are related, it may not be 
surprising that the timing of the mediation effects did not correspond to the timing of the related 
intervention components. The mediation effect of changes in behavioral activation occurred 
approximately three weeks after the component was introduced, and the mediation effect of changes 
in goal reengagement occurred approximately four weeks before the component was introduced. This 
is also in line with previous findings regarding the weak relation between offering a certain 
intervention component and a change in the corresponding mediator (8, 28). 
 No other significant mediators of intervention effect were found. This means that changes in 
relaxation, coping self-efficacy, and the cognitive coping strategies catastrophizing and positive 
refocusing were no significant mediators. In most previous reviews (5-7) changes in cognitions were 
found to be mediators of CBT for depression, but one review found no evidence for changes in 
cognitions as a mediator (8). In the current study, changes in cognitions were not measured, but 
changes in the use of cognitive coping strategies was included. This may be comparable to a change in 
cognitions, but changes in the use of cognitive coping strategies were not found to be mediators. These 
cognitive coping strategies were addressed in the intervention and also did improve in the intervention 
group. However, the use of these strategies also improved in the control group. Future studies may 
investigate changes in cognitions as a mediator of intervention effect. 
  
Strengths and limitations 
Some strengths and weaknesses of this study may be identified. An important strength was that a 
temporal pattern of change was investigated because multiple measurement moments were included 
during the intervention period. Many previous mediation studies only included a pretest and a post-
test, which is not sufficient to demonstrate a timeline and ‘real’ mediation effects (4). In addition, 
multiple mediators were investigated that corresponded to components of the intervention. Another 
strength was that advanced state of the art statistical analyses were used: MSEM and ALT. 
Furthermore, all available data was used in the analyses, so participants with some missing 
measurement moments were not totally excluded from the analyses. Last, return effects from the 
dependent variable to the mediators were investigated, to study the strength of the mediation effects. 
A weakness of this study is that the measurement of some mediators included the use of self-designed 
questionnaires with only a few items. The reliability of these questionnaires was mostly adequate, but 
 
 
the validity needs to be investigated. Only a few items were used, because the questionnaires were 
administered multiple times and it should not take too much time to complete them. Another 
weakness was that there was much drop-out during the study. However, the drop-out rate was 
comparable to other studies regarding the effectiveness of Internet interventions (31, 32). No 
differences in demographic and HIV specific characteristics (e.g. duration of HIV) were found between 
drop-outs and completers in the current study (2), so probably attrition bias was not a problem. Finally, 
a selection of mediators was investigated in the current study. Other mediators may also have an effect 
and may be assessed in future studies. 
  
Future research 
In future studies, mediators may be more elaborately assessed with validated questionnaires with 
more items. Attrition may be prevented by using techniques that were previously suggested, such as 
inducing hope for benefits of the intervention and reducing time barriers by using habit-forming 
strategies (33). Other potential mediators may be investigated, such as changes in worrying. 
Additionally, it is important to study what the mechanisms of change of the intervention are. This is a 
challenge to investigate, as the relation between intervention components, mediators, and 
mechanisms of change is weak. As a first step, dismantling studies may be conducted, where each 
component of the intervention is provided to a different group of participants, and will be compared 
to a group that receives the complete intervention (4). In this way, it can be investigated which 
components may be related to changes in specific mediators. Furthermore, manipulation of a 
proposed mechanism of change may be conducted to study the effects on the outcome (4). 
  
Conclusion 
To conclude, potential mediators of a guided Internet-based intervention for PLWH with depressive 
symptoms were studied. The intervention was previously found to be effective in decreasing 
depressive symptoms, compared to a control group receiving attention only. We found that changes 
in behavioral activation and goal reengagement were significant mediators of the intervention effect. 
The mediation effect of changes in behavioral activation seemed to be stronger than for changes in 
goal reengagement. The mediators that were found in this study may suggest possible mechanisms of 
change of the intervention. More research into these mechanisms of change is needed to find out how 
the intervention works. The outcomes of these studies may be used to optimize the intervention and 




Mediators of a guided web-based self-help intervention for people with HIV and depressive symptoms
 
 
treatment, they did decrease (28). More research should be conducted into the relation between 
offering certain components of the intervention and the change in corresponding mediators. 
Goal reengagement and behavioral activation as components of the intervention are related, 
as both are trying to increase the amount of (positive) activities to improve one’s mood. In addition, in 
interventions that include behavioral activation, goal setting is often included as a first step of 
activation (29, 30). Since behavioral activation and goal reengagement are related, it may not be 
surprising that the timing of the mediation effects did not correspond to the timing of the related 
intervention components. The mediation effect of changes in behavioral activation occurred 
approximately three weeks after the component was introduced, and the mediation effect of changes 
in goal reengagement occurred approximately four weeks before the component was introduced. This 
is also in line with previous findings regarding the weak relation between offering a certain 
intervention component and a change in the corresponding mediator (8, 28). 
 No other significant mediators of intervention effect were found. This means that changes in 
relaxation, coping self-efficacy, and the cognitive coping strategies catastrophizing and positive 
refocusing were no significant mediators. In most previous reviews (5-7) changes in cognitions were 
found to be mediators of CBT for depression, but one review found no evidence for changes in 
cognitions as a mediator (8). In the current study, changes in cognitions were not measured, but 
changes in the use of cognitive coping strategies was included. This may be comparable to a change in 
cognitions, but changes in the use of cognitive coping strategies were not found to be mediators. These 
cognitive coping strategies were addressed in the intervention and also did improve in the intervention 
group. However, the use of these strategies also improved in the control group. Future studies may 
investigate changes in cognitions as a mediator of intervention effect. 
  
Strengths and limitations 
Some strengths and weaknesses of this study may be identified. An important strength was that a 
temporal pattern of change was investigated because multiple measurement moments were included 
during the intervention period. Many previous mediation studies only included a pretest and a post-
test, which is not sufficient to demonstrate a timeline and ‘real’ mediation effects (4). In addition, 
multiple mediators were investigated that corresponded to components of the intervention. Another 
strength was that advanced state of the art statistical analyses were used: MSEM and ALT. 
Furthermore, all available data was used in the analyses, so participants with some missing 
measurement moments were not totally excluded from the analyses. Last, return effects from the 
dependent variable to the mediators were investigated, to study the strength of the mediation effects. 
A weakness of this study is that the measurement of some mediators included the use of self-designed 
questionnaires with only a few items. The reliability of these questionnaires was mostly adequate, but 
 
 
the validity needs to be investigated. Only a few items were used, because the questionnaires were 
administered multiple times and it should not take too much time to complete them. Another 
weakness was that there was much drop-out during the study. However, the drop-out rate was 
comparable to other studies regarding the effectiveness of Internet interventions (31, 32). No 
differences in demographic and HIV specific characteristics (e.g. duration of HIV) were found between 
drop-outs and completers in the current study (2), so probably attrition bias was not a problem. Finally, 
a selection of mediators was investigated in the current study. Other mediators may also have an effect 
and may be assessed in future studies. 
  
Future research 
In future studies, mediators may be more elaborately assessed with validated questionnaires with 
more items. Attrition may be prevented by using techniques that were previously suggested, such as 
inducing hope for benefits of the intervention and reducing time barriers by using habit-forming 
strategies (33). Other potential mediators may be investigated, such as changes in worrying. 
Additionally, it is important to study what the mechanisms of change of the intervention are. This is a 
challenge to investigate, as the relation between intervention components, mediators, and 
mechanisms of change is weak. As a first step, dismantling studies may be conducted, where each 
component of the intervention is provided to a different group of participants, and will be compared 
to a group that receives the complete intervention (4). In this way, it can be investigated which 
components may be related to changes in specific mediators. Furthermore, manipulation of a 
proposed mechanism of change may be conducted to study the effects on the outcome (4). 
  
Conclusion 
To conclude, potential mediators of a guided Internet-based intervention for PLWH with depressive 
symptoms were studied. The intervention was previously found to be effective in decreasing 
depressive symptoms, compared to a control group receiving attention only. We found that changes 
in behavioral activation and goal reengagement were significant mediators of the intervention effect. 
The mediation effect of changes in behavioral activation seemed to be stronger than for changes in 
goal reengagement. The mediators that were found in this study may suggest possible mechanisms of 
change of the intervention. More research into these mechanisms of change is needed to find out how 
the intervention works. The outcomes of these studies may be used to optimize the intervention and 







We would like to thank all patients and coaches that participated in the study. In addition, we thank 
all nursing consultants and doctors that recruited participants for the study. This study was supported 





Appendix 1. Items and scoring of the questionnaires 
 
Depressive symptoms (PHQ-2) 
Over the last week, how often have you been bothered by any of the following problems? Score from 
0 (not at all) to 3 (nearly every day). 
1 Little interest or pleasure in doing things. 
2 Feeling down, depressed, or hopeless. 
 
Activation (BADS) 
Please indicate to what extent the following statements apply to you over the past week. Score from 
0 (not at all) to 6 (completely). 
1 I engaged in a wide and diverse array of activities. 
2 I am content with the amount and types of things I did. 
 
Relaxation 
Please indicate which answer is most appropriate to you over the past week. Score 1 (yes), 2 
(sometimes), 3 (no). 
1 Is it difficult for you to relax? 
 
Cognitive coping: catastrophizing and positive refocusing (CERQ-short) 
Please read the sentences below and indicate how often you had the following thoughts over the past 
week. Score from 1 ((almost) never) to 5 ((almost) always). 
1 I keep thinking about how terrible it is that I have HIV. 
2 I continually think how horrible it is to have HIV. 
3 I think of pleasant things that have nothing to do with having HIV. 
4 I think of something nice instead of having HIV. 
 
Goal reengagement (GDGRS) 
We will ask you to click the answer to the statement that you think best suits you during the past week. 
Score from 1 (totally disagree) to 5 (totally agree). 
1 If I have to stop pursuing an important goal in my life because I have HIV I start working on 
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Click the answer that is most applicable to you over the past week. Score from 1 (totally disagree) to 5 
(totally agree). 
1 I am confident that I can deal with having HIV. 
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Objective: The aim of this study was to evaluate the cost-utility of a guided Internet-based intervention 
for people living with HIV and depressive symptoms, compared to attention only (control condition). 
It was previously found that the intervention was effective in decreasing depressive symptoms, 
compared to the control group. 
Methods: This economic evaluation was conducted alongside a randomized controlled trial. The 
control group received attention only and was put on a waiting list. Quality adjusted life years were 
calculated over six months. The study was conducted from a societal perspective and included 
intervention costs, healthcare costs, and non-healthcare costs. Participants completed a pretest, a 
post-test after two to three months, and a second post-test after six months. Cost-utility acceptability 
curves were constructed and two sensitivity analyses were conducted. 
Results: No differences between the intervention and the control group were found in quality adjusted 
life years and total societal costs. The results indicate that the intervention is likely to be cost-effective, 
compared to attention only. The findings of the sensitivity analyses point in the same direction. 
Conclusion: More research with larger samples is necessary to confirm the findings. The outcomes of 
this study may inform policy makers to decide which interventions will be included in policies. The 
guided Internet intervention may improve psychological care for people living with HIV and depressive 
symptoms, against low costs. 
Trial registration: Nederlands Trialregister NTR5407, September 11, 2015. 
 






People living with HIV (PLWH) often suffer from depressive symptoms (1). Next to a negative influence 
of depressive symptoms on the quality of life of PLWH (2, 3), the symptoms are also associated with 
high healthcare costs (4-6). These healthcare costs, such as inpatient and outpatient services and use 
of medication, for PLWH with depression (or other psychiatric diseases) varied a lot between studies, 
from $17,911 to $33,037 per person per year in the USA between 1995 and 2010 (4-6). In addition to 
direct healthcare costs, more indirect costs related to losses in productivity from work due to illness 
may be present. As far as we know, no research is available regarding these indirect costs of PLWH 
with depressive symptoms. Though, it has been found that the reported annual indirect costs for PLWH, 
irrespective of depressive symptoms, range from €1,353 per person in 2010 in Italy (7), to €19,786 per 
person in 2002 in Switzerland (8). For people with depression, irrespective of HIV, the annual indirect 
costs have been investigated in 2010 in 30 European countries and were found to be €1,782 on average 
per person (9). 
 Because of the effect of depressive symptoms on quality of life and the high costs, it is 
important to treat PLWH. Several psychological interventions were found to be effective in reducing 
depressive symptoms in PLWH, such as cognitive behavioral therapy (CBT) and mindfulness (10-15). In 
addition to studying the effectiveness, it is also important to conduct economic evaluations of 
psychological interventions. Health insurance companies and policy makers are interested in the 
results of economic evaluations, to decide which interventions will be reimbursed and included in 
health care policies. Economic evaluations of psychological interventions for PLWH with depressive 
symptoms are scarce. One study found that collaborative care, including education, activation, and 
self-management, for depression in PLWH was likely to be cost-effective compared to usual care (16). 
 Internet-based interventions are used more and more often for people with depressive 
symptoms. Previous meta-analyses have found that Internet-based interventions are effective to treat 
depressive symptoms (17-19), also in people with a chronic somatic disease (20). Mixed results were 
found in previous studies regarding the cost-effectiveness of Internet-based interventions for 
depression, compared to different conditions. Two systematic reviews have found that guided 
Internet-based interventions for depression are likely to be cost-effective when compared to wait-list, 
treatment as usual, attention only, and unguided Internet-based CBT (21, 22). However, the results of 
an individual-participant data meta-analysis suggested that guided Internet interventions for 
depression were not cost-effective compared to care as usual, psychoeducation, or wait-list (23). Only 
a few studies were included in these reviews and meta-analysis, since many RCTs only investigated the 
effectiveness of Internet interventions, and not their cost-effectiveness. Therefore, more economic 
evaluations of Internet interventions on depression are needed. 
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 In 2015, we have developed an Internet-based CBT intervention for PLWH with depressive 
symptoms: Living positive with HIV (24). In a randomized controlled trial (RCT), we have found that the 
intervention including telephone coaching was effective in reducing depressive symptoms, compared 
to a control condition that received attention only and was put on a waiting list (25). The aim of the 
current study was to evaluate the cost-utility of the intervention, compared to attention only. 
Therefore, an economic evaluation has been conducted alongside the RCT. We expected that effects 
would be larger in the intervention group compared to the control group. Costs were expected to be 
lower in the intervention group than in the control group, as intervention costs are low and PLWH in 
the intervention group will feel better over time, make less use of healthcare services and experience 
less decreases in productivity at work. The outcomes of this economic evaluation are important for 
policy makers; when it is found that the intervention is cost-effective compared to attention only, 
chances are higher that it will be included in health care policies. 
 
Methods 
Participants and procedure 
This study was part of an RCT with an intervention and a control condition. The methods of this study 
are explained in detail elsewhere (24). Between February and December 2015, PLWH in 23 of the 26 
HIV treatment centers in the Netherlands were screened on depressive symptoms with the Patient 
Health Questionnaire-2 (PHQ-2) (26) by their nursing consultants and doctors during regular 
consultations. The PHQ-2 contains the first two questions of the Patient Health Questionnaire-9 (PHQ-
9) (27). When patients had a PHQ-2 score > 0 they were informed about the study and referred to the 
researchers after permission. 
Subsequently, the researchers called the patients to inform and screen them on the inclusion 
criteria of the study: > 17 years old; HIV diagnosis > 6 months; good understanding of Dutch or English; 
available for eight weeks to work on the intervention; having Internet access and an e-mail address; 
no severe cognitive impairments; no current treatment from psychologist/psychiatrist; PHQ-9 (27) 
score > 4 and < 20 (mild to moderate depressive symptoms); PHQ-9 score question nine < 2 (none or 
few suicidal thoughts); and no use of antidepressants, or use for more than three months without a 
change in dosage or kind of antidepressants in the past three months. Patients with severe depressive 
symptoms and/or suicidal thoughts were referred to their general practitioner or nursing 
consultant/doctor at the HIV treatment center. 
When patients were eligible and willing to participate they signed online informed consent. 
Thereafter, they completed the pretest and were randomly allocated to one of the two conditions. 
Randomization was stratified by treatment center and gender in blocks of six participants. An 
 
 
independent researcher used random number tables to create the sequence, which was hidden from 
the main researcher. When participants were finished with the intervention (maximum ten weeks after 
the pretest) or after eight weeks in the control group, they received the first post-test. The second 
post-test was completed three months later. Participants that completed all questionnaires during the 
study received €25. The study was approved by the medical ethics committee of the Leiden University 
Medical Center (LUMC; nr. P14.091). 
 
Study conditions 
Guided Internet-based intervention 
The intervention ‘Living positive with HIV’ was provided on a secured website. It contains CBT and 
consists of psychoeducation and exercises. The four main components are activation, relaxation, 
changing negative cognitions, and goal attainment. The intervention consists of eight lessons, which 
may be completed in eight weeks, one to two hours per week. In addition, participants received 
telephone support from a coach of about 15 minutes per week. Participants were asked how they were 
doing and how they progressed with the intervention. Furthermore, coaches motivated the participant 
to continue with the intervention by using motivational interviewing. Coaching was provided until 
participants completed the intervention, with a maximum of ten weeks. Coaches were Master 
students in clinical psychology or graduates with a Master’s degree in psychology. They were trained 
to provide the coaching and they followed a manual with guidelines. In the beginning of the study, 
supervision sessions with coaches and the main researcher were arranged (later individual supervision 
via e-mail and phone). 
 
Control condition 
Participants in the control condition received attention only from a coach and were put on a waiting 
list. The coach called them for about five minutes per week during the first eight weeks of the waiting 
period. The well-being of participants was checked and they were motivated to continue with the study. 
When depressive symptoms worsened and became severe, participants were referred to their general 
practitioner or HIV treatment center. A couple of participants (see Table 1) started with psychological 
treatment before the first post-test was completed, e.g. treatment from a psychologist or psychiatrist. 
Participants were invited to start with the intervention after the second post-test. This control 
condition was different from standard care. PLWH with depressive symptoms in the Netherlands are 
often treated by a psychologist, psychiatrist, or general practitioner. In addition, mild to moderate 
depressive symptoms are not always recognized and treated in PLWH. Thus it could also be argued 
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All assessments were completed online. 
 
Quality of life 
The research question regarding the cost-utility analysis was added in a later stage of the study. 
Therefore, the PHQ-9 was used to indirectly measure quality of life as it was already included in the 
assessments to measure depressive symptoms. The PHQ-9 consists of nine items that are scored on a 
scale from zero to three, and higher scores indicate more depressive symptoms. Psychometric 
properties of the PHQ-9 are adequate (28). PHQ-9 scores were converted to Short-Form Six-Dimension 
(SF-6D) utilities (29), using a mapping algorithm. Mapping algorithms transform outcomes of disease 
specific measures into health-related quality of life utilities. Item specific weightings from the PHQ-9 
mapping table of Brazier et al. (2014) (29), were used to convert PHQ-9 item scores to an SF-6D utility. 
The original PHQ-9 has nine questions and one extra question that is scored differently (If you checked 
off any problems, how difficult have these problems made it for you to do your work, take care of 
things at home, or get along with other people?). This last question was not included in our assessment. 
However, to apply the item specific weighting from the PHQ-9 mapping table (29), also the individual 
score on question ten was needed. Therefore, the mean score of the nine PHQ-9 questions (per 
participant, per assessment) was used as the score on question ten. Thereafter, the SF-6D utilities were 
calculated; they range from zero (death) to one (perfect health). With the SF-6D utilities, Quality 
Adjusted Life Years (QALYs) were calculated over six months with the area-under-the-curve method. 
Higher QALYs point to more improvement in quality of life. The duration between completing the 
pretest and the post-tests varied between participants. The mean duration from pretest to post-test 2 
was six months, therefore we adjusted all QALYs and costs to a duration of six months. 
 
Costs 
The economic evaluation was conducted from a societal perspective and included intervention costs, 
healthcare costs, and non-healthcare costs (e.g. productivity losses). All costs were adjusted to the 
year 2017 with the Consumer Price Index (30). The cost-effectiveness of the intervention compared to 




The costs of the intervention consisted of costs for the website, coaching, training, and supervision of 
coaches. Website costs included costs related to updates, domain, and security. The fixed costs for the 
development of the website (€13,102) were not included in the analysis. These costs were not included 
 
 
because they were one-off and they do not play a role when the intervention is further implemented. 
Coaches received a volunteer fee of €20.13 for the whole trajectory of coaching of one participant in 
the intervention group, and €12.58 for the whole trajectory of coaching of one participant in the 
control group. The costs related to training and supervision of coaches included the time investment 
of the main researcher multiplied by the hourly pay rate of the researcher (€21.00). The total costs for 




Use of healthcare services during the study was measured with the Trimbos/iMTA questionnaire for 
Costs associated with Psychiatric Illness (TiC-P) (31) at post-test 2. This questionnaire measures the 
amount of visits to healthcare providers (e.g. general practitioner), day treatments, hospital 
admissions, and medication use since the start of the study (i.e. period of six months). The use of 
healthcare services was multiplied by the standard costs of these services, according to Dutch tariffs 
(32). The reference price for a consultation with the general practitioner was for example €33.41, for 
a session with a physiotherapist €33.41, and for a hospital outpatient doctor visit €92.14. Medication 
use (including dosage and amount) was multiplied with medications costs (33). 
  
Non-healthcare costs 
Non-healthcare costs are related to being absent from work due to illness (absenteeism), being less 
productive at work due to mental or physical problems (presenteeism), and the inability to perform 
unpaid work such as domestic tasks or voluntary work due to mental or physical problems. 
Absenteeism, presenteeism, and the inability to perform unpaid work since the start of the study (i.e. 
period of six months) were assessed with the TiC-P at post-test 2. The friction cost method was used 
to calculate costs associated with absenteeism. This method assumes that after a certain period of 
time (the friction period; 85 days) the productivity loss due to an absent employee should be resolved. 
The number of hours that one was absent within the friction period was multiplied by the standard 
productivity costs per hour, based on gender (€38.37 for males and 31.99 for females) (32). The 
Osterhaus method was used to calculate costs related to presenteeism (31). The productivity loss due 
to presenteeism (in hours) was calculated by: number of days with productivity losses * number of 
hours worked per day * one minus the efficiency on these days ranging from zero (could not do 
anything) to one (able to do as much as normal). The productivity loss due to presenteeism was 
multiplied by the standard productivity costs per hour, based on gender (32). To calculate costs related 
to the inability to perform unpaid work, the number of hours that would be spend by others to take 
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The analyses were based on the intention to treat sample. The pretest was completed by 188 PLWH, 
which were randomized to the intervention group (n= 97) or control group (n = 91). Seventy-five 
participants (77%) in the intervention group completed post-test 1 and 64 (66%) completed post-test 
2. In the control group, 77 participants (85%) completed post-test 1 and 67 (74%) completed post-test 
2. The number of participants that completed the TiC-P questionnaire is smaller (n = 38 in the 
intervention group and n = 41 in the control group), because this questionnaire was added to the 
assessment at a later stage. We investigated differences in baseline characteristics between the 
participants that completed the TiC-P and the participants that did not receive the TiC-P. No differences 
between the groups were found, except on age. Participants that completed the TiC-P had a mean age 
of 44.09 (SD = 9.73) and participants that did not receive the TiC-P had a mean age of 48.75 (SD = 
10.21).  
Missing data were imputed by conducting multiple imputation by chained equations (MICE) in 
Stata /IC 14.2. A total of 100 imputed datasets were generated, which were pooled according to 
Rubin’s rules (34) for the analyses. Multiple imputation involves filling in the missing values multiple 
times, creating multiple “complete” datasets. Missing values are imputed based on the observed 
values for a given individual and the relations observed in the data for other participants, by including 
the observed variables in the imputation model. The following variables were used in the model: group 
(intervention or control), age, gender, time since HIV diagnosis, nationality, marital status, sexual 
orientation, education, AIDS diagnosis, time between pretest and post-test 1, time between pretest 
and post-test 2, scores on the Crandell Cognitions Inventory (CCI) (35), scores on generalized Anxiety 
Disorder-7 (GAD-7) (36) questionnaire, scores on relaxation questionnaire (self-designed), SF-6D 
utilities, and all cost variables. Questionnaire scores on the pretest, post-test 1 and post-test 2 were 
used as predictors. To assess values to impute, a series of regression models are run whereby each 
variable with missing data is modeled conditional upon the other variables in the data. This means that 
for the participants that did not complete the TiC-P, the relation between TiC-P outcomes and age 
observed in the data for other participants was taken into account by imputing missing values for the 
individuals without TiC-P data. In this way, MICE reduces bias due to selectively missing values, without 
ignoring the uncertainty of the imputation. 
 The cost-utility of the intervention group compared to the control group was evaluated with 
bootstrapping. A new intervention is cost-effective compared to an alternative when the extra cost of 
one extra QALY is less than the decision maker’s willingness to pay (WTP) for it (37). In the current 
 
 
cost-utility analysis the WTP was varied from €0 to €100,000. Using Microsoft Excel, 1000 bootstrap 
samples were created. The net benefit was calculated for different values of WTP for each sample: net 
benefit = WTP *Δ QALY – Δ total societal costs (37). When the net benefit is > 0, the intervention is 
cost-effective compared to the control condition for that sample. Thereafter, a cost-utility acceptability 
curve was constructed, which displays the probability of the intervention being cost-effective 
compared to attention only for a range of WTP values, i.e. the proportion of bootstrap samples for 
which the net benefit > 0. Cost-effectiveness is likely when the probability that the intervention is cost-
effective is above 0.5 for a given WTP. 
 Two sensitivity analyses were conducted to investigate the robustness of the results. The first 
sensitivity analysis included only healthcare costs and no non-healthcare costs. This analysis was 
conducted to inform policy makers that are mainly interested in the healthcare perspective, instead of 
the societal perspective. The second sensitivity analysis included antiretroviral therapy (ART) costs on 
top of the costs of other medication. We expected no differences in use of ART between groups, as 





In HIV treatments centers 3642 PLWH were screened, of which 445 were screened by the researchers. 
Thereafter, 188 PLWH completed the pretest and were randomized. Figure 1 presents a flow chart of 
participants during various stages in the study. 
 The majority of the sample was male (n = 166, 88%), and the mean age was 46.30 years (SD = 
10.63). Ninety-five participants (51%) were employed and participants had HIV for 9.87 years on 
average (SD = 6.58). A minority of the participants had AIDS (n = 23, 12%), 184 (98%) participants used 
ART, and 22 (12%) used psychotropic medication. Participants suffered from moderate depressive 
symptoms at baseline (PHQ-9 score: M = 11.44, SD = 4.50). More information regarding baseline 
characteristics of the sample can be found elsewhere (25). 
213
8
Cost-utility of an online intervention compared to attention only for people with HIV and depression
 
 




The analyses were based on the intention to treat sample. The pretest was completed by 188 PLWH, 
which were randomized to the intervention group (n= 97) or control group (n = 91). Seventy-five 
participants (77%) in the intervention group completed post-test 1 and 64 (66%) completed post-test 
2. In the control group, 77 participants (85%) completed post-test 1 and 67 (74%) completed post-test 
2. The number of participants that completed the TiC-P questionnaire is smaller (n = 38 in the 
intervention group and n = 41 in the control group), because this questionnaire was added to the 
assessment at a later stage. We investigated differences in baseline characteristics between the 
participants that completed the TiC-P and the participants that did not receive the TiC-P. No differences 
between the groups were found, except on age. Participants that completed the TiC-P had a mean age 
of 44.09 (SD = 9.73) and participants that did not receive the TiC-P had a mean age of 48.75 (SD = 
10.21).  
Missing data were imputed by conducting multiple imputation by chained equations (MICE) in 
Stata /IC 14.2. A total of 100 imputed datasets were generated, which were pooled according to 
Rubin’s rules (34) for the analyses. Multiple imputation involves filling in the missing values multiple 
times, creating multiple “complete” datasets. Missing values are imputed based on the observed 
values for a given individual and the relations observed in the data for other participants, by including 
the observed variables in the imputation model. The following variables were used in the model: group 
(intervention or control), age, gender, time since HIV diagnosis, nationality, marital status, sexual 
orientation, education, AIDS diagnosis, time between pretest and post-test 1, time between pretest 
and post-test 2, scores on the Crandell Cognitions Inventory (CCI) (35), scores on generalized Anxiety 
Disorder-7 (GAD-7) (36) questionnaire, scores on relaxation questionnaire (self-designed), SF-6D 
utilities, and all cost variables. Questionnaire scores on the pretest, post-test 1 and post-test 2 were 
used as predictors. To assess values to impute, a series of regression models are run whereby each 
variable with missing data is modeled conditional upon the other variables in the data. This means that 
for the participants that did not complete the TiC-P, the relation between TiC-P outcomes and age 
observed in the data for other participants was taken into account by imputing missing values for the 
individuals without TiC-P data. In this way, MICE reduces bias due to selectively missing values, without 
ignoring the uncertainty of the imputation. 
 The cost-utility of the intervention group compared to the control group was evaluated with 
bootstrapping. A new intervention is cost-effective compared to an alternative when the extra cost of 
one extra QALY is less than the decision maker’s willingness to pay (WTP) for it (37). In the current 
 
 
cost-utility analysis the WTP was varied from €0 to €100,000. Using Microsoft Excel, 1000 bootstrap 
samples were created. The net benefit was calculated for different values of WTP for each sample: net 
benefit = WTP *Δ QALY – Δ total societal costs (37). When the net benefit is > 0, the intervention is 
cost-effective compared to the control condition for that sample. Thereafter, a cost-utility acceptability 
curve was constructed, which displays the probability of the intervention being cost-effective 
compared to attention only for a range of WTP values, i.e. the proportion of bootstrap samples for 
which the net benefit > 0. Cost-effectiveness is likely when the probability that the intervention is cost-
effective is above 0.5 for a given WTP. 
 Two sensitivity analyses were conducted to investigate the robustness of the results. The first 
sensitivity analysis included only healthcare costs and no non-healthcare costs. This analysis was 
conducted to inform policy makers that are mainly interested in the healthcare perspective, instead of 
the societal perspective. The second sensitivity analysis included antiretroviral therapy (ART) costs on 
top of the costs of other medication. We expected no differences in use of ART between groups, as 





In HIV treatments centers 3642 PLWH were screened, of which 445 were screened by the researchers. 
Thereafter, 188 PLWH completed the pretest and were randomized. Figure 1 presents a flow chart of 
participants during various stages in the study. 
 The majority of the sample was male (n = 166, 88%), and the mean age was 46.30 years (SD = 
10.63). Ninety-five participants (51%) were employed and participants had HIV for 9.87 years on 
average (SD = 6.58). A minority of the participants had AIDS (n = 23, 12%), 184 (98%) participants used 
ART, and 22 (12%) used psychotropic medication. Participants suffered from moderate depressive 
symptoms at baseline (PHQ-9 score: M = 11.44, SD = 4.50). More information regarding baseline 







Figure 1. Flow chart of participants in the study. 
 
Quality of life 
Figure 2 presents the mean SF-6D utilities over the course of the study. The utilities of the intervention 
group were significantly higher than the utilities of the control group at post-test 1 (difference: 0.03; 
95% CI [0.001, 0.05]). There were no significant differences between groups on the SF-6D utilities at 
post-test 2. Though, utilities increased from pretest to post-test 2 in both groups. In addition, mean 
QALYs over the course of the study were 0.34 (SEM = 0.003) in the intervention group and 0.33 (SEM 








Figure 2. Mean SF-6D utilities over the course of the study in both groups. The data are based on the 
pooled results of 100 multiple imputed datasets. Error bars: 95% CI. 
 
Costs 
Table 1 shows the societal costs, divided into healthcare and non-healthcare costs in both groups. In 
addition, the number of participants that made use of each item was shown. Except for the costs for 
the website and the coaching, no significant differences in costs between groups were found. 
 
Cost-utility 
Figure 3 presents the cost-utility acceptability curves of the base case analysis and the two sensitivity 
analyses. The results of the base case analysis indicate that for all values of WTP, the intervention 
demonstrates a higher probability of being cost-effective, compared to attention only. The cost-utility 
acceptability curve of the sensitivity analysis with only healthcare costs included shows that for all 
values of WTP > €5,000, the intervention demonstrates a higher probability to be cost-effective, 
compared to attention only. Including ART costs in the medication costs, leads to mean additional costs 
of €2,802 (SEM = 391) in the intervention group and €3,657 (SEM = 442) in the control group, with no 
significant differences between groups (difference: -856; 95% CI [-2005, 294]). The results of the 
sensitivity analysis including ART costs indicate that the intervention has a higher probability of being 
cost-effective for all values of WTP, compared to attention only. 
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Figure 3. Cost-utility acceptability curves showing the probability that the guided online intervention  
is cost-effective compared to attention only for different values of willingness to pay. 
 
Discussion 
The current study aimed to investigate the cost-utility of a guided online intervention for PLWH with 
depressive symptoms, compared to attention only. We found no significant difference between groups 
in QALYs and total societal costs. The results indicate that for all values of WTP, the guided online 
intervention is likely to be cost-effective compared to attention only. In addition, the results of the two 
sensitivity analyses point in the same direction. 
It has been found previously that collaborative care for PLWH with depressive symptoms was 
likely to be cost-effective compared to usual care (16). This is in line with our findings. Previous reviews 
(21, 22) and a meta-analysis (23) found mixed results regarding the cost-effectiveness of Internet 
interventions for depression, compared to different control conditions. The number of economic 
evaluations of Internet interventions for depression is small, especially in PLWH with depression. More 
of these economic evaluations are recommended. 
In contrast to expectations, QALYs were not significantly different between groups. QALYs 
were calculated from the SF-6D utilities, and these were obtained by converting PHQ-9 scores. The SF-
 
 
6D is a general measure of quality of life, which also includes e.g. physical functioning. Hence, when 
PHQ-9 scores are converted into SF-6D utilities, differences between groups on mental health may 
have been weakened. A difference between groups on the SF-6D (and QALYs) is therefore more 
difficult to find in evaluating the effect of an intervention specifically targeting mental health. Though, 
it was previously found that the intervention was effective in decreasing depressive symptoms, 
compared to the control group (25). 
We expected that costs would be higher in the control group than in the intervention group, 
but we have not found this. Healthcare and non-healthcare costs were not significantly different 
between groups. It is not clear what the costs would have been when participants would not have 
received any treatment (no coaching calls and waiting list), because we did not include a no-treatment 
control group. Furthermore, this study had not enough power to detect differences in costs between 
groups, because of the wide confidence intervals around the costs. This is the case in many economic 
evaluations that are conducted alongside clinical trials, because the sample size is too small; the power 
calculation is based on the clinical outcomes and not on the cost outcomes (38). 
This study had some strengths and limitations. An important strength was that we performed 
an intention to treat analysis, with all participants that were randomized at baseline. Furthermore, the 
economic evaluation was conducted from a societal perspective and also included non-healthcare 
costs, in contrast to economic evaluations that only include healthcare costs. Lastly, two sensitivity 
analyses were conducted and these provided similar results as the main analysis. A first limitation is 
that there was a lot of missing data, especially on the costs, that needed to be imputed. This is related 
to the fact that cost-effectiveness was not a pre-specified outcome of the trial. Second, we did not 
administer the tenth question of the PHQ-9 and therefore the answer to this question was estimated 
by calculating the mean over the other nine items, before converting PHQ-9 scores into SF-6D utilities. 
Third, the costs were estimated retrospectively at the second post-test. Participants had to remember 
their healthcare use and productivity losses during the last six months, which is quite a long period and 
may have led to recall bias. Last, in the current study the comparison group was an attention only 
waiting list control condition, instead of usual care. When usual care would be used as comparison 
group, it may be investigated if the intervention is more cost-effective than usual care. Because of 
these limitations, the results should be interpreted with caution. Future studies with larger samples 
can investigate the cost-effectiveness of the intervention, compared to face-to-face interventions 
(usual care) for PLWH with depressive symptoms. In addition, longer follow-up measurements may be 
included to study the long term effects and cost-effectiveness of the intervention compared to a 
control condition. 
In conclusion, this study investigated the cost-utility of a guided Internet intervention for PLWH 
with depressive symptoms, compared to attention only. It was previously found that the intervention 
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was effective in decreasing depressive symptoms compared to the control group (25). We found no 
differences between groups in QALYs and total societal costs. However, the results indicate that the 
intervention is likely to be cost-effective compared to attention only. When future studies find similar 
results, policy makers may use this information to include the intervention in health care policies. 
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As depressive symptoms are frequently reported by people living with HIV (PLWH) (1‐3), it is important 
to treat them adequately. Treatments for depressive symptoms in PLWH include mostly face‐to‐face 
Cognitive Behavior Therapy (CBT). eHealth interventions are upcoming in the last years and may have 
advantages compared to face‐to‐face interventions. For example, more people may be reached, 
perceived stigma may be reduced because of the anonymity of eHealth interventions, and the 
interventions are in general easily accessible. The first aim of this dissertation was to study and 
summarize the effects of psychosocial interventions for PLWH to improve mental health and 
antiretroviral therapy (ART) adherence. The second aim was to evaluate the effectiveness of the 
eHealth intervention ‘Living positive with HIV’ which was developed for PLWH with depressive 
symptoms. In addition, moderators and mediators of intervention effect were investigated, as well as 
the cost‐utility of the intervention compared to attention only (control condition).  
In this chapter, the results of all chapters are summarized and discussed. Strengths and weaknesses of 
the studies are addressed, just as implications for clinical practice. The discussion ends with directions 
for future research and an overall conclusion. 
 
Summary of main findings 
Chapter 2 contains a systematic review and meta‐analysis of the effectiveness of psychosocial 
interventions for PLWH to improve mental health. Several characteristics that may influence the 
effectiveness of interventions were investigated (e.g. treatment provider). Depression, anxiety, quality 
of life, and psychological well‐being were the outcome measures in this study. The meta‐analysis 
included 62 studies. It was found that psychosocial interventions had a small positive effect on the 
mental health of PLWH. There was evidence for publication bias; the effect size was smaller when it 
was corrected for publication bias. No differences were found between diverse intervention types, so 
CBT may for example be as effective as mindfulness in improving mental health. Six characteristics that 
influenced the effect of the intervention on depression were found. For example, studies that had 
psychologists as treatment providers had larger effect sizes than studies with other treatment 
providers. Additionally, larger effects have been found for studies that only included PLWH with 
depressive symptoms, instead of all PLWH. Previous meta‐analyses mostly have found small to 
moderate effect sizes of psychosocial interventions on the mental health of PLWH (4‐6). These 
differences in effect sizes between this meta‐analysis and previous meta‐analyses may be explained 
by the primary focus of the included interventions. Most previous meta‐analyses included 
interventions with a primary focus on improving mental health. This meta‐analysis was more broad, 
and also included interventions that measured mental health outcomes, but did not have mental 
health as the primary focus of the intervention. As expected, larger effects were found in this meta‐
analysis for interventions with the primary focus on improving mental health. We can conclude that 
 
 
psychosocial interventions are of importance for PLWH to improve their mental health, and they 
should be incorporated in healthcare. 
 
Chapter 3 consists of a systematic review and meta-analysis that aimed to study the effectiveness of 
psychosocial interventions to improve ART adherence in PLWH. Forty-three RCTs were included in the 
meta-analysis. The results indicated that psychosocial interventions had a small to moderate positive 
effect on ART adherence in PLWH. There was no evidence for publication bias. It was found that various 
intervention types may be effective for various PLWH groups. The results of this study are in line with 
most previous meta-analyses and reviews, which also found that psychosocial interventions may have 
a positive effect on medication adherence in PLWH (7-10). Improving medication adherence in PLWH 
is important, because it promotes their health and the public health, as it decreases transmission risk. 
Therefore, the use of psychosocial interventions for PLWH with adherence difficulties should be 
encouraged. 
 
In Chapter 4 the study protocol for the RCT on the effectiveness of the eHealth intervention ‘Living 
positive with HIV’ for PLWH with depressive symptoms was described. The intervention group was 
compared to a control group that was on a waiting list and received weekly attention only from a coach 
via telephone. The online CBT intervention was based on a self-help booklet that was found to be 
effective in previous research. Thereafter, the booklet was adapted and converted into the online 
intervention which consists of four components: activation, relaxation, changing negative cognitions, 
and goal attainment. Participants worked on the intervention for approximately eight weeks, one to 
two hours a week. Participants in the intervention group also received telephone support from a coach 
for about 15 minutes per week. PLWH with mild to moderate depressive symptoms were included in 
the study. The RCT included a pretest, three measurements during the intervention/waiting period, 
and three post-tests. Chapters 5 to 8 report on the results of the RCT. 
 
The effectiveness of the guided eHealth intervention ‘Living positive with HIV’ was investigated in 
Chapter 5. Participants were 188 PLWH with mild to moderate depressive symptoms, of which 97 were 
randomly allocated to the intervention group and 91 to the control group. It was found that the 
intervention was effective in decreasing depressive symptoms on the short and long term, compared 
to the attention only control group. Furthermore, the intervention was effective in reducing anxiety 
symptoms, compared to the control group. Significantly more participants in the intervention group 
reached the criteria for clinically significant change in depressive symptoms than in the control group. 
Lastly, the intervention and the coach were positively evaluated by the participants. In the past, only 
four studies (11-14) investigated the effectiveness of computerized/Internet interventions for PLWH 
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with depressive symptoms, and three were not effective (11-13). The results described in Chapter 5 
are comparable to the large body of literature that found that eHealth interventions are effective for 
people with depressive symptoms (15-20), also for people with a comorbid chronic somatic disease 
(21). As eHealth interventions have certain advantages compared to face-to-face interventions, and 
were found to be effective, they may be used more frequently in the future for PLWH with depressive 
symptoms. It is important to pay attention to specific factors that were found to contribute to the 
effectiveness of eHealth interventions, such as the addition of guidance (16, 19, 20). 
 
In Chapter 6 moderators of change of the Internet-based intervention for PLWH with depressive 
symptoms were examined. Many possible moderators were investigated: demographic characteristics 
(e.g. gender), HIV characteristics (e.g. duration of having HIV), and psychological characteristics (e.g. 
baseline anxiety symptoms). One moderator of intervention effect was found: coping self-efficacy. 
That is, participants with low coping self-efficacy improved more in the intervention group than in the 
control group, and participants with high coping self-efficacy improved in both groups. The aim of this 
study was to find out who benefits the most from the intervention. It can be concluded that the 
intervention may be effective for all PLWH with mild to moderate depressive symptoms, regardless of 
certain demographic characteristics, HIV characteristics, or psychological characteristics. It may be 
especially important to treat PLWH with low coping self-efficacy, as they do not improve with only 
minimal attention. However, some participants did not improve after following the intervention. This 
was not related to any of the investigated characteristics. Though, it is important to examine in future 
studies why some participants do not improve and what could be done to address this. 
 
In Chapter 7 the results of the mediation analysis were presented. The aim was to explore mediating 
variables that could help to identify mechanisms of change of the intervention ‘Living positive with 
HIV’. Potential mediators that were included in the study were changes in behavioral activation, 
relaxation, the cognitive coping strategies catastrophizing and positive refocusing, goal reengagement, 
and coping self-efficacy. It was found that increases in behavioral activation and goal reengagement 
were significant mediators of intervention effect. The mediation effect occurred probably between 
week three and five for behavioral activation and between week one and three for goal reengagement. 
The mediation effect of behavioral activation seemed to be slightly stronger than that of goal 
reengagement. The mediators that were found in this study may suggest possible mechanisms of 
change of the intervention. More research is necessary to find these possible mechanisms of change 
to have an indication of how the intervention works. After these studies have been conducted the 




Chapter 8 includes a cost-utility analysis of the guided online intervention for PLWH and depressive 
symptoms, compared to attention only. The outcome quality of life was operationalized as Quality 
Adjusted Life Years (QALYs) over six months. The economic evaluation was conducted from a societal 
perspective and included intervention costs, healthcare costs, and non-healthcare costs (e.g. losses in 
productivity) over six months. Results demonstrated that there were no significant differences in 
QALYs and healthcare and non-healthcare costs between groups. We found that it is very likely that 
the online intervention is cost-effective compared to attention only. That is, the intervention is 
preferred over attention only to decrease depressive symptoms in PLWH. As the sample that 
completed questionnaires about costs was small, more research regarding the cost-utility of the 
intervention is needed. 
 
General discussion 
The results of our study add to the literature that eHealth interventions may be effective for PLWH 
with depressive symptoms. These results are in line with previous research, which found that eHealth 
interventions may decrease depression (15-20). Additionally, previous studies found that eHealth 
interventions for people with chronic somatic conditions, such as tinnitus, irritable bowel syndrome, 
chronic pain, and diabetes, may be effective in decreasing depressive symptoms (21). The between-
group effect sizes in our study were medium, and mostly larger than reported in previous studies (19, 
21). In addition, the results may be meaningful for clinical practice, as many participants in the 
intervention group showed clinically significant improvement in depressive symptoms, compared to 
the control group. 
Furthermore, it was found that the effects of the intervention were enduring. This is important, 
since many studies (see also chapter 2 of this dissertation) found positive effects of psychological 
interventions on the short term, that were not maintained on the long term (4). Hence, longer follow-
up measurements are necessary to investigate the effects of the intervention after six months. In 
addition, long term moderator effects may also be investigated. 
 Besides an effect on depressive symptoms, participants also showed a reduction in anxiety 
symptoms after following the intervention. The aim of the intervention was to reduce depressive 
symptoms, but some components may also have an effect on anxiety symptoms. For example, the 
assignments where participants identified and changed negative thoughts into more positive thoughts 
may also be used to change anxious thoughts, which is an effective strategy in CBT for anxiety (22, 23). 
It was previously found that interventions for depressive symptoms may also enhance quality of life 
(see also chapter 2 of this dissertation) (6) and medication adherence of PLWH (chapter 3) (8, 24). 
Consequently, following this intervention may contribute to an improved physical health, next to an 
improved mental health. 
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Implementation of the intervention 
The results of this thesis show that the online intervention may be effective, so we are ready to 
implement the intervention in routine care. Implementation of the intervention is important, but there 
are some challenges. Many effective eHealth interventions for people with mental health problems 
are not successfully implemented in routine care (25-27). Research regarding the implementation of 
eHealth interventions is scarce, compared to the many effectiveness trials that have been conducted 
(27, 28). Barriers in implementation are for example that health care professionals and patients have 
a lack of experience and confidence in eHealth interventions, and a lack of availability and 
appropriateness of resources such as personnel and funding to implement and deliver eHealth 
interventions (29, 30). Since we already have contact with almost all HIV treatment centers in the 
Netherlands, we will approach them for implementation. Some of the treatment centers already 
showed interest in implementation and almost all doctors and HIV nursing consultants are enthusiastic 
about our intervention. We assume that this will facilitate the implementation process. 
During implementation, the provider of the coaching is a topic of consideration. In the current 
study, coaches were Master students and graduates in clinical psychology. Master students and 
graduates may also be coaches when the intervention is implemented. However, coaching may also 
be provided by others, e.g. nursing consultants in HIV treatment centers. This may increase the 
scalability of the intervention. It was previously found that there was no difference in effectiveness 
between studies with experienced (e.g. psychologists) or less experienced (e.g. students) coaches (18, 
31). Though, it is important that the coaches are trained and supervised (32).  
 Two questions regarding our eHealth intervention that often arise are: 1) is it possible to use 
this intervention in people with depressive symptoms, but no HIV?; and 2) can PLWH also use a general 
eHealth CBT intervention for depressive symptoms? When answering these questions, it is important 
to note that our intervention was specifically designed for PLWH with depressive symptoms. Therefore, 
many examples are provided in the text and exercises that are related to living with HIV. In addition, 
we developed our intervention after preparatory studies to investigate the specific needs of PLWH 
with depressive symptoms and correlates of depressive symptoms in PLWH. Yet, PLWH may also use 
a general eHealth CBT intervention for depressive symptoms, but our intervention may be more 
adjusted to their needs and wishes. Regarding the use of this intervention in people without HIV, it is 
possible to adapt this intervention for use in people with depressive symptoms without HIV. Though, 
studies are necessary then to investigate the needs of the population and the correlates of depressive 
symptoms, after which the intervention can be adapted. 
 Participants in our study were asked to provide feedback on the intervention. Most 
participants were satisfied with the intervention, but they also had suggestions for improvement. For 
example, comments that were mentioned sometimes were that the intervention was too much 
 
 
focused on HIV, that there was too much text, and that the lesson concerning changing negative 
cognitions into more positive cognitions was difficult. Before implementation, we will adapt the 
intervention by taking into account these comments. People with low eHealth literacy - that have less 
abilities to seek, find, and understand digital health information and use this information to solve a 
health problem (33) - may help us to adapt the intervention and make it suitable for everyone. In 
addition, at the moment, our intervention is standardized and the same for each participant. In the 
future, the intervention may be individually tailored to the needs and wishes of participants. For 
example, some participants already used relaxation exercises. Hence, these participants may skip the 
lesson concerning relaxation exercises. It was previously found that tailored eHealth interventions for 
depression may be effective (34, 35). 
 
The importance of coaching 
The coaching in our study seemed to be important. The control group was put on a waiting list and 
received attention only from a coach. Depressive symptoms of participants in the control group 
improved, as was found in previous studies with attention only control conditions (36, 37). Several 
participants in the control group of our study valued the contact with the coach, as was also reflected 
in the high grades for the coaches. The fact that the coach called participants each week, listened to 
their stories, and kept an eye on them may lead to a decrease in depressive symptoms, as was also 
suggested by others (38-40). Participants in the intervention group indicated that they valued the 
support from the coach, it helped them to continue with the intervention, and they evaluated the 
coach as friendly and caring. In addition, coaches received high satisfaction grades of the participants.  
Previous meta-analyses have found that guided eHealth interventions showed larger effects 
than unguided interventions (16, 19, 20), and resulted in less attrition during the study (19, 31). 
However, in our study, it was not possible to determine the effectiveness of the intervention and the 
coaching separately, as they were provided together. To explore this, in future research the 
effectiveness of the following three active conditions compared to no treatment might be investigated: 
a condition that receives the eHealth intervention, a condition that receives coaching, and a condition 
that receives both. 
 
Decreasing drop-out in eHealth interventions 
The drop-out rate in our study was 19%. That means that almost one out of five participants did not 
complete the first post-test, which is comparable to other eHealth interventions (19, 21). In our 
previous study regarding the effectiveness of an unguided self-help booklet for PLWH with depressive 
symptoms, there was a drop-out of 40% (41). In the current study, coaching was added to decrease 
drop-out and this seemed to be effective, as drop-out decreased to 19%. In addition, in the meta-
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The results of this thesis show that the online intervention may be effective, so we are ready to 
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Netherlands, we will approach them for implementation. Some of the treatment centers already 
showed interest in implementation and almost all doctors and HIV nursing consultants are enthusiastic 
about our intervention. We assume that this will facilitate the implementation process. 
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analysis described in Chapter 2 on the effectiveness of (mostly face-to-face) psychosocial interventions 
on mental health of PLWH, the average drop-out was 18%. So, drop-out is also a problem in face-to-
face interventions. It was previously investigated which barriers may be experienced to continue with 
an eHealth intervention for people with depressive symptoms and risk factors for cardiovascular 
disease, and which motivating factors may influence adherence (42). It was found that barriers for 
persistence were not valuing the intervention as a benefit for self, forgetfulness, increasing distress 
from following the intervention, and completing the intervention was not experienced as a priority. 
Some of these factors were also mentioned by participants in our study. The most common reasons 
for drop-out were preference for face-to-face treatment, intervention did not fit needs, not enough 
time, intervention was too confronting, and depressive symptoms decreased. 
On the other hand, motivating factors that were previously found were perceived benefit for 
self and/or others, commitment to the researchers, and dependence on reminders (42). 
Recommendations to improve adherence to eHealth interventions may include optimizing intrinsic 
motivation and overcoming the barriers mentioned above. This can be done by educating users about 
the benefits of eHealth interventions in general and this intervention in particular. In addition, habit 
forming strategies may be imbedded in the intervention, such as planning when to work on the 
intervention. Reminders can be sent to increase adherence. Last, personal feedback on improvements 
may also benefit adherence to the intervention (42). Most of these recommendations were included 
in our study. An important aim of the coaching was to reduce drop-out. Therefore, coaches used 
motivational interviewing to motivate participants to continue with the intervention. In addition, 
coaches also discussed the planning of lessons with participants and reminders were sent. Last, 
coaches gave feedback on improvements during the intervention period. We can conclude that we 
incorporated many different strategies in our study to decrease drop-out. Still, drop-out cannot be 
prevented completely and more research is necessary on how to improve adherence to eHealth 
interventions for people with mental health problems.  
 
What is the best control condition? 
In our study we used an attention only waiting list control condition. There is much debate about which 
control conditions are most suitable in RCTs evaluating psychological interventions (43-46). In no 
treatment control conditions, participants do not expect to benefit over time and they may start 
looking for other treatments when they feel they need it. To the contrary, in waiting list control 
conditions participants wait until they can start with the intervention and in general do not look for 
other treatments. Therefore, studies with no treatment control conditions may find smaller effect sizes 
than studies with waiting list control conditions, because some participants in no treatment control 
conditions start with treatment during the study (45, 46). In our study, participants in the control group 
 
 
were free to start with treatment, and some also actually did that. Hence, the effect size in our study 
may be smaller than expected. 
All types of control conditions have advantages and disadvantages. It was previously argued 
that attention control conditions may not be useful in pragmatic behavioral trials, but usual care or 
another effective intervention may be more appropriate as a comparison condition (43). Attention 
may be difficult to provide without any content and therapeutic elements, so most of these attention 
control conditions are actually interventions. These ‘attention interventions’ may only exist in research 
and are not generally provided in clinical practice. However, the advantage of an attention control 
condition is that it may be useful for investigating possible mediators of intervention effect (47). In this 
way, it is possible to control for non-specific mediators. Studying mediation effects was a major aim of 
our study. In addition, when one uses an attention control condition, it is important to describe both 
the intervention and control procedures clearly in a manual, monitor the behavior of the therapists in 
both conditions, and provide equivalent supervision to the therapists in both conditions. These 
suggestions were all followed in our study. 
Usual care as control condition may also have disadvantages, it may not be adequately 
described at the start of the study what usual care is, for example (47). As a consequence, it is possible 
that usual care is provided differently between therapists or institutions. It can be concluded that each 
control condition has advantages and disadvantages. The choice of which control condition is suitable 
in an RCT depends among other things on the phase of the trial, the research question, and the 
available resources (45, 47). 
 
Strengths and limitations 
A strength of the meta-analyses in this dissertation is that a high statistical power was obtained, due 
to a large amount of included studies (62 and 43). Additionally, a variety of psychosocial interventions 
was included in the meta-analyses, and differences between intervention types were investigated. An 
important strength of the RCT in this dissertation is that PLWH throughout the Netherlands were 
included in the study. We had collaborations with almost all HIV treatment centers. Since there may 
be differences in the HIV population between regions, this large coverage increases the generalizability 
of the findings. Another strength is that we investigated many different characteristics of the 
intervention. Next to the effectiveness, also moderators, mediators, and the cost-effectiveness of the 
intervention have been studied. The moderator analysis indicated that the intervention may be 
effective for all participants, regardless of specific characteristics. When implementing the intervention, 
it is useful to know that it may be provided to all PLWH. Additionally, it is valuable that we found two 
mediators of the intervention effect, behavioral activation and goal reengagement. This may give us 
more information about possible working mechanisms of the intervention, which should be 
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prevented completely and more research is necessary on how to improve adherence to eHealth 
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looking for other treatments when they feel they need it. To the contrary, in waiting list control 
conditions participants wait until they can start with the intervention and in general do not look for 
other treatments. Therefore, studies with no treatment control conditions may find smaller effect sizes 
than studies with waiting list control conditions, because some participants in no treatment control 
conditions start with treatment during the study (45, 46). In our study, participants in the control group 
 
 
were free to start with treatment, and some also actually did that. Hence, the effect size in our study 
may be smaller than expected. 
All types of control conditions have advantages and disadvantages. It was previously argued 
that attention control conditions may not be useful in pragmatic behavioral trials, but usual care or 
another effective intervention may be more appropriate as a comparison condition (43). Attention 
may be difficult to provide without any content and therapeutic elements, so most of these attention 
control conditions are actually interventions. These ‘attention interventions’ may only exist in research 
and are not generally provided in clinical practice. However, the advantage of an attention control 
condition is that it may be useful for investigating possible mediators of intervention effect (47). In this 
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our study. In addition, when one uses an attention control condition, it is important to describe both 
the intervention and control procedures clearly in a manual, monitor the behavior of the therapists in 
both conditions, and provide equivalent supervision to the therapists in both conditions. These 
suggestions were all followed in our study. 
Usual care as control condition may also have disadvantages, it may not be adequately 
described at the start of the study what usual care is, for example (47). As a consequence, it is possible 
that usual care is provided differently between therapists or institutions. It can be concluded that each 
control condition has advantages and disadvantages. The choice of which control condition is suitable 
in an RCT depends among other things on the phase of the trial, the research question, and the 
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A strength of the meta-analyses in this dissertation is that a high statistical power was obtained, due 
to a large amount of included studies (62 and 43). Additionally, a variety of psychosocial interventions 
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it is useful to know that it may be provided to all PLWH. Additionally, it is valuable that we found two 
mediators of the intervention effect, behavioral activation and goal reengagement. This may give us 





investigated further. And from an economical perspective it is important that it is likely that the 
intervention is cost-effective compared to attention only, which may convince policy makers to include 
the intervention in health care policies. In addition, the program was available in Dutch and English, 
which allowed English speaking PLWH to participate in the study. The intervention can now be adapted 
for use in other countries, because it is already translated. Lastly, we used two outcome measures for 
depressive symptoms, the PHQ-9 and the CES-D. The intervention was found to be effective on both 
outcome measures, which increases the strength of our findings. 
 A limitation of the meta-analysis regarding the effectiveness of psychosocial interventions on 
mental health is that there was evidence of publication bias. Furthermore, the meta-analysis regarding 
the effectiveness of psychosocial interventions on medication adherence only investigated short-term 
effects. A limitation of the RCT is that we did not investigate the long-term effect of the intervention 
after six months. It is possible that the effect of the intervention on depressive symptoms decreases 
over time. The meta-analysis in Chapter 2 also found that the effects of psychosocial interventions 
diminished over time (follow-ups longer than nine months were included). Furthermore, a limitation 
is that there was a lot of missing data regarding costs, because only at a later stage we decided to study 
the cost-effectiveness. However, multiple imputation was used to impute missing data and an intent 
to treat analysis was conducted. In addition, only self-report measures were used in our study. Other 
measures such as interviews may provide more information about symptoms and the presence of a 
depressive disorder. On the other hand, interviews are also time consuming and we investigated the 
effect of the intervention on the severity of depressive symptoms and not on the presence of a 
depressive disorder. Last, PLWH with severe depressive symptoms and/or suicidal ideation were 
excluded from this study. In general, people with severe depressive symptoms are offered face-to-face 
treatment (48, 49). Yet, it was found previously that an online self-help intervention for depression 
and anxiety was especially effective for patients with high levels of baseline symptoms (50). 
 
Clinical implications 
In the meta-analyses in Chapter 2 and 3 we found that psychosocial interventions in general were 
effective in improving depression, anxiety, quality of life, psychological well-being, and medication 
adherence. Therefore, it is important that these interventions are incorporated in the healthcare for 
PLWH to improve their physical and mental health. 
The results of this dissertation show that the guided online self-help intervention ‘Living 
positive with HIV’ was effective in decreasing depressive symptoms. In addition, participants were 
generally satisfied with the intervention and the coaching. This indicates that the intervention may be 
implemented in routine mental healthcare in the Netherlands for PLWH with mild to moderate 
depressive symptoms. With eHealth interventions many PLWH can be reached, also PLWH that may 
 
 
not use face-to-face interventions. As eHealth interventions seem promising for PLWH with mental 
health problems and have certain benefits compared to face-to-face interventions, they may be more 
widely implemented. 
 A couple of participants indicated that the intervention did not fit their needs completely and 
that they preferred face-to-face treatment from a psychologist. Furthermore, the intervention was not 
effective for every participant, some participants showed (almost) no change in depressive symptoms. 
It is important to pay attention to the preferences of each patient and monitor progress during the 
intervention. When the personal needs are not completely met or when the intervention does not lead 
to sufficient progress, other treatment options should be offered (51, 52). 
 The findings of the moderator analysis indicate that (in theory) the intervention may be 
effective for all participants. This implicates that the intervention may be provided to all PLWH, 
regardless of certain demographic characteristics, HIV characteristics, or psychological characteristics. 
In addition, we found that behavioural activation and goal reengagement may be mediators of the 
intervention effect. In future research, mechanisms of change of the intervention may be investigated 
and the intervention may be optimized. Furthermore, we found that it is likely that the intervention 
was cost-effective compared to attention only. These findings may inform policy makers that decide 
which interventions will be included in health care policies. As our intervention seems to be effective 
against low costs, it may be included in health care policies. 
  
Recommendations for future research 
As HIV is very prevalent in other parts of the world, such as Africa, it is recommended to adapt the 
intervention to the local culture of these countries and investigate its effectiveness there (53). At the 
end of the study participants gave feedback on the intervention and the coaching. The intervention 
may be adapted according to this feedback. Thereafter, the intervention may be implemented and the 
effectiveness and the implementation may be investigated. The long-term effect of the intervention 
may also be studied. Additionally, the cost-effectiveness of the intervention compared to usual care 
may be examined in a larger sample. Since depressive symptoms may have an influence on adherence 
to ART and quality of life, it is interesting to investigate the effect of the intervention on these 
outcomes. Furthermore, the effect of the intervention may be compared to the effect of face-to-face 
CBT for PLWH. 
 In addition, more research may be conducted in specific subgroups, such as PLWH with more 
severe depressive symptoms and/or suicidal ideation. We did not include these patients in our study, 
but they may be included in a follow-up study with more intensive monitoring or coaching. Also, more 
studies may be conducted into deterioration after the intervention; which patients are most vulnerable 
for deterioration and how can it be prevented. 
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health problems and have certain benefits compared to face-to-face interventions, they may be more 
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 A couple of participants indicated that the intervention did not fit their needs completely and 
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may be adapted according to this feedback. Thereafter, the intervention may be implemented and the 
effectiveness and the implementation may be investigated. The long-term effect of the intervention 
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 In many HIV treatment centers in the Netherlands PLWH are not screened on mental health 
problems, so these problems often remain undetected and untreated (54). We recommend to 
compose and implement a screening instrument for prevalent mental health problems among PLWH 
such as depressive symptoms, anxiety symptoms, posttraumatic stress symptoms, and substance use 
(55). When mental health problems are detected, PLWH may be referred to effective interventions. 
The effect of this screening instrument may be studied in the future. 
 Last, the role of the coach on the effectiveness of the eHealth intervention and adherence may 
be investigated. Three conditions may be compared in such a study: the intervention with coaching, 
the intervention without coaching, and only coaching. 
 
Conclusion 
The results of the meta-analyses in this dissertation point to the effectiveness of psychosocial 
interventions to improve depressive symptoms, anxiety symptoms, quality of life, psychological well-
being, and medication adherence. The results of the RCT in this dissertation indicate that the eHealth 
intervention ‘Living positive with HIV’ was effective in decreasing depressive symptoms, compared to 
a control group that received attention only. It was also found that (in theory) the intervention may be 
effective for all PLWH, regardless of certain baseline characteristics. Especially PLWH with low coping 
self-efficacy may start with the intervention, as they do not improve with attention only. Furthermore, 
behavioral activation and goal reengagement were found to be mediators of the intervention effect. 
Also, the intervention is likely to be cost-effective compared to attention only. As eHealth interventions 
have certain benefits compared to face-to-face interventions, they may be more widely implemented 
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Summary and general discussion
 
 
 In many HIV treatment centers in the Netherlands PLWH are not screened on mental health 
problems, so these problems often remain undetected and untreated (54). We recommend to 
compose and implement a screening instrument for prevalent mental health problems among PLWH 
such as depressive symptoms, anxiety symptoms, posttraumatic stress symptoms, and substance use 
(55). When mental health problems are detected, PLWH may be referred to effective interventions. 
The effect of this screening instrument may be studied in the future. 
 Last, the role of the coach on the effectiveness of the eHealth intervention and adherence may 
be investigated. Three conditions may be compared in such a study: the intervention with coaching, 
the intervention without coaching, and only coaching. 
 
Conclusion 
The results of the meta-analyses in this dissertation point to the effectiveness of psychosocial 
interventions to improve depressive symptoms, anxiety symptoms, quality of life, psychological well-
being, and medication adherence. The results of the RCT in this dissertation indicate that the eHealth 
intervention ‘Living positive with HIV’ was effective in decreasing depressive symptoms, compared to 
a control group that received attention only. It was also found that (in theory) the intervention may be 
effective for all PLWH, regardless of certain baseline characteristics. Especially PLWH with low coping 
self-efficacy may start with the intervention, as they do not improve with attention only. Furthermore, 
behavioral activation and goal reengagement were found to be mediators of the intervention effect. 
Also, the intervention is likely to be cost-effective compared to attention only. As eHealth interventions 
have certain benefits compared to face-to-face interventions, they may be more widely implemented 
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Nederlandse samenvatting (Dutch summary) 
 
Hoofdstuk 1 is de inleiding van dit proefschrift. Depressieve klachten komen vaak voor bij mensen met 
hiv en hebben een grote impact op individuen en op de maatschappij. Psychologische interventies voor 
mensen met hiv en depressieve klachten werden in eerder onderzoek effectief bevonden. Vooral 
cognitieve gedragstherapie (CGT) blijkt effectief te zijn. Er is echter behoefte aan interventies waar 
men minder last heeft van stigma, die flexibeler zijn in tijd en plaats om de interventie te volgen, meer 
mensen kunnen bereiken en goedkoper zijn. eHealth interventies kunnen op deze behoeften inspelen 
en bleken in eerder onderzoek effectief te zijn bij mensen met depressieve klachten. Er is tot nu toe 
echter niet veel onderzoek gedaan naar eHealth bij mensen met hiv en depressieve klachten, terwijl 
dit een groep is die veel baat kan hebben bij eHealth interventies. Daarnaast zijn studies naar 
moderatoren en mediatoren van het effect van eHealth interventies schaars, evenals economische 
evaluaties van eHealth interventies. 
Een aantal jaren geleden is er een zelfhulpboek ontwikkeld voor mensen met hiv en depressieve 
klachten. Het zelfhulpboek is onderzocht en bleek effectief te zijn. Vervolgens is er een eHealth 
interventie ontwikkeld: ‘Positief leven met hiv’, gebaseerd op het zelfhulpboek. Het doel van dit 
proefschrift was om de effectiviteit te onderzoeken van ‘Positief leven met hiv’ op het verminderen 
van depressieve klachten. 
 
Hoofdstuk 2 bevat een systematische review en meta-analyse van de effectiviteit van psychosociale 
interventies voor mensen met hiv die als doel hebben om de mentale gezondheid te verbeteren. 
Verschillende kenmerken die de effectiviteit van interventies kunnen beïnvloeden werden onderzocht 
(bijvoorbeeld type behandelaar en duur van de interventie). Depressie, angst, kwaliteit van leven en 
psychisch welbevinden waren de uitkomstmaten in dit onderzoek. De meta-analyse bevatte 62 studies. 
Het bleek dat psychosociale interventies een klein positief effect hadden op de mentale gezondheid 
van mensen met hiv. We vonden bewijs voor publicatiebias; het effect was kleiner wanneer hiervoor 
werd gecorrigeerd. Er werden geen verschillen gevonden tussen diverse typen interventies, CGT kan 
bijvoorbeeld even effectief zijn als mindfulness bij het verbeteren van de mentale gezondheid. Er 
werden zes kenmerken gevonden die het effect van de interventie op depressie beïnvloedden. Studies 
met psychologen als behandelaars vonden bijvoorbeeld grotere effecten dan studies met andere 
behandelaars. Daarnaast zijn er grotere effecten gevonden in onderzoeken die alleen mensen met hiv 
en depressieve klachten hebben geïncludeerd, in vergelijking tot studies die alle mensen met hiv 
includeerden. In eerdere meta-analyses werden meestal kleine tot matig positieve effecten van 
psychosociale interventies op de mentale gezondheid van mensen met hiv gevonden. Deze verschillen 
 
 
in effectgroottes tussen deze meta-analyse en eerdere meta-analyses kunnen worden verklaard door 
de focus van de interventies. De meeste eerdere meta-analyses bevatten interventies met als 
belangrijkste focus het verbeteren van de mentale gezondheid. Deze meta-analyse was breder en 
omvatte ook studies met als secundaire uitkomstmaat mentale gezondheid, maar waar het verbeteren 
van de mentale gezondheid niet het voornaamste doel van de interventie was, maar bijvoorbeeld het 
verhogen van de therapietrouw. Zoals verwacht werden grotere effecten gevonden in deze meta-
analyse voor interventies met als belangrijkste focus het verbeteren van de mentale gezondheid. We 
kunnen concluderen dat psychosociale interventies van belang zijn voor mensen met hiv om hun 
mentale gezondheid te verbeteren, en adviseren om ze op te nemen in de gezondheidszorg. 
 
Hoofdstuk 3 bestaat uit een systematische review en meta-analyse gericht op de effectiviteit van 
psychosociale interventies ter verbetering van de medicatietrouw van antiretrovirale therapie (ART) 
bij mensen met hiv. In de meta-analyse werden 43 RCT’s opgenomen. De resultaten gaven aan dat 
psychosociale interventies een klein tot matig positief effect hadden op de medicatietrouw van 
mensen met hiv. Er was geen bewijs voor publicatiebias. Het bleek dat diverse interventietypen (b.v. 
CGT en sociale steun) effectief kunnen zijn voor diverse groepen mensen (b.v. risicogroep voor 
problemen met medicatietrouw en groep die al problemen heeft). De resultaten van dit onderzoek zijn 
in lijn met de meeste eerdere meta-analyses en reviews, die ook hebben aangetoond dat psychosociale 
interventies een positief effect kunnen hebben op de medicatietrouw van mensen met hiv. Het 
verbeteren van de medicatietrouw in deze groep is belangrijk, het kan hun gezondheid en de 
volksgezondheid bevorderen, omdat het transmissierisico vermindert. Daarom moet het gebruik van 
psychosociale interventies bij mensen met hiv die moeite hebben met medicatietrouw worden 
aangemoedigd. 
 
In Hoofdstuk 4 werd het studieprotocol voor de RCT beschreven met betrekking tot de effectiviteit 
van de eHealth interventie 'Positief leven met hiv'. De interventiegroep wordt vergeleken met een 
controlegroep die op een wachtlijst staat en wekelijks alleen een kort telefoontje krijgt van een coach. 
De online CGT interventie is gebaseerd op een zelfhulpboek dat in eerder onderzoek effectief bleek te 
zijn. Het boek is aangepast en omgezet in de online interventie die bestaat uit vier componenten: 
activering, ontspanning, het veranderen van negatieve gedachten en het werken aan doelen. 
Deelnemers werken ongeveer acht weken aan de interventie, één tot twee uur per week. Deelnemers 
in de interventiegroep krijgen ook ongeveer 15 minuten per week telefonische ondersteuning van een 
coach. Mensen met hiv en lichte tot matige depressieve klachten worden in het onderzoek 
geïncludeerd. De RCT omvat een pretest, drie metingen tijdens de interventie / wachtperiode en drie 




Nederlandse samenvatting (Dutch summary) 
 
Hoofdstuk 1 is de inleiding van dit proefschrift. Depressieve klachten komen vaak voor bij mensen met 
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in de interventiegroep krijgen ook ongeveer 15 minuten per week telefonische ondersteuning van een 
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geïncludeerd. De RCT omvat een pretest, drie metingen tijdens de interventie / wachtperiode en drie 





De effectiviteit van de begeleide eHealth interventie 'Positief leven met hiv' werd onderzocht in 
Hoofdstuk 5. Deelnemers waren 188 mensen met hiv en lichte tot matige depressieve klachten, 
waarvan er 97 random werden toegewezen aan de interventiegroep en 91 aan de controlegroep. We 
vonden dat de interventie effectief was in het verlagen van depressieve klachten op de korte en lange 
termijn (tot zes maanden na afronding), in vergelijking met de controlegroep die alleen aandacht kreeg. 
Bovendien was de interventie effectief in het verminderen van angstklachten, vergeleken met de 
controlegroep. Aanzienlijk meer deelnemers in de interventiegroep bereikten de criteria voor klinisch 
significante verandering in depressieve klachten dan in de controlegroep. Ten slotte werden de 
interventie en de coach positief beoordeeld door de deelnemers. In het verleden onderzochten slechts 
vier studies de effectiviteit van computer / internetinterventies voor mensen met hiv en depressieve 
klachten en drie ervan waren niet effectief. De beschreven resultaten in hoofdstuk 5 zijn in lijn met de 
grote hoeveelheid literatuur die aantoonde dat eHealth interventies effectief zijn voor mensen met 
(een chronische somatische ziekte en) depressieve klachten. Omdat eHealth interventies bepaalde 
voordelen hebben in vergelijking met face-to-face interventies en effectief bleken te zijn, kunnen ze in 
de toekomst vaker worden gebruikt voor mensen met hiv en depressieve klachten. 
 
In Hoofdstuk 6 werden moderatoren van verandering op de online interventie voor mensen met hiv 
en depressieve klachten onderzocht. Moderatoren zijn factoren die de effectiviteit van een 
behandeling beïnvloeden. Veel mogelijke moderatoren werden bestudeerd: demografische 
kenmerken (bijvoorbeeld geslacht), kenmerken gerelateerd aan hiv (bijvoorbeeld tijd sinds hiv 
diagnose) en psychologische kenmerken (bijvoorbeeld angstklachten). Er is één moderator van 
interventie effect gevonden: zelfvertrouwen in het omgaan met hiv. De resultaten lieten zien dat 
deelnemers met weinig vertrouwen in hun coping vaardigheden in de interventiegroep meer 
verbeterden dan in de controlegroep, en dat deelnemers met veel vertrouwen in hun coping 
vaardigheden in beide groepen evenveel verbeterden. Het doel van deze studie was om erachter te 
komen wie het meeste baat heeft bij de interventie. Er kan worden geconcludeerd dat de interventie 
effectief kan zijn voor alle mensen met hiv met lichte tot matige depressieve klachten, ongeacht 
bepaalde demografische kenmerken, hiv kenmerken of psychologische kenmerken. Het kan met name 
belangrijk zijn om mensen met hiv met weinig vertrouwen in hun coping vaardigheden te behandelen, 
omdat zij over het algemeen niet verbeteren met slechts minimale aandacht. Sommige deelnemers 
verbeterden echter niet na het volgen van de interventie. Dit was niet gerelateerd aan een van de 
onderzochte kenmerken. Het is echter belangrijk om in toekomstige studies te onderzoeken waarom 




In Hoofdstuk 7 werden de resultaten van de mediatie analyse gepresenteerd. Het doel was om 
variabelen te identificeren die wijzen naar mechanismen van verandering tijdens de interventie 
'Positief leven met hiv'. Mogelijke mediatoren die we hebben onderzocht waren componenten van de 
interventie: veranderingen in gedragsactivering, ontspanning, de cognitieve coping strategieën 
catastroferen en positieve heroriëntatie, doelen stellen en vertrouwen in eigen coping vaardigheden. 
Het bleek dat toenames in doelen stellen en gedragsactivering een belangrijke mediator waren voor 
het interventie effect. Het mediatie effect trad waarschijnlijk op tussen week 1 en 3 voor doelen stellen 
en tussen week 3 en 5 voor gedragsactivering. Het mediatie effect van gedragsactivering leek iets 
sterker dan dat van doelen stellen. De mediatoren die in deze studie werden gevonden, kunnen 
mogelijke mechanismen voor verandering van de interventie suggereren. Meer onderzoek is nodig om 
deze mogelijke mechanismen van verandering te vinden om een indicatie te krijgen van hoe de 
interventie werkt. Nadat deze onderzoeken zijn uitgevoerd, kan de interventie worden 
geoptimaliseerd en kunnen depressieve klachten van mensen met hiv nog beter worden verminderd. 
 
Hoofdstuk 8 bevat een kostenutiliteitsanalyse van de begeleide online interventie voor mensen met 
hiv en depressieve klachten, in vergelijking met alleen aandacht. Kwaliteit van leven werd gemeten als 
voor kwaliteit gecorrigeerde levensjaren gedurende zes maanden. De economische evaluatie werd 
uitgevoerd vanuit een maatschappelijk perspectief en omvatte interventiekosten, medische kosten en 
niet-medische kosten (bijvoorbeeld productiviteitsverlies) gedurende zes maanden. De resultaten 
toonden aan dat er geen significante verschillen waren tussen de groepen in voor kwaliteit 
gecorrigeerde levensjaren en medische en niet-medische kosten. We hebben vastgesteld dat het zeer 
waarschijnlijk is dat de online interventie kosteneffectief is in vergelijking met alleen aandacht. Dat wil 
zeggen dat de interventie de voorkeur heeft boven alleen aandacht om depressieve klachten bij 
mensen met hiv te verminderen. Deze bevindingen kunnen beleidsmakers informeren over welke 
interventies zouden kunnen worden opgenomen in het zorgaanbod. Omdat onze interventie effectief 
lijkt te zijn tegen lage kosten, zou deze kunnen worden opgenomen in het zorgaanbod. Aangezien het 
aantal mensen dat vragenlijsten over de kosten invulde klein was, is meer onderzoek nodig naar de 
kostenutiliteit van de interventie. 
 
Hoofdstuk 9 is de discussie van dit proefschrift. Hier worden de resultaten samengevat en sterktes en 
zwaktes van de studies besproken. Tevens worden de klinische implicaties van het proefschrift 
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Implementatie van de interventie 
De resultaten van dit proefschrift laten zien dat de begeleide online zelfhulpinterventie 'Positief leven 
met hiv' effectief was in het verminderen van depressieve klachten. Bovendien waren de deelnemers 
over het algemeen tevreden over de interventie en de coaching. Dit geeft aan dat de interventie kan 
worden geïmplementeerd in de reguliere geestelijke gezondheidszorg in Nederland voor mensen met 
hiv met lichte tot matige depressieve klachten. Met eHealth interventies kunnen veel mensen met hiv 
worden bereikt, ook mensen die geen gebruik maken van face-to-face interventies. eHealth 
interventies lijken veelbelovend voor mensen met hiv met psychische problemen en hebben bepaalde 
voordelen in vergelijking met face-to-face interventies, zoals meer flexibiliteit in tijd en plek om de 
interventie te volgen en lagere kosten. Om die reden kunnen ze op bredere schaal worden 
geïmplementeerd. 
Implementatie van ‘Positief leven met hiv’ is belangrijk, maar er zijn enkele uitdagingen. Veel 
effectieve eHealth interventies voor mensen met psychische problemen worden niet succesvol 
geïmplementeerd in de reguliere zorg. Onderzoek naar de implementatie van eHealth interventies is 
schaars, vergeleken met de vele effectiviteitsstudies die zijn uitgevoerd. Belemmeringen bij de 
uitvoering zijn bijvoorbeeld dat zorgprofessionals en patiënten een gebrek aan ervaring en vertrouwen 
hebben in eHealth interventies en een gebrek aan beschikbaarheid en geschiktheid van middelen zoals 
personeel en financiering om eHealth interventies te implementeren. Omdat we al contact hebben 
met bijna alle hiv behandelcentra in Nederland, zullen we ze benaderen voor implementatie. Sommige 
behandelcentra hebben al belangstelling getoond voor implementatie en bijna alle artsen en hiv 
consulenten zijn enthousiast over deze interventie. We nemen aan dat dit het implementatieproces 
zal vergemakkelijken. 
Een aantal deelnemers in onze studie gaf aan dat de interventie niet volledig aan hun 
behoeften voldeed en dat zij de voorkeur gaven aan een face-to-face behandeling door een psycholoog. 
Bovendien was de interventie niet effectief voor elke deelnemer, sommige deelnemers vertoonden 
(bijna) geen verandering in depressieve klachten. Het is belangrijk om aandacht te besteden aan de 
voorkeuren van de patiënt en de voortgang tijdens de interventie te bewaken. Wanneer niet aan de 
persoonlijke behoefte wordt voldaan of wanneer de interventie niet tot voldoende vooruitgang leidt, 
moeten andere behandelingen worden aangeboden. 
 
Toekomst 
Omdat hiv veel voorkomt in andere delen van de wereld, zoals Afrika, is het aan te bevelen om de 
interventie aan te passen aan de lokale cultuur van deze landen en daar de effectiviteit te onderzoeken. 
Verder gaven deelnemers aan het einde van de studie feedback over de interventie en de coaching. 
De interventie kan aan de hand van deze feedback worden aangepast. Omdat depressieve klachten 
 
 
invloed kunnen hebben op therapietrouw en kwaliteit van leven, is het interessant om het effect van 
de interventie op deze uitkomsten te onderzoeken. 
Bovendien kan meer onderzoek worden uitgevoerd in specifieke subgroepen, zoals mensen 
met hiv met ernstige depressieve klachten en/of zelfmoordgedachten. We hebben deze patiënten niet 
geïncludeerd in onze studie, maar ze kunnen worden geïncludeerd in een vervolgonderzoek met 
intensievere monitoring of coaching. 
In veel hiv behandelcentra in Nederland worden mensen met hiv niet gescreend op psychische 
problemen, dus deze problemen blijven vaak onopgemerkt en onbehandeld. We raden aan om een 
screeningsinstrument te ontwikkelen en implementeren voor veelvoorkomende mentale 
gezondheidsproblemen bij mensen met hiv, zoals depressieve symptomen, angstsymptomen, 
posttraumatische stresssymptomen en middelengebruik. Wanneer psychische problemen worden 
ontdekt, kunnen mensen met hiv worden verwezen naar effectieve interventies. Het effect van dit 
screeningsinstrument kan in de toekomst worden onderzocht. 
Ten slotte kan de rol van de coach op de effectiviteit van de eHealth interventie en 
therapietrouw worden onderzocht. Drie condities kunnen in een dergelijke studie worden vergeleken: 
de interventie met coaching, de interventie zonder coaching en alleen coaching. 
 
Conclusie 
De resultaten van dit proefschrift wijzen erop dat (online) psychologische interventies effectief kunnen 
zijn voor mensen met hiv en depressieve klachten. De online interventie ‘Positief leven met hiv’ is klaar 
voor implementatie. Online interventies zijn veelbelovend in de (geestelijke) gezondheidszorg en 
zouden meer ingezet kunnen worden in de psychologische zorg voor mensen met hiv om ervoor te 
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En dan nu het hoofdstuk dat iedereen altijd als eerste leest: het dankwoord. Ik grijp dan ook graag de  
gelegenheid aan om alle mensen te bedanken die betrokken zijn geweest bij het tot stand komen van 
dit proefschrift. 
 
Allereerst alle deelnemers aan het onderzoek: ontzettend bedankt. Zonder jullie was dit proefschrift 
er niet geweest. 
Mijn promotor Philip: wat heb ik veel van jou geleerd. Ik vind jou altijd heel wijs en je hebt me vele 
goede adviezen gegeven. Je hebt soms net een andere kijk op zaken, waardoor het even allemaal 
anders wordt, maar uiteindelijk wel beter. 
Mijn co-promotor Nadia: ik vind het heel waardevol dat jij in de praktijk werkt als psycholoog, naast je 
baan op de Universiteit. Dat neem je altijd mee in het onderzoek, maar ook in persoonlijke gesprekken 
die we hebben gehad. Je hebt me vaak geholpen om anders om te gaan met tegenslagen, dat was erg 
fijn. 
Mijn co-promotor Vivian: wat ben je altijd betrokken bij het onderzoek, het onderwijs en bij mij. Heel 
fijn dat we goed samen konden sparren over hoe we dingen aan gingen pakken in het onderzoek. En 
natuurlijk Kaapstad: dat was geweldig leuk en gezellig, samen met Boitumelo en Ellen. We vergaten 
bijna dat we ook nog op congres waren. 
 
Hiv-behandelcentra: bedankt allemaal voor het screenen van zoveel hiv-patiënten. Meer dan 3600 in 
totaal, wow! 
Coaches: jullie hebben alle deelnemers gecoacht tijdens het volgen van het programma of in de 
wachtperiode. De deelnemers waren heel blij met jullie: dank hiervoor. 
De methodologen: Elise, Tom en Elske: jullie weten echt alles van statistiek en analyses. Jullie konden 
dit zo aan me uitleggen dat ik het ook echt snapte. 
Studenten: o.a. Pascalle, Anne, Daan, en Dennis: bedankt voor jullie hulp bij het screenen van 
patiënten, het invoeren van data en het werken aan de meta-analyses. 
De leden van de lees- en oppositiecommissie: Prof. dr. de Rooij, Prof. dr. van der Does, Prof. dr. 
Chavannes, Prof. dr. Evers, Prof. dr. Riper en Prof. dr. de Wit: bedankt voor het lezen van mijn 
proefschrift en/of het opponeren tijdens mijn promotie. 
 
De afdeling Klinische Psychologie en in het bijzonder mijn (oud) mede-aio’s: Charlotte, Lisa, Maartje, 
Boitumelo, Dianne, Loes, Mirjam, Lisanne, Marie-Louise, Danielle, Myrthe, Angelos, Margit, Melanie, 
 
 
Anke, Yvette, Sylvia, Kaya en Stefanie. Het was heel fijn om met jullie alle promotie ups en downs te 
delen. Dank voor de vele goede gesprekken en adviezen. Stefanie: bedankt voor het ontwerpen van 
mijn kaft. 
Mijn collega’s in het LUMC: o.a. Eline, Jiska, Rianne, Marise en Cynthia: jullie interesse in mij en in mijn 
proefschrift is al vanaf het begin heel groot geweest. Fijn dat ik bij jullie terecht kon met proefschrift 
en postdoc issues. 
Het vd Werff borrelgroepje: o.a. Charlie, Bernadet en Roy: dank voor de vele leuke, gekke en gezellige 
momenten. Met jullie dacht ik niet aan werk, maar was er alleen maar lol. 
 
Mijn paranimfen: Dana en Andreas. Dana, ik kan altijd terecht bij jou met vragen over van alles. Jij 
zorgde voor de nodige afleiding door alle borrels en etentjes en andere gekkigheid. Je doet echt alles 
voor iedereen en we kunnen heel goed samen lachen . Andreas, mijn promotietijd was niet hetzelfde 
geweest zonder jou. Wij zaten samen op een kamer en hebben het hele traject samen beleefd. Je hebt 
me geholpen, b.v. met het maken van mooie grafieken, maar we hebben ook heel veel lol gehad. Ik 
mis je, nu je in het verre België zit. 
Sandy: jij bent eigenlijk mijn derde paranimf ;). Ik ben heel blij dat je mijn collega en vriendin bent 
geworden. Je hebt me vele nuttige adviezen gegeven op werk en persoonlijk gebied. Alle uitjes met 
jou zijn een feest. 
 
Mijn lieve vriendinnen: Audrey, Diana, Marlies, Brenda, Sharon, Emmely, Jaqueline en Iris: we hebben 
alleen maar leuke dingen gedaan de afgelopen jaren die niks met werk te maken hadden. Jullie kennen 
mij heel goed en hebben voor veel mooie momenten gezorgd. 
 
Mijn familie: Martijn, Dewi, Wassili, Noah, Anne, Julia, Kelvin, Joey en Malou: de warme band die wij 
hebben is heel belangrijk voor mij. Ik geniet ervan om samen met jullie te zijn en leuke dingen te doen. 
 
Mijn ouders: Mam, Gianni, pap en Jolan: jullie zijn er altijd voor me en geloven altijd in mij. En jullie 
voorzien in dé belangrijke behoeftes: lekker eten en wijn . Ik voel dat jullie trots op me zijn en dat 






En dan nu het hoofdstuk dat iedereen altijd als eerste leest: het dankwoord. Ik grijp dan ook graag de  
gelegenheid aan om alle mensen te bedanken die betrokken zijn geweest bij het tot stand komen van 
dit proefschrift. 
 
Allereerst alle deelnemers aan het onderzoek: ontzettend bedankt. Zonder jullie was dit proefschrift 
er niet geweest. 
Mijn promotor Philip: wat heb ik veel van jou geleerd. Ik vind jou altijd heel wijs en je hebt me vele 
goede adviezen gegeven. Je hebt soms net een andere kijk op zaken, waardoor het even allemaal 
anders wordt, maar uiteindelijk wel beter. 
Mijn co-promotor Nadia: ik vind het heel waardevol dat jij in de praktijk werkt als psycholoog, naast je 
baan op de Universiteit. Dat neem je altijd mee in het onderzoek, maar ook in persoonlijke gesprekken 
die we hebben gehad. Je hebt me vaak geholpen om anders om te gaan met tegenslagen, dat was erg 
fijn. 
Mijn co-promotor Vivian: wat ben je altijd betrokken bij het onderzoek, het onderwijs en bij mij. Heel 
fijn dat we goed samen konden sparren over hoe we dingen aan gingen pakken in het onderzoek. En 
natuurlijk Kaapstad: dat was geweldig leuk en gezellig, samen met Boitumelo en Ellen. We vergaten 
bijna dat we ook nog op congres waren. 
 
Hiv-behandelcentra: bedankt allemaal voor het screenen van zoveel hiv-patiënten. Meer dan 3600 in 
totaal, wow! 
Coaches: jullie hebben alle deelnemers gecoacht tijdens het volgen van het programma of in de 
wachtperiode. De deelnemers waren heel blij met jullie: dank hiervoor. 
De methodologen: Elise, Tom en Elske: jullie weten echt alles van statistiek en analyses. Jullie konden 
dit zo aan me uitleggen dat ik het ook echt snapte. 
Studenten: o.a. Pascalle, Anne, Daan, en Dennis: bedankt voor jullie hulp bij het screenen van 
patiënten, het invoeren van data en het werken aan de meta-analyses. 
De leden van de lees- en oppositiecommissie: Prof. dr. de Rooij, Prof. dr. van der Does, Prof. dr. 
Chavannes, Prof. dr. Evers, Prof. dr. Riper en Prof. dr. de Wit: bedankt voor het lezen van mijn 
proefschrift en/of het opponeren tijdens mijn promotie. 
 
De afdeling Klinische Psychologie en in het bijzonder mijn (oud) mede-aio’s: Charlotte, Lisa, Maartje, 
Boitumelo, Dianne, Loes, Mirjam, Lisanne, Marie-Louise, Danielle, Myrthe, Angelos, Margit, Melanie, 
 
 
Anke, Yvette, Sylvia, Kaya en Stefanie. Het was heel fijn om met jullie alle promotie ups en downs te 
delen. Dank voor de vele goede gesprekken en adviezen. Stefanie: bedankt voor het ontwerpen van 
mijn kaft. 
Mijn collega’s in het LUMC: o.a. Eline, Jiska, Rianne, Marise en Cynthia: jullie interesse in mij en in mijn 
proefschrift is al vanaf het begin heel groot geweest. Fijn dat ik bij jullie terecht kon met proefschrift 
en postdoc issues. 
Het vd Werff borrelgroepje: o.a. Charlie, Bernadet en Roy: dank voor de vele leuke, gekke en gezellige 
momenten. Met jullie dacht ik niet aan werk, maar was er alleen maar lol. 
 
Mijn paranimfen: Dana en Andreas. Dana, ik kan altijd terecht bij jou met vragen over van alles. Jij 
zorgde voor de nodige afleiding door alle borrels en etentjes en andere gekkigheid. Je doet echt alles 
voor iedereen en we kunnen heel goed samen lachen . Andreas, mijn promotietijd was niet hetzelfde 
geweest zonder jou. Wij zaten samen op een kamer en hebben het hele traject samen beleefd. Je hebt 
me geholpen, b.v. met het maken van mooie grafieken, maar we hebben ook heel veel lol gehad. Ik 
mis je, nu je in het verre België zit. 
Sandy: jij bent eigenlijk mijn derde paranimf ;). Ik ben heel blij dat je mijn collega en vriendin bent 
geworden. Je hebt me vele nuttige adviezen gegeven op werk en persoonlijk gebied. Alle uitjes met 
jou zijn een feest. 
 
Mijn lieve vriendinnen: Audrey, Diana, Marlies, Brenda, Sharon, Emmely, Jaqueline en Iris: we hebben 
alleen maar leuke dingen gedaan de afgelopen jaren die niks met werk te maken hadden. Jullie kennen 
mij heel goed en hebben voor veel mooie momenten gezorgd. 
 
Mijn familie: Martijn, Dewi, Wassili, Noah, Anne, Julia, Kelvin, Joey en Malou: de warme band die wij 
hebben is heel belangrijk voor mij. Ik geniet ervan om samen met jullie te zijn en leuke dingen te doen. 
 
Mijn ouders: Mam, Gianni, pap en Jolan: jullie zijn er altijd voor me en geloven altijd in mij. En jullie 
voorzien in dé belangrijke behoeftes: lekker eten en wijn . Ik voel dat jullie trots op me zijn en dat 














Woensdag 26 juni 2019
11.15 uur
Groot Auditorium
Academiegebouw
Universiteit Leiden
Rapenburg 73
 
Receptie na afloop
 
Paranimfen
Dana van Son
Andreas Burger
Paranimf.sanne@gmail.com
